id	sid	tid	token	lemma	pos
cord-299560-np6nfvf2	1	1	key	key	NN
cord-299560-np6nfvf2	1	2	:	:	:
cord-299560-np6nfvf2	2	1	cord-299560-np6nfvf2	cord-299560-np6nfvf2	NNP
cord-299560-np6nfvf2	2	2	authors	author	NNS
cord-299560-np6nfvf2	2	3	:	:	:
cord-299560-np6nfvf2	2	4	Hendaus	Hendaus	NNP
cord-299560-np6nfvf2	2	5	,	,	,
cord-299560-np6nfvf2	2	6	Mohamed	Mohamed	NNP
cord-299560-np6nfvf2	2	7	A.	a.	NN
cord-299560-np6nfvf2	2	8	title	title	NN
cord-299560-np6nfvf2	2	9	:	:	:
cord-299560-np6nfvf2	2	10	Remdesivir	Remdesivir	NNP
cord-299560-np6nfvf2	2	11	in	in	IN
cord-299560-np6nfvf2	2	12	the	the	DT
cord-299560-np6nfvf2	2	13	treatment	treatment	NN
cord-299560-np6nfvf2	2	14	of	of	IN
cord-299560-np6nfvf2	2	15	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	2	16	disease	disease	NN
cord-299560-np6nfvf2	2	17	2019	2019	CD
cord-299560-np6nfvf2	2	18	(	(	-LRB-
cord-299560-np6nfvf2	2	19	COVID-19	COVID-19	NNP
cord-299560-np6nfvf2	2	20	)	)	-RRB-
cord-299560-np6nfvf2	2	21	:	:	:
cord-299560-np6nfvf2	2	22	a	a	DT
cord-299560-np6nfvf2	2	23	simplified	simplified	JJ
cord-299560-np6nfvf2	2	24	summary	summary	NN
cord-299560-np6nfvf2	2	25	date	date	NN
cord-299560-np6nfvf2	2	26	:	:	:
cord-299560-np6nfvf2	2	27	2020	2020	CD
cord-299560-np6nfvf2	2	28	-	-	HYPH
cord-299560-np6nfvf2	2	29	05	05	CD
cord-299560-np6nfvf2	2	30	-	-	HYPH
cord-299560-np6nfvf2	2	31	20	20	CD
cord-299560-np6nfvf2	2	32	journal	journal	NN
cord-299560-np6nfvf2	2	33	:	:	:
cord-299560-np6nfvf2	2	34	J	J	NNP
cord-299560-np6nfvf2	2	35	Biomol	Biomol	NNP
cord-299560-np6nfvf2	2	36	Struct	Struct	NNP
cord-299560-np6nfvf2	2	37	Dyn	Dyn	NNP
cord-299560-np6nfvf2	2	38	DOI	doi	NN
cord-299560-np6nfvf2	2	39	:	:	:
cord-299560-np6nfvf2	2	40	10.1080/07391102.2020.1767691	10.1080/07391102.2020.1767691	NN
cord-299560-np6nfvf2	2	41	sha	sha	NN
cord-299560-np6nfvf2	2	42	:	:	:
cord-299560-np6nfvf2	2	43	5b4c58a72735267d2c9e1da133c35c8d885a917b	5b4c58a72735267d2c9e1da133c35c8d885a917b	CD
cord-299560-np6nfvf2	2	44	doc_id	doc_id	CD
cord-299560-np6nfvf2	2	45	:	:	:
cord-299560-np6nfvf2	2	46	299560	299560	CD
cord-299560-np6nfvf2	2	47	cord_uid	cord_uid	NNS
cord-299560-np6nfvf2	2	48	:	:	:
cord-299560-np6nfvf2	3	1	np6nfvf2	np6nfvf2	NNP
cord-299560-np6nfvf2	4	1	The	the	DT
cord-299560-np6nfvf2	4	2	pandemic	pandemic	NN
cord-299560-np6nfvf2	4	3	of	of	IN
cord-299560-np6nfvf2	4	4	COVID-19	COVID-19	NNP
cord-299560-np6nfvf2	4	5	(	(	-LRB-
cord-299560-np6nfvf2	4	6	Coronavirus	Coronavirus	NNP
cord-299560-np6nfvf2	4	7	Disease-2019	Disease-2019	NNP
cord-299560-np6nfvf2	4	8	)	)	-RRB-
cord-299560-np6nfvf2	4	9	is	be	VBZ
cord-299560-np6nfvf2	4	10	an	an	DT
cord-299560-np6nfvf2	4	11	extremely	extremely	RB
cord-299560-np6nfvf2	4	12	contagious	contagious	JJ
cord-299560-np6nfvf2	4	13	respiratory	respiratory	JJ
cord-299560-np6nfvf2	4	14	illness	illness	NN
cord-299560-np6nfvf2	4	15	due	due	IN
cord-299560-np6nfvf2	4	16	to	to	IN
cord-299560-np6nfvf2	4	17	a	a	DT
cord-299560-np6nfvf2	4	18	novel	novel	JJ
cord-299560-np6nfvf2	4	19	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	4	20	,	,	,
cord-299560-np6nfvf2	4	21	SARS	SARS	NNP
cord-299560-np6nfvf2	4	22	-	-	HYPH
cord-299560-np6nfvf2	4	23	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	4	24	.	.	.
cord-299560-np6nfvf2	5	1	Certain	certain	JJ
cord-299560-np6nfvf2	5	2	drugs	drug	NNS
cord-299560-np6nfvf2	5	3	have	have	VBP
cord-299560-np6nfvf2	5	4	several	several	JJ
cord-299560-np6nfvf2	5	5	protein	protein	NN
cord-299560-np6nfvf2	5	6	targets	target	NNS
cord-299560-np6nfvf2	5	7	and	and	CC
cord-299560-np6nfvf2	5	8	many	many	JJ
cord-299560-np6nfvf2	5	9	illnesses	illness	NNS
cord-299560-np6nfvf2	5	10	share	share	VBP
cord-299560-np6nfvf2	5	11	overlapping	overlap	VBG
cord-299560-np6nfvf2	5	12	molecular	molecular	JJ
cord-299560-np6nfvf2	5	13	paths	path	NNS
cord-299560-np6nfvf2	5	14	.	.	.
cord-299560-np6nfvf2	6	1	In	in	IN
cord-299560-np6nfvf2	6	2	such	such	JJ
cord-299560-np6nfvf2	6	3	cases	case	NNS
cord-299560-np6nfvf2	6	4	,	,	,
cord-299560-np6nfvf2	6	5	reusing	reuse	VBG
cord-299560-np6nfvf2	6	6	drugs	drug	NNS
cord-299560-np6nfvf2	6	7	for	for	IN
cord-299560-np6nfvf2	6	8	more	more	JJR
cord-299560-np6nfvf2	6	9	than	than	IN
cord-299560-np6nfvf2	6	10	one	one	CD
cord-299560-np6nfvf2	6	11	objective	objective	NN
cord-299560-np6nfvf2	6	12	and	and	CC
cord-299560-np6nfvf2	6	13	finding	find	VBG
cord-299560-np6nfvf2	6	14	their	-PRON-	PRP$
cord-299560-np6nfvf2	6	15	novice	novice	NN
cord-299560-np6nfvf2	6	16	uses	use	NNS
cord-299560-np6nfvf2	6	17	can	can	MD
cord-299560-np6nfvf2	6	18	considerably	considerably	RB
cord-299560-np6nfvf2	6	19	decrease	decrease	VB
cord-299560-np6nfvf2	6	20	the	the	DT
cord-299560-np6nfvf2	6	21	time	time	NN
cord-299560-np6nfvf2	6	22	in	in	IN
cord-299560-np6nfvf2	6	23	finding	find	VBG
cord-299560-np6nfvf2	6	24	new	new	JJ
cord-299560-np6nfvf2	6	25	cures	cure	NNS
cord-299560-np6nfvf2	6	26	for	for	IN
cord-299560-np6nfvf2	6	27	unforeseen	unforeseen	JJ
cord-299560-np6nfvf2	6	28	diseases	disease	NNS
cord-299560-np6nfvf2	6	29	.	.	.
cord-299560-np6nfvf2	7	1	Remdesivir	Remdesivir	NNP
cord-299560-np6nfvf2	7	2	has	have	VBZ
cord-299560-np6nfvf2	7	3	been	be	VBN
cord-299560-np6nfvf2	7	4	recently	recently	RB
cord-299560-np6nfvf2	7	5	a	a	DT
cord-299560-np6nfvf2	7	6	strong	strong	JJ
cord-299560-np6nfvf2	7	7	candidate	candidate	NN
cord-299560-np6nfvf2	7	8	for	for	IN
cord-299560-np6nfvf2	7	9	the	the	DT
cord-299560-np6nfvf2	7	10	treatment	treatment	NN
cord-299560-np6nfvf2	7	11	of	of	IN
cord-299560-np6nfvf2	7	12	Covid-19	covid-19	NN
cord-299560-np6nfvf2	7	13	.	.	.
cord-299560-np6nfvf2	8	1	In	in	IN
cord-299560-np6nfvf2	8	2	this	this	DT
cord-299560-np6nfvf2	8	3	commentary	commentary	NN
cord-299560-np6nfvf2	8	4	,	,	,
cord-299560-np6nfvf2	8	5	we	-PRON-	PRP
cord-299560-np6nfvf2	8	6	have	have	VBP
cord-299560-np6nfvf2	8	7	portrayed	portray	VBN
cord-299560-np6nfvf2	8	8	the	the	DT
cord-299560-np6nfvf2	8	9	structure	structure	NN
cord-299560-np6nfvf2	8	10	of	of	IN
cord-299560-np6nfvf2	8	11	the	the	DT
cord-299560-np6nfvf2	8	12	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	8	13	in	in	IN
cord-299560-np6nfvf2	8	14	a	a	DT
cord-299560-np6nfvf2	8	15	simple	simple	JJ
cord-299560-np6nfvf2	8	16	way	way	NN
cord-299560-np6nfvf2	8	17	as	as	RB
cord-299560-np6nfvf2	8	18	well	well	RB
cord-299560-np6nfvf2	8	19	as	as	IN
cord-299560-np6nfvf2	8	20	the	the	DT
cord-299560-np6nfvf2	8	21	site	site	NN
cord-299560-np6nfvf2	8	22	where	where	WRB
cord-299560-np6nfvf2	8	23	remdesivir	remdesivir	NNP
cord-299560-np6nfvf2	8	24	acts	act	VBZ
cord-299560-np6nfvf2	8	25	.	.	.
cord-299560-np6nfvf2	9	1	We	-PRON-	PRP
cord-299560-np6nfvf2	9	2	have	have	VBP
cord-299560-np6nfvf2	9	3	also	also	RB
cord-299560-np6nfvf2	9	4	displayed	display	VBN
cord-299560-np6nfvf2	9	5	the	the	DT
cord-299560-np6nfvf2	9	6	ongoing	ongoing	JJ
cord-299560-np6nfvf2	9	7	clinical	clinical	JJ
cord-299560-np6nfvf2	9	8	trials	trial	NNS
cord-299560-np6nfvf2	9	9	,	,	,
cord-299560-np6nfvf2	9	10	as	as	RB
cord-299560-np6nfvf2	9	11	well	well	RB
cord-299560-np6nfvf2	9	12	as	as	IN
cord-299560-np6nfvf2	9	13	a	a	DT
cord-299560-np6nfvf2	9	14	published	publish	VBN
cord-299560-np6nfvf2	9	15	study	study	NN
cord-299560-np6nfvf2	9	16	that	that	WDT
cord-299560-np6nfvf2	9	17	was	be	VBD
cord-299560-np6nfvf2	9	18	conducted	conduct	VBN
cord-299560-np6nfvf2	9	19	on	on	IN
cord-299560-np6nfvf2	9	20	compassionate	compassionate	JJ
cord-299560-np6nfvf2	9	21	base	base	NN
cord-299560-np6nfvf2	9	22	.	.	.
cord-299560-np6nfvf2	10	1	The	the	DT
cord-299560-np6nfvf2	10	2	covid-19	covid-19	CD
cord-299560-np6nfvf2	10	3	pandemic	pandemic	NN
cord-299560-np6nfvf2	10	4	might	may	MD
cord-299560-np6nfvf2	10	5	wean	wean	VB
cord-299560-np6nfvf2	10	6	down	down	RP
cord-299560-np6nfvf2	10	7	by	by	IN
cord-299560-np6nfvf2	10	8	the	the	DT
cord-299560-np6nfvf2	10	9	end	end	NN
cord-299560-np6nfvf2	10	10	of	of	IN
cord-299560-np6nfvf2	10	11	summer	summer	NN
cord-299560-np6nfvf2	10	12	2020	2020	CD
cord-299560-np6nfvf2	10	13	,	,	,
cord-299560-np6nfvf2	10	14	but	but	CC
cord-299560-np6nfvf2	10	15	the	the	DT
cord-299560-np6nfvf2	10	16	risk	risk	NN
cord-299560-np6nfvf2	10	17	of	of	IN
cord-299560-np6nfvf2	10	18	seasonality	seasonality	NN
cord-299560-np6nfvf2	10	19	exists	exist	VBZ
cord-299560-np6nfvf2	10	20	.	.	.
cord-299560-np6nfvf2	11	1	Therefore	therefore	RB
cord-299560-np6nfvf2	11	2	,	,	,
cord-299560-np6nfvf2	11	3	future	future	JJ
cord-299560-np6nfvf2	11	4	disposal	disposal	NN
cord-299560-np6nfvf2	11	5	of	of	IN
cord-299560-np6nfvf2	11	6	agents	agent	NNS
cord-299560-np6nfvf2	11	7	such	such	JJ
cord-299560-np6nfvf2	11	8	as	as	IN
cord-299560-np6nfvf2	11	9	remdesivir	remdesivir	NNP
cord-299560-np6nfvf2	11	10	might	may	MD
cord-299560-np6nfvf2	11	11	be	be	VB
cord-299560-np6nfvf2	11	12	crucial	crucial	JJ
cord-299560-np6nfvf2	11	13	for	for	IN
cord-299560-np6nfvf2	11	14	ensuring	ensure	VBG
cord-299560-np6nfvf2	11	15	an	an	DT
cord-299560-np6nfvf2	11	16	efficient	efficient	JJ
cord-299560-np6nfvf2	11	17	treatment	treatment	NN
cord-299560-np6nfvf2	11	18	,	,	,
cord-299560-np6nfvf2	11	19	decrease	decrease	VB
cord-299560-np6nfvf2	11	20	mortality	mortality	NN
cord-299560-np6nfvf2	11	21	and	and	CC
cord-299560-np6nfvf2	11	22	allow	allow	VB
cord-299560-np6nfvf2	11	23	early	early	JJ
cord-299560-np6nfvf2	11	24	discharge	discharge	NN
cord-299560-np6nfvf2	11	25	.	.	.
cord-299560-np6nfvf2	12	1	Communicated	communicate	VBN
cord-299560-np6nfvf2	12	2	by	by	IN
cord-299560-np6nfvf2	12	3	Ramaswamy	Ramaswamy	NNP
cord-299560-np6nfvf2	12	4	H.	H.	NNP
cord-299560-np6nfvf2	12	5	Sarma	Sarma	NNP
cord-299560-np6nfvf2	13	1	The	the	DT
cord-299560-np6nfvf2	13	2	pandemic	pandemic	NN
cord-299560-np6nfvf2	13	3	of	of	IN
cord-299560-np6nfvf2	13	4	COVID-19	COVID-19	NNP
cord-299560-np6nfvf2	13	5	(	(	-LRB-
cord-299560-np6nfvf2	13	6	Coronavirus	Coronavirus	NNP
cord-299560-np6nfvf2	13	7	Disease-2019	Disease-2019	NNP
cord-299560-np6nfvf2	13	8	)	)	-RRB-
cord-299560-np6nfvf2	13	9	is	be	VBZ
cord-299560-np6nfvf2	13	10	an	an	DT
cord-299560-np6nfvf2	13	11	extremely	extremely	RB
cord-299560-np6nfvf2	13	12	contagious	contagious	JJ
cord-299560-np6nfvf2	13	13	respiratory	respiratory	JJ
cord-299560-np6nfvf2	13	14	illness	illness	NN
cord-299560-np6nfvf2	14	1	(	(	-LRB-
cord-299560-np6nfvf2	14	2	Elmezayen	Elmezayen	NNP
cord-299560-np6nfvf2	14	3	et	et	FW
cord-299560-np6nfvf2	14	4	al	al	NNP
cord-299560-np6nfvf2	14	5	.	.	.
cord-299560-np6nfvf2	15	1	,	,	,
cord-299560-np6nfvf2	15	2	2020	2020	CD
cord-299560-np6nfvf2	15	3	;	;	:
cord-299560-np6nfvf2	15	4	Sarma	Sarma	NNP
cord-299560-np6nfvf2	15	5	et	et	NNP
cord-299560-np6nfvf2	15	6	al	al	NNP
cord-299560-np6nfvf2	15	7	.	.	NNP
cord-299560-np6nfvf2	15	8	,	,	,
cord-299560-np6nfvf2	15	9	2020	2020	CD
cord-299560-np6nfvf2	15	10	)	)	-RRB-
cord-299560-np6nfvf2	15	11	.	.	.
cord-299560-np6nfvf2	16	1	Globally	globally	RB
cord-299560-np6nfvf2	16	2	,	,	,
cord-299560-np6nfvf2	16	3	scientists	scientist	NNS
cord-299560-np6nfvf2	16	4	are	be	VBP
cord-299560-np6nfvf2	16	5	attempting	attempt	VBG
cord-299560-np6nfvf2	16	6	to	to	TO
cord-299560-np6nfvf2	16	7	study	study	VB
cord-299560-np6nfvf2	16	8	this	this	DT
cord-299560-np6nfvf2	16	9	novel	novel	JJ
cord-299560-np6nfvf2	16	10	virus	virus	NN
cord-299560-np6nfvf2	16	11	,	,	,
cord-299560-np6nfvf2	16	12	and	and	CC
cord-299560-np6nfvf2	16	13	to	to	TO
cord-299560-np6nfvf2	16	14	discover	discover	VB
cord-299560-np6nfvf2	16	15	efficient	efficient	JJ
cord-299560-np6nfvf2	16	16	management	management	NN
cord-299560-np6nfvf2	16	17	to	to	TO
cord-299560-np6nfvf2	16	18	control	control	VB
cord-299560-np6nfvf2	16	19	and	and	CC
cord-299560-np6nfvf2	16	20	prevent	prevent	VB
cord-299560-np6nfvf2	16	21	the	the	DT
cord-299560-np6nfvf2	16	22	illness	illness	NN
cord-299560-np6nfvf2	17	1	(	(	-LRB-
cord-299560-np6nfvf2	17	2	Enayatkhani	Enayatkhani	NNP
cord-299560-np6nfvf2	17	3	et	et	NNP
cord-299560-np6nfvf2	17	4	al	al	NNP
cord-299560-np6nfvf2	17	5	.	.	NNP
cord-299560-np6nfvf2	17	6	,	,	,
cord-299560-np6nfvf2	17	7	2020	2020	CD
cord-299560-np6nfvf2	17	8	)	)	-RRB-
cord-299560-np6nfvf2	17	9	.	.	.
cord-299560-np6nfvf2	18	1	The	the	DT
cord-299560-np6nfvf2	18	2	common	common	JJ
cord-299560-np6nfvf2	18	3	symptoms	symptom	NNS
cord-299560-np6nfvf2	18	4	of	of	IN
cord-299560-np6nfvf2	18	5	Covid-19	covid-19	JJ
cord-299560-np6nfvf2	18	6	symptoms	symptom	NNS
cord-299560-np6nfvf2	18	7	are	be	VBP
cord-299560-np6nfvf2	18	8	malaise	malaise	NN
cord-299560-np6nfvf2	18	9	,	,	,
cord-299560-np6nfvf2	18	10	fever	fever	NN
cord-299560-np6nfvf2	18	11	,	,	,
cord-299560-np6nfvf2	18	12	shortness	shortness	NN
cord-299560-np6nfvf2	18	13	of	of	IN
cord-299560-np6nfvf2	18	14	breath	breath	NN
cord-299560-np6nfvf2	18	15	,	,	,
cord-299560-np6nfvf2	18	16	dry	dry	JJ
cord-299560-np6nfvf2	18	17	cough	cough	NN
cord-299560-np6nfvf2	18	18	,	,	,
cord-299560-np6nfvf2	18	19	malaise	malaise	NN
cord-299560-np6nfvf2	18	20	,	,	,
cord-299560-np6nfvf2	18	21	while	while	IN
cord-299560-np6nfvf2	18	22	decreased	decrease	VBD
cord-299560-np6nfvf2	18	23	or	or	CC
cord-299560-np6nfvf2	18	24	loss	loss	NN
cord-299560-np6nfvf2	18	25	of	of	IN
cord-299560-np6nfvf2	18	26	taste	taste	NN
cord-299560-np6nfvf2	18	27	and	and	CC
cord-299560-np6nfvf2	18	28	olfactory	olfactory	JJ
cord-299560-np6nfvf2	18	29	perceptions	perception	NNS
cord-299560-np6nfvf2	18	30	have	have	VBP
cord-299560-np6nfvf2	18	31	been	be	VBN
cord-299560-np6nfvf2	18	32	reported	report	VBN
cord-299560-np6nfvf2	18	33	(	(	-LRB-
cord-299560-np6nfvf2	18	34	Elfiky	Elfiky	NNP
cord-299560-np6nfvf2	18	35	,	,	,
cord-299560-np6nfvf2	18	36	2020a	2020a	CD
cord-299560-np6nfvf2	18	37	)	)	-RRB-
cord-299560-np6nfvf2	18	38	.	.	.
cord-299560-np6nfvf2	19	1	The	the	DT
cord-299560-np6nfvf2	19	2	Covid-19	covid-19	NN
cord-299560-np6nfvf2	19	3	virus	virus	NN
cord-299560-np6nfvf2	19	4	spreads	spread	VBZ
cord-299560-np6nfvf2	19	5	mainly	mainly	RB
cord-299560-np6nfvf2	19	6	through	through	IN
cord-299560-np6nfvf2	19	7	saliva	saliva	NN
cord-299560-np6nfvf2	19	8	,	,	,
cord-299560-np6nfvf2	19	9	droplets	droplet	NNS
cord-299560-np6nfvf2	19	10	,	,	,
cord-299560-np6nfvf2	19	11	or	or	CC
cord-299560-np6nfvf2	19	12	discharges	discharge	NNS
cord-299560-np6nfvf2	19	13	from	from	IN
cord-299560-np6nfvf2	19	14	the	the	DT
cord-299560-np6nfvf2	19	15	nose	nose	NN
cord-299560-np6nfvf2	19	16	of	of	IN
cord-299560-np6nfvf2	19	17	an	an	DT
cord-299560-np6nfvf2	19	18	infected	infected	JJ
cord-299560-np6nfvf2	19	19	individual	individual	NN
cord-299560-np6nfvf2	19	20	after	after	IN
cord-299560-np6nfvf2	19	21	coughing	cough	VBG
cord-299560-np6nfvf2	19	22	or	or	CC
cord-299560-np6nfvf2	19	23	sneezing	sneeze	VBG
cord-299560-np6nfvf2	19	24	(	(	-LRB-
cord-299560-np6nfvf2	19	25	Pant	Pant	NNP
cord-299560-np6nfvf2	19	26	et	et	FW
cord-299560-np6nfvf2	19	27	al	al	NNP
cord-299560-np6nfvf2	19	28	.	.	NNP
cord-299560-np6nfvf2	19	29	,	,	,
cord-299560-np6nfvf2	19	30	2020	2020	CD
cord-299560-np6nfvf2	19	31	)	)	-RRB-
cord-299560-np6nfvf2	19	32	.	.	.
cord-299560-np6nfvf2	20	1	The	the	DT
cord-299560-np6nfvf2	20	2	incubation	incubation	NN
cord-299560-np6nfvf2	20	3	period	period	NN
cord-299560-np6nfvf2	20	4	can	can	MD
cord-299560-np6nfvf2	20	5	range	range	VB
cord-299560-np6nfvf2	20	6	from	from	IN
cord-299560-np6nfvf2	20	7	two	two	CD
cord-299560-np6nfvf2	20	8	to	to	TO
cord-299560-np6nfvf2	20	9	fourteen	fourteen	CD
cord-299560-np6nfvf2	20	10	days	day	NNS
cord-299560-np6nfvf2	21	1	(	(	-LRB-
cord-299560-np6nfvf2	21	2	Abdelli	Abdelli	NNP
cord-299560-np6nfvf2	21	3	et	et	NNP
cord-299560-np6nfvf2	21	4	al	al	NNP
cord-299560-np6nfvf2	21	5	.	.	NNP
cord-299560-np6nfvf2	21	6	,	,	,
cord-299560-np6nfvf2	21	7	2020	2020	CD
cord-299560-np6nfvf2	21	8	)	)	-RRB-
cord-299560-np6nfvf2	21	9	.	.	.
cord-299560-np6nfvf2	22	1	Since	since	IN
cord-299560-np6nfvf2	22	2	reported	report	VBN
cord-299560-np6nfvf2	22	3	in	in	IN
cord-299560-np6nfvf2	22	4	December	December	NNP
cord-299560-np6nfvf2	22	5	2019	2019	CD
cord-299560-np6nfvf2	22	6	,	,	,
cord-299560-np6nfvf2	22	7	it	-PRON-	PRP
cord-299560-np6nfvf2	22	8	has	have	VBZ
cord-299560-np6nfvf2	22	9	infected	infect	VBN
cord-299560-np6nfvf2	22	10	2	2	CD
cord-299560-np6nfvf2	22	11	,	,	,
cord-299560-np6nfvf2	22	12	160	160	CD
cord-299560-np6nfvf2	22	13	,	,	,
cord-299560-np6nfvf2	22	14	207	207	CD
cord-299560-np6nfvf2	22	15	individuals	individual	NNS
cord-299560-np6nfvf2	22	16	,	,	,
cord-299560-np6nfvf2	22	17	leading	lead	VBG
cord-299560-np6nfvf2	22	18	to	to	IN
cord-299560-np6nfvf2	22	19	146,088	146,088	CD
cord-299560-np6nfvf2	22	20	deaths	death	NNS
cord-299560-np6nfvf2	22	21	globally	globally	RB
cord-299560-np6nfvf2	22	22	(	(	-LRB-
cord-299560-np6nfvf2	22	23	WHO	who	WP
cord-299560-np6nfvf2	22	24	,	,	,
cord-299560-np6nfvf2	22	25	2020a	2020a	CD
cord-299560-np6nfvf2	22	26	)	)	-RRB-
cord-299560-np6nfvf2	22	27	.	.	.
cord-299560-np6nfvf2	23	1	The	the	DT
cord-299560-np6nfvf2	23	2	first	first	JJ
cord-299560-np6nfvf2	23	3	reported	reported	JJ
cord-299560-np6nfvf2	23	4	death	death	NN
cord-299560-np6nfvf2	23	5	was	be	VBD
cord-299560-np6nfvf2	23	6	on	on	IN
cord-299560-np6nfvf2	23	7	11	11	CD
cord-299560-np6nfvf2	23	8	January	January	NNP
cord-299560-np6nfvf2	23	9	2020	2020	CD
cord-299560-np6nfvf2	23	10	and	and	CC
cord-299560-np6nfvf2	23	11	the	the	DT
cord-299560-np6nfvf2	23	12	transmission	transmission	NN
cord-299560-np6nfvf2	23	13	from	from	IN
cord-299560-np6nfvf2	23	14	patients	patient	NNS
cord-299560-np6nfvf2	23	15	to	to	IN
cord-299560-np6nfvf2	23	16	healthcare	healthcare	NN
cord-299560-np6nfvf2	23	17	workers	worker	NNS
cord-299560-np6nfvf2	23	18	was	be	VBD
cord-299560-np6nfvf2	23	19	first	first	RB
cord-299560-np6nfvf2	23	20	documented	document	VBN
cord-299560-np6nfvf2	23	21	on	on	IN
cord-299560-np6nfvf2	23	22	20	20	CD
cord-299560-np6nfvf2	23	23	January	January	NNP
cord-299560-np6nfvf2	23	24	2020	2020	CD
cord-299560-np6nfvf2	24	1	(	(	-LRB-
cord-299560-np6nfvf2	24	2	Enmozhi	Enmozhi	NNP
cord-299560-np6nfvf2	24	3	et	et	NNP
cord-299560-np6nfvf2	24	4	al	al	NNP
cord-299560-np6nfvf2	24	5	.	.	NNP
cord-299560-np6nfvf2	24	6	,	,	,
cord-299560-np6nfvf2	24	7	2020	2020	CD
cord-299560-np6nfvf2	24	8	)	)	-RRB-
cord-299560-np6nfvf2	24	9	.	.	.
cord-299560-np6nfvf2	25	1	Moreover	moreover	RB
cord-299560-np6nfvf2	25	2	,	,	,
cord-299560-np6nfvf2	25	3	the	the	DT
cord-299560-np6nfvf2	25	4	lives	life	NNS
cord-299560-np6nfvf2	25	5	of	of	IN
cord-299560-np6nfvf2	25	6	millions	million	NNS
cord-299560-np6nfvf2	25	7	of	of	IN
cord-299560-np6nfvf2	25	8	people	people	NNS
cord-299560-np6nfvf2	25	9	have	have	VBP
cord-299560-np6nfvf2	25	10	been	be	VBN
cord-299560-np6nfvf2	25	11	affected	affect	VBN
cord-299560-np6nfvf2	25	12	due	due	IN
cord-299560-np6nfvf2	25	13	to	to	IN
cord-299560-np6nfvf2	25	14	isolations	isolation	NNS
cord-299560-np6nfvf2	25	15	,	,	,
cord-299560-np6nfvf2	25	16	required	require	VBN
cord-299560-np6nfvf2	25	17	lockdowns	lockdown	NNS
cord-299560-np6nfvf2	25	18	,	,	,
cord-299560-np6nfvf2	25	19	and	and	CC
cord-299560-np6nfvf2	25	20	quarantines	quarantine	NNS
cord-299560-np6nfvf2	25	21	.	.	.
cord-299560-np6nfvf2	26	1	Thus	thus	RB
cord-299560-np6nfvf2	26	2	the	the	DT
cord-299560-np6nfvf2	26	3	dreaded	dreaded	JJ
cord-299560-np6nfvf2	26	4	effect	effect	NN
cord-299560-np6nfvf2	26	5	of	of	IN
cord-299560-np6nfvf2	26	6	the	the	DT
cord-299560-np6nfvf2	26	7	COVID-19	COVID-19	NNP
cord-299560-np6nfvf2	26	8	pandemic	pandemic	NN
cord-299560-np6nfvf2	26	9	has	have	VBZ
cord-299560-np6nfvf2	26	10	imposed	impose	VBN
cord-299560-np6nfvf2	26	11	main	main	JJ
cord-299560-np6nfvf2	26	12	challenges	challenge	NNS
cord-299560-np6nfvf2	26	13	for	for	IN
cord-299560-np6nfvf2	26	14	worldwide	worldwide	JJ
cord-299560-np6nfvf2	26	15	well	well	RB
cord-299560-np6nfvf2	26	16	-	-	HYPH
cord-299560-np6nfvf2	26	17	being	being	NN
cord-299560-np6nfvf2	26	18	,	,	,
cord-299560-np6nfvf2	26	19	economy	economy	NN
cord-299560-np6nfvf2	26	20	and	and	CC
cord-299560-np6nfvf2	26	21	society	society	NN
cord-299560-np6nfvf2	27	1	(	(	-LRB-
cord-299560-np6nfvf2	27	2	Joshi	Joshi	NNP
cord-299560-np6nfvf2	27	3	et	et	NNP
cord-299560-np6nfvf2	27	4	al	al	NNP
cord-299560-np6nfvf2	27	5	.	.	NNP
cord-299560-np6nfvf2	27	6	,	,	,
cord-299560-np6nfvf2	27	7	2020	2020	CD
cord-299560-np6nfvf2	27	8	;	;	:
cord-299560-np6nfvf2	27	9	Umesh	Umesh	NNP
cord-299560-np6nfvf2	27	10	et	et	NNP
cord-299560-np6nfvf2	27	11	al	al	NNP
cord-299560-np6nfvf2	27	12	.	.	NNP
cord-299560-np6nfvf2	27	13	,	,	,
cord-299560-np6nfvf2	27	14	2020	2020	CD
cord-299560-np6nfvf2	27	15	)	)	-RRB-
cord-299560-np6nfvf2	27	16	.	.	.
cord-299560-np6nfvf2	28	1	Coronavirus	Coronavirus	NNP
cord-299560-np6nfvf2	28	2	is	be	VBZ
cord-299560-np6nfvf2	28	3	lavish	lavish	JJ
cord-299560-np6nfvf2	28	4	in	in	IN
cord-299560-np6nfvf2	28	5	mammals	mammal	NNS
cord-299560-np6nfvf2	28	6	and	and	CC
cord-299560-np6nfvf2	28	7	birds	bird	NNS
cord-299560-np6nfvf2	28	8	and	and	CC
cord-299560-np6nfvf2	28	9	institute	institute	VB
cord-299560-np6nfvf2	28	10	a	a	DT
cord-299560-np6nfvf2	28	11	large	large	JJ
cord-299560-np6nfvf2	28	12	family	family	NN
cord-299560-np6nfvf2	28	13	of	of	IN
cord-299560-np6nfvf2	28	14	non	non	JJ
cord-299560-np6nfvf2	28	15	-	-	JJ
cord-299560-np6nfvf2	28	16	segmented	segmented	JJ
cord-299560-np6nfvf2	28	17	,	,	,
cord-299560-np6nfvf2	28	18	enveloped	envelop	VBN
cord-299560-np6nfvf2	28	19	,	,	,
cord-299560-np6nfvf2	28	20	positive	positive	JJ
cord-299560-np6nfvf2	28	21	-	-	HYPH
cord-299560-np6nfvf2	28	22	sense	sense	NN
cord-299560-np6nfvf2	28	23	,	,	,
cord-299560-np6nfvf2	28	24	single	single	RB
cord-299560-np6nfvf2	28	25	-	-	HYPH
cord-299560-np6nfvf2	28	26	stranded	strand	VBN
cord-299560-np6nfvf2	28	27	RNA	RNA	NNP
cord-299560-np6nfvf2	28	28	betacoronavirus	betacoronavirus	NN
cord-299560-np6nfvf2	28	29	of	of	IN
cord-299560-np6nfvf2	28	30	the	the	DT
cord-299560-np6nfvf2	28	31	family	family	NN
cord-299560-np6nfvf2	28	32	Coronaviridae	Coronaviridae	NNP
cord-299560-np6nfvf2	28	33	(	(	-LRB-
cord-299560-np6nfvf2	28	34	Schoeman	Schoeman	NNP
cord-299560-np6nfvf2	28	35	&	&	CC
cord-299560-np6nfvf2	28	36	Fielding	Fielding	NNP
cord-299560-np6nfvf2	28	37	,	,	,
cord-299560-np6nfvf2	28	38	2019	2019	CD
cord-299560-np6nfvf2	28	39	)	)	-RRB-
cord-299560-np6nfvf2	28	40	,	,	,
cord-299560-np6nfvf2	28	41	and	and	CC
cord-299560-np6nfvf2	28	42	has	have	VBZ
cord-299560-np6nfvf2	28	43	a	a	DT
cord-299560-np6nfvf2	28	44	high	high	JJ
cord-299560-np6nfvf2	28	45	frequency	frequency	NN
cord-299560-np6nfvf2	28	46	of	of	IN
cord-299560-np6nfvf2	28	47	genomic	genomic	JJ
cord-299560-np6nfvf2	28	48	recombination	recombination	NN
cord-299560-np6nfvf2	28	49	and	and	CC
cord-299560-np6nfvf2	28	50	mutation	mutation	NN
cord-299560-np6nfvf2	28	51	(	(	-LRB-
cord-299560-np6nfvf2	28	52	Khan	Khan	NNP
cord-299560-np6nfvf2	28	53	,	,	,
cord-299560-np6nfvf2	28	54	Zia	Zia	NNP
cord-299560-np6nfvf2	28	55	,	,	,
cord-299560-np6nfvf2	29	1	et	et	NNP
cord-299560-np6nfvf2	29	2	al	al	NNP
cord-299560-np6nfvf2	29	3	.	.	NNP
cord-299560-np6nfvf2	29	4	,	,	,
cord-299560-np6nfvf2	29	5	2020	2020	CD
cord-299560-np6nfvf2	29	6	)	)	-RRB-
cord-299560-np6nfvf2	29	7	.	.	.
cord-299560-np6nfvf2	30	1	This	this	DT
cord-299560-np6nfvf2	30	2	genetic	genetic	JJ
cord-299560-np6nfvf2	30	3	modification	modification	NN
cord-299560-np6nfvf2	30	4	of	of	IN
cord-299560-np6nfvf2	30	5	CoV	CoV	NNP
cord-299560-np6nfvf2	30	6	can	can	MD
cord-299560-np6nfvf2	30	7	hinder	hinder	VB
cord-299560-np6nfvf2	30	8	the	the	DT
cord-299560-np6nfvf2	30	9	production	production	NN
cord-299560-np6nfvf2	30	10	of	of	IN
cord-299560-np6nfvf2	30	11	efficient	efficient	JJ
cord-299560-np6nfvf2	30	12	vaccine	vaccine	NN
cord-299560-np6nfvf2	30	13	(	(	-LRB-
cord-299560-np6nfvf2	30	14	Hasan	Hasan	NNP
cord-299560-np6nfvf2	30	15	et	et	NNP
cord-299560-np6nfvf2	30	16	al	al	NNP
cord-299560-np6nfvf2	30	17	.	.	NNP
cord-299560-np6nfvf2	30	18	,	,	,
cord-299560-np6nfvf2	30	19	2020	2020	CD
cord-299560-np6nfvf2	30	20	)	)	-RRB-
cord-299560-np6nfvf2	30	21	.	.	.
cord-299560-np6nfvf2	31	1	Bats	bat	NNS
cord-299560-np6nfvf2	31	2	are	be	VBP
cord-299560-np6nfvf2	31	3	the	the	DT
cord-299560-np6nfvf2	31	4	main	main	JJ
cord-299560-np6nfvf2	31	5	harbor	harbor	NN
cord-299560-np6nfvf2	31	6	to	to	IN
cord-299560-np6nfvf2	31	7	the	the	DT
cord-299560-np6nfvf2	31	8	ultimate	ultimate	JJ
cord-299560-np6nfvf2	31	9	variety	variety	NN
cord-299560-np6nfvf2	31	10	of	of	IN
cord-299560-np6nfvf2	31	11	genotypes	genotype	NNS
cord-299560-np6nfvf2	31	12	with	with	IN
cord-299560-np6nfvf2	31	13	spread	spread	NN
cord-299560-np6nfvf2	31	14	via	via	IN
cord-299560-np6nfvf2	31	15	an	an	DT
cord-299560-np6nfvf2	31	16	unknown	unknown	JJ
cord-299560-np6nfvf2	31	17	intermediate	intermediate	JJ
cord-299560-np6nfvf2	31	18	mammal	mammal	NN
cord-299560-np6nfvf2	31	19	host	host	NN
cord-299560-np6nfvf2	31	20	to	to	IN
cord-299560-np6nfvf2	31	21	humans	human	NNS
cord-299560-np6nfvf2	31	22	.	.	.
cord-299560-np6nfvf2	32	1	Overall	overall	RB
cord-299560-np6nfvf2	32	2	,	,	,
cord-299560-np6nfvf2	32	3	human	human	JJ
cord-299560-np6nfvf2	32	4	and	and	CC
cord-299560-np6nfvf2	32	5	animal	animal	NN
cord-299560-np6nfvf2	32	6	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	32	7	comprises	comprise	VBZ
cord-299560-np6nfvf2	32	8	of	of	IN
cord-299560-np6nfvf2	32	9	four	four	CD
cord-299560-np6nfvf2	32	10	genera	genus	NNS
cord-299560-np6nfvf2	32	11	namely	namely	RB
cord-299560-np6nfvf2	32	12	a	a	DT
cord-299560-np6nfvf2	32	13	,	,	,
cord-299560-np6nfvf2	32	14	b	b	NN
cord-299560-np6nfvf2	32	15	,	,	,
cord-299560-np6nfvf2	32	16	c	c	NN
cord-299560-np6nfvf2	32	17	and	and	CC
cord-299560-np6nfvf2	32	18	d	d	NN
cord-299560-np6nfvf2	32	19	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	32	20	genus	genus	NN
cord-299560-np6nfvf2	32	21	(	(	-LRB-
cord-299560-np6nfvf2	32	22	Sinha	Sinha	NNP
cord-299560-np6nfvf2	32	23	et	et	NNP
cord-299560-np6nfvf2	32	24	al	al	NNP
cord-299560-np6nfvf2	32	25	.	.	NNP
cord-299560-np6nfvf2	32	26	,	,	,
cord-299560-np6nfvf2	32	27	2020	2020	CD
cord-299560-np6nfvf2	32	28	)	)	-RRB-
cord-299560-np6nfvf2	32	29	.	.	.
cord-299560-np6nfvf2	33	1	The	the	DT
cord-299560-np6nfvf2	33	2	b	b	NN
cord-299560-np6nfvf2	33	3	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	33	4	includes	include	VBZ
cord-299560-np6nfvf2	33	5	the	the	DT
cord-299560-np6nfvf2	33	6	Middle	Middle	NNP
cord-299560-np6nfvf2	33	7	East	East	NNP
cord-299560-np6nfvf2	33	8	respiratory	respiratory	JJ
cord-299560-np6nfvf2	33	9	syndrome	syndrome	NN
cord-299560-np6nfvf2	33	10	(	(	-LRB-
cord-299560-np6nfvf2	33	11	MERS	MERS	NNP
cord-299560-np6nfvf2	33	12	)	)	-RRB-
cord-299560-np6nfvf2	33	13	,	,	,
cord-299560-np6nfvf2	33	14	severe	severe	JJ
cord-299560-np6nfvf2	33	15	acute	acute	JJ
cord-299560-np6nfvf2	33	16	respiratory	respiratory	JJ
cord-299560-np6nfvf2	33	17	syndrome	syndrome	NN
cord-299560-np6nfvf2	33	18	(	(	-LRB-
cord-299560-np6nfvf2	33	19	SARS	SARS	NNP
cord-299560-np6nfvf2	33	20	)	)	-RRB-
cord-299560-np6nfvf2	33	21	,	,	,
cord-299560-np6nfvf2	33	22	and	and	CC
cord-299560-np6nfvf2	33	23	SARS	SARS	NNP
cord-299560-np6nfvf2	33	24	-	-	HYPH
cord-299560-np6nfvf2	33	25	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	33	26	(	(	-LRB-
cord-299560-np6nfvf2	33	27	Khan	Khan	NNP
cord-299560-np6nfvf2	33	28	,	,	,
cord-299560-np6nfvf2	33	29	Jha	Jha	NNP
cord-299560-np6nfvf2	33	30	,	,	,
cord-299560-np6nfvf2	33	31	et	et	NNP
cord-299560-np6nfvf2	33	32	al	al	NNP
cord-299560-np6nfvf2	33	33	.	.	NNP
cord-299560-np6nfvf2	33	34	,	,	,
cord-299560-np6nfvf2	33	35	2020	2020	CD
cord-299560-np6nfvf2	33	36	;	;	.
cord-299560-np6nfvf2	34	1	Sahu	Sahu	NNP
cord-299560-np6nfvf2	34	2	et	et	FW
cord-299560-np6nfvf2	34	3	al	al	NNP
cord-299560-np6nfvf2	34	4	.	.	NNP
cord-299560-np6nfvf2	34	5	,	,	,
cord-299560-np6nfvf2	34	6	2020	2020	CD
cord-299560-np6nfvf2	34	7	)	)	-RRB-
cord-299560-np6nfvf2	34	8	.	.	.
cord-299560-np6nfvf2	35	1	The	the	DT
cord-299560-np6nfvf2	35	2	CoV	cov	NN
cord-299560-np6nfvf2	35	3	family	family	NN
cord-299560-np6nfvf2	35	4	has	have	VBZ
cord-299560-np6nfvf2	35	5	a	a	DT
cord-299560-np6nfvf2	35	6	sizable	sizable	JJ
cord-299560-np6nfvf2	35	7	homogeneous	homogeneous	JJ
cord-299560-np6nfvf2	35	8	"	"	``
cord-299560-np6nfvf2	35	9	spike	spike	NN
cord-299560-np6nfvf2	35	10	protein	protein	NN
cord-299560-np6nfvf2	35	11	"	"	''
cord-299560-np6nfvf2	35	12	(	(	-LRB-
cord-299560-np6nfvf2	35	13	Figure	figure	NN
cord-299560-np6nfvf2	35	14	1	1	CD
cord-299560-np6nfvf2	35	15	)	)	-RRB-
cord-299560-np6nfvf2	35	16	.	.	.
cord-299560-np6nfvf2	36	1	The	the	DT
cord-299560-np6nfvf2	36	2	role	role	NN
cord-299560-np6nfvf2	36	3	of	of	IN
cord-299560-np6nfvf2	36	4	the	the	DT
cord-299560-np6nfvf2	36	5	spike	spike	NN
cord-299560-np6nfvf2	36	6	(	(	-LRB-
cord-299560-np6nfvf2	36	7	S	s	NN
cord-299560-np6nfvf2	36	8	)	)	-RRB-
cord-299560-np6nfvf2	36	9	protein	protein	NN
cord-299560-np6nfvf2	36	10	,	,	,
cord-299560-np6nfvf2	36	11	which	which	WDT
cord-299560-np6nfvf2	36	12	is	be	VBZ
cord-299560-np6nfvf2	36	13	composed	compose	VBN
cord-299560-np6nfvf2	36	14	of	of	IN
cord-299560-np6nfvf2	36	15	1300	1300	CD
cord-299560-np6nfvf2	36	16	amino	amino	NN
cord-299560-np6nfvf2	36	17	acids	acid	NNS
cord-299560-np6nfvf2	36	18	(	(	-LRB-
cord-299560-np6nfvf2	36	19	Elfiky	Elfiky	NNP
cord-299560-np6nfvf2	36	20	,	,	,
cord-299560-np6nfvf2	36	21	2020b	2020b	CD
cord-299560-np6nfvf2	36	22	)	)	-RRB-
cord-299560-np6nfvf2	36	23	,	,	,
cord-299560-np6nfvf2	36	24	is	be	VBZ
cord-299560-np6nfvf2	36	25	to	to	TO
cord-299560-np6nfvf2	36	26	interact	interact	VB
cord-299560-np6nfvf2	36	27	with	with	IN
cord-299560-np6nfvf2	36	28	the	the	DT
cord-299560-np6nfvf2	36	29	host	host	NN
cord-299560-np6nfvf2	36	30	cells	cell	NNS
cord-299560-np6nfvf2	36	31	,	,	,
cord-299560-np6nfvf2	36	32	such	such	JJ
cord-299560-np6nfvf2	36	33	as	as	IN
cord-299560-np6nfvf2	36	34	the	the	DT
cord-299560-np6nfvf2	36	35	pulmonary	pulmonary	JJ
cord-299560-np6nfvf2	36	36	and	and	CC
cord-299560-np6nfvf2	36	37	parabronchial	parabronchial	JJ
cord-299560-np6nfvf2	36	38	epithelial	epithelial	JJ
cord-299560-np6nfvf2	36	39	cell	cell	NN
cord-299560-np6nfvf2	36	40	,	,	,
cord-299560-np6nfvf2	36	41	and	and	CC
cord-299560-np6nfvf2	36	42	assists	assist	VBZ
cord-299560-np6nfvf2	36	43	the	the	DT
cord-299560-np6nfvf2	36	44	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	36	45	to	to	TO
cord-299560-np6nfvf2	36	46	enter	enter	VB
cord-299560-np6nfvf2	36	47	through	through	IN
cord-299560-np6nfvf2	36	48	the	the	DT
cord-299560-np6nfvf2	36	49	epithelial	epithelial	JJ
cord-299560-np6nfvf2	36	50	cell	cell	NN
cord-299560-np6nfvf2	36	51	membrane	membrane	NN
cord-299560-np6nfvf2	36	52	(	(	-LRB-
cord-299560-np6nfvf2	36	53	Boopathi	Boopathi	NNP
cord-299560-np6nfvf2	36	54	et	et	NNP
cord-299560-np6nfvf2	36	55	al	al	NNP
cord-299560-np6nfvf2	36	56	.	.	NNP
cord-299560-np6nfvf2	36	57	,	,	,
cord-299560-np6nfvf2	36	58	2020	2020	CD
cord-299560-np6nfvf2	36	59	;	;	:
cord-299560-np6nfvf2	36	60	Xia	Xia	NNP
cord-299560-np6nfvf2	36	61	et	et	NNP
cord-299560-np6nfvf2	36	62	al	al	NNP
cord-299560-np6nfvf2	36	63	.	.	NNP
cord-299560-np6nfvf2	36	64	,	,	,
cord-299560-np6nfvf2	36	65	2020	2020	CD
cord-299560-np6nfvf2	36	66	)	)	-RRB-
cord-299560-np6nfvf2	36	67	.	.	.
cord-299560-np6nfvf2	37	1	Moreover	moreover	RB
cord-299560-np6nfvf2	37	2	,	,	,
cord-299560-np6nfvf2	37	3	the	the	DT
cord-299560-np6nfvf2	37	4	alveolar	alveolar	JJ
cord-299560-np6nfvf2	37	5	epithelial	epithelial	JJ
cord-299560-np6nfvf2	37	6	cells	cell	NNS
cord-299560-np6nfvf2	37	7	have	have	VBP
cord-299560-np6nfvf2	37	8	ample	ample	JJ
cord-299560-np6nfvf2	37	9	expression	expression	NN
cord-299560-np6nfvf2	37	10	of	of	IN
cord-299560-np6nfvf2	37	11	angiotensin	angiotensin	NN
cord-299560-np6nfvf2	37	12	-	-	HYPH
cord-299560-np6nfvf2	37	13	converting	convert	VBG
cord-299560-np6nfvf2	37	14	enzyme	enzyme	NN
cord-299560-np6nfvf2	37	15	2	2	CD
cord-299560-np6nfvf2	37	16	(	(	-LRB-
cord-299560-np6nfvf2	37	17	ACE2	ACE2	NNP
cord-299560-np6nfvf2	37	18	)	)	-RRB-
cord-299560-np6nfvf2	37	19	,	,	,
cord-299560-np6nfvf2	37	20	which	which	WDT
cord-299560-np6nfvf2	37	21	is	be	VBZ
cord-299560-np6nfvf2	37	22	an	an	DT
cord-299560-np6nfvf2	37	23	aim	aim	NN
cord-299560-np6nfvf2	37	24	by	by	IN
cord-299560-np6nfvf2	37	25	the	the	DT
cord-299560-np6nfvf2	37	26	virus	virus	NN
cord-299560-np6nfvf2	37	27	.	.	.
cord-299560-np6nfvf2	38	1	The	the	DT
cord-299560-np6nfvf2	38	2	detection	detection	NN
cord-299560-np6nfvf2	38	3	of	of	IN
cord-299560-np6nfvf2	38	4	ACE2	ACE2	NNP
cord-299560-np6nfvf2	38	5	by	by	IN
cord-299560-np6nfvf2	38	6	the	the	DT
cord-299560-np6nfvf2	38	7	S	S	NNP
cord-299560-np6nfvf2	38	8	protein	protein	NN
cord-299560-np6nfvf2	38	9	of	of	IN
cord-299560-np6nfvf2	38	10	the	the	DT
cord-299560-np6nfvf2	38	11	virus	virus	NN
cord-299560-np6nfvf2	38	12	permits	permit	VBZ
cord-299560-np6nfvf2	38	13	the	the	DT
cord-299560-np6nfvf2	38	14	invasion	invasion	NN
cord-299560-np6nfvf2	38	15	of	of	IN
cord-299560-np6nfvf2	38	16	the	the	DT
cord-299560-np6nfvf2	38	17	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	38	18	into	into	IN
cord-299560-np6nfvf2	38	19	the	the	DT
cord-299560-np6nfvf2	38	20	human	human	JJ
cord-299560-np6nfvf2	38	21	circulation	circulation	NN
cord-299560-np6nfvf2	38	22	system	system	NN
cord-299560-np6nfvf2	38	23	(	(	-LRB-
cord-299560-np6nfvf2	38	24	Belouzard	Belouzard	NNP
cord-299560-np6nfvf2	38	25	et	et	NNP
cord-299560-np6nfvf2	38	26	al	al	NNP
cord-299560-np6nfvf2	38	27	.	.	NNP
cord-299560-np6nfvf2	38	28	,	,	,
cord-299560-np6nfvf2	38	29	2009	2009	CD
cord-299560-np6nfvf2	38	30	)	)	-RRB-
cord-299560-np6nfvf2	38	31	.	.	.
cord-299560-np6nfvf2	39	1	Single	single	JJ
cord-299560-np6nfvf2	39	2	-	-	HYPH
cord-299560-np6nfvf2	39	3	strand	strand	NN
cord-299560-np6nfvf2	39	4	RNA	RNA	NNP
cord-299560-np6nfvf2	39	5	(	(	-LRB-
cord-299560-np6nfvf2	39	6	22	22	CD
cord-299560-np6nfvf2	39	7	-	-	SYM
cord-299560-np6nfvf2	39	8	26	26	CD
cord-299560-np6nfvf2	39	9	kilobases	kilobase	NNS
cord-299560-np6nfvf2	39	10	)	)	-RRB-
cord-299560-np6nfvf2	39	11	viruses	virus	NNS
cord-299560-np6nfvf2	39	12	such	such	JJ
cord-299560-np6nfvf2	39	13	as	as	IN
cord-299560-np6nfvf2	39	14	the	the	DT
cord-299560-np6nfvf2	39	15	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	39	16	family	family	NN
cord-299560-np6nfvf2	39	17	reproduce	reproduce	VB
cord-299560-np6nfvf2	39	18	the	the	DT
cord-299560-np6nfvf2	39	19	virus	virus	NN
cord-299560-np6nfvf2	39	20	genomes	genome	NNS
cord-299560-np6nfvf2	39	21	by	by	IN
cord-299560-np6nfvf2	39	22	capitalizing	capitalize	VBG
cord-299560-np6nfvf2	39	23	on	on	IN
cord-299560-np6nfvf2	39	24	host	host	NN
cord-299560-np6nfvf2	39	25	cells	cell	NNS
cord-299560-np6nfvf2	39	26	.	.	.
cord-299560-np6nfvf2	40	1	For	for	IN
cord-299560-np6nfvf2	40	2	instance	instance	NN
cord-299560-np6nfvf2	40	3	,	,	,
cord-299560-np6nfvf2	40	4	after	after	IN
cord-299560-np6nfvf2	40	5	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	40	6	comes	come	VBZ
cord-299560-np6nfvf2	40	7	near	near	IN
cord-299560-np6nfvf2	40	8	the	the	DT
cord-299560-np6nfvf2	40	9	ribosome	ribosome	NN
cord-299560-np6nfvf2	40	10	of	of	IN
cord-299560-np6nfvf2	40	11	the	the	DT
cord-299560-np6nfvf2	40	12	epithelial	epithelial	JJ
cord-299560-np6nfvf2	40	13	cells	cell	NNS
cord-299560-np6nfvf2	40	14	or	or	CC
cord-299560-np6nfvf2	40	15	other	other	JJ
cord-299560-np6nfvf2	40	16	host	host	NN
cord-299560-np6nfvf2	40	17	cells	cell	NNS
cord-299560-np6nfvf2	40	18	,	,	,
cord-299560-np6nfvf2	40	19	it	-PRON-	PRP
cord-299560-np6nfvf2	40	20	utilizes	utilize	VBZ
cord-299560-np6nfvf2	40	21	the	the	DT
cord-299560-np6nfvf2	40	22	ribosome	ribosome	NN
cord-299560-np6nfvf2	40	23	of	of	IN
cord-299560-np6nfvf2	40	24	the	the	DT
cord-299560-np6nfvf2	40	25	host	host	NN
cord-299560-np6nfvf2	40	26	cell	cell	NN
cord-299560-np6nfvf2	40	27	to	to	TO
cord-299560-np6nfvf2	40	28	replicate	replicate	VB
cord-299560-np6nfvf2	40	29	polyproteins	polyprotein	NNS
cord-299560-np6nfvf2	40	30	.	.	.
cord-299560-np6nfvf2	41	1	The	the	DT
cord-299560-np6nfvf2	41	2	replication	replication	NN
cord-299560-np6nfvf2	41	3	and	and	CC
cord-299560-np6nfvf2	41	4	ensuing	ensue	VBG
cord-299560-np6nfvf2	41	5	procedures	procedure	NNS
cord-299560-np6nfvf2	41	6	of	of	IN
cord-299560-np6nfvf2	41	7	precursor	precursor	NN
cord-299560-np6nfvf2	41	8	polyproteins	polyprotein	NNS
cord-299560-np6nfvf2	41	9	can	can	MD
cord-299560-np6nfvf2	41	10	arise	arise	VB
cord-299560-np6nfvf2	41	11	in	in	IN
cord-299560-np6nfvf2	41	12	the	the	DT
cord-299560-np6nfvf2	41	13	epithelial	epithelial	JJ
cord-299560-np6nfvf2	41	14	cells	cell	NNS
cord-299560-np6nfvf2	42	1	(	(	-LRB-
cord-299560-np6nfvf2	42	2	Hoffmann	Hoffmann	NNP
cord-299560-np6nfvf2	42	3	et	et	NNP
cord-299560-np6nfvf2	42	4	al	al	NNP
cord-299560-np6nfvf2	42	5	.	.	NNP
cord-299560-np6nfvf2	42	6	,	,	,
cord-299560-np6nfvf2	42	7	2020	2020	CD
cord-299560-np6nfvf2	42	8	;	;	:
cord-299560-np6nfvf2	42	9	Wahedi	Wahedi	NNP
cord-299560-np6nfvf2	42	10	et	et	NNP
cord-299560-np6nfvf2	42	11	al	al	NNP
cord-299560-np6nfvf2	42	12	.	.	NNP
cord-299560-np6nfvf2	42	13	,	,	,
cord-299560-np6nfvf2	42	14	2020	2020	CD
cord-299560-np6nfvf2	42	15	)	)	-RRB-
cord-299560-np6nfvf2	42	16	.	.	.
cord-299560-np6nfvf2	43	1	After	after	IN
cord-299560-np6nfvf2	43	2	the	the	DT
cord-299560-np6nfvf2	43	3	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	43	4	polyproteins	polyprotein	NNS
cord-299560-np6nfvf2	43	5	are	be	VBP
cord-299560-np6nfvf2	43	6	exhibited	exhibit	VBN
cord-299560-np6nfvf2	43	7	,	,	,
cord-299560-np6nfvf2	43	8	two	two	CD
cord-299560-np6nfvf2	43	9	enzymes	enzyme	NNS
cord-299560-np6nfvf2	43	10	,	,	,
cord-299560-np6nfvf2	43	11	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	43	12	main	main	JJ
cord-299560-np6nfvf2	43	13	proteinase	proteinase	NN
cord-299560-np6nfvf2	43	14	(	(	-LRB-
cord-299560-np6nfvf2	43	15	3CLpro	3clpro	CD
cord-299560-np6nfvf2	43	16	)	)	-RRB-
cord-299560-np6nfvf2	43	17	and	and	CC
cord-299560-np6nfvf2	43	18	the	the	DT
cord-299560-np6nfvf2	43	19	papain	papain	NN
cord-299560-np6nfvf2	43	20	-	-	HYPH
cord-299560-np6nfvf2	43	21	like	like	JJ
cord-299560-np6nfvf2	43	22	protease	protease	NN
cord-299560-np6nfvf2	43	23	(	(	-LRB-
cord-299560-np6nfvf2	43	24	PLpro	PLpro	NNP
cord-299560-np6nfvf2	43	25	)	)	-RRB-
cord-299560-np6nfvf2	43	26	are	be	VBP
cord-299560-np6nfvf2	43	27	believed	believe	VBN
cord-299560-np6nfvf2	43	28	to	to	TO
cord-299560-np6nfvf2	43	29	be	be	VB
cord-299560-np6nfvf2	43	30	involved	involve	VBN
cord-299560-np6nfvf2	43	31	in	in	IN
cord-299560-np6nfvf2	43	32	cleaving	cleave	VBG
cord-299560-np6nfvf2	43	33	the	the	DT
cord-299560-np6nfvf2	43	34	polyproteins	polyprotein	NNS
cord-299560-np6nfvf2	43	35	into	into	IN
cord-299560-np6nfvf2	43	36	smaller	small	JJR
cord-299560-np6nfvf2	43	37	products	product	NNS
cord-299560-np6nfvf2	43	38	used	use	VBN
cord-299560-np6nfvf2	43	39	for	for	IN
cord-299560-np6nfvf2	43	40	replicating	replicate	VBG
cord-299560-np6nfvf2	43	41	new	new	JJ
cord-299560-np6nfvf2	43	42	viruses	virus	NNS
cord-299560-np6nfvf2	43	43	.	.	.
cord-299560-np6nfvf2	44	1	In	in	IN
cord-299560-np6nfvf2	44	2	order	order	NN
cord-299560-np6nfvf2	44	3	to	to	TO
cord-299560-np6nfvf2	44	4	produce	produce	VB
cord-299560-np6nfvf2	44	5	the	the	DT
cord-299560-np6nfvf2	44	6	daughter	daughter	NN
cord-299560-np6nfvf2	44	7	RNA	RNA	NNP
cord-299560-np6nfvf2	44	8	genome	genome	NN
cord-299560-np6nfvf2	44	9	,	,	,
cord-299560-np6nfvf2	44	10	the	the	DT
cord-299560-np6nfvf2	44	11	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	44	12	exhibits	exhibit	VBZ
cord-299560-np6nfvf2	44	13	an	an	DT
cord-299560-np6nfvf2	44	14	RNA	RNA	NNP
cord-299560-np6nfvf2	44	15	-	-	HYPH
cord-299560-np6nfvf2	44	16	dependent	dependent	JJ
cord-299560-np6nfvf2	44	17	RNA	RNA	NNP
cord-299560-np6nfvf2	44	18	polymerase	polymerase	NN
cord-299560-np6nfvf2	44	19	(	(	-LRB-
cord-299560-np6nfvf2	44	20	RdRp	RdRp	NNP
cord-299560-np6nfvf2	44	21	)	)	-RRB-
cord-299560-np6nfvf2	44	22	,	,	,
cord-299560-np6nfvf2	44	23	which	which	WDT
cord-299560-np6nfvf2	44	24	is	be	VBZ
cord-299560-np6nfvf2	44	25	an	an	DT
cord-299560-np6nfvf2	44	26	important	important	JJ
cord-299560-np6nfvf2	44	27	replicase	replicase	NN
cord-299560-np6nfvf2	44	28	that	that	WDT
cord-299560-np6nfvf2	44	29	catalyzes	catalyze	VBZ
cord-299560-np6nfvf2	44	30	the	the	DT
cord-299560-np6nfvf2	44	31	synthesis	synthesis	NN
cord-299560-np6nfvf2	44	32	of	of	IN
cord-299560-np6nfvf2	44	33	a	a	DT
cord-299560-np6nfvf2	44	34	complementary	complementary	JJ
cord-299560-np6nfvf2	44	35	RNA	RNA	NNP
cord-299560-np6nfvf2	44	36	strand	strand	NN
cord-299560-np6nfvf2	44	37	using	use	VBG
cord-299560-np6nfvf2	44	38	the	the	DT
cord-299560-np6nfvf2	44	39	virus	virus	NN
cord-299560-np6nfvf2	44	40	RNA	RNA	NNP
cord-299560-np6nfvf2	44	41	(	(	-LRB-
cord-299560-np6nfvf2	44	42	Wrapp	Wrapp	NNP
cord-299560-np6nfvf2	44	43	et	et	NNP
cord-299560-np6nfvf2	44	44	al	al	NNP
cord-299560-np6nfvf2	44	45	.	.	NNP
cord-299560-np6nfvf2	44	46	,	,	,
cord-299560-np6nfvf2	44	47	2020	2020	CD
cord-299560-np6nfvf2	44	48	)	)	-RRB-
cord-299560-np6nfvf2	44	49	.	.	.
cord-299560-np6nfvf2	45	1	CoVs	CoVs	NNP
cord-299560-np6nfvf2	45	2	gather	gather	VBP
cord-299560-np6nfvf2	45	3	together	together	RB
cord-299560-np6nfvf2	45	4	near	near	IN
cord-299560-np6nfvf2	45	5	intracellular	intracellular	JJ
cord-299560-np6nfvf2	45	6	membranes	membrane	NNS
cord-299560-np6nfvf2	45	7	within	within	IN
cord-299560-np6nfvf2	45	8	the	the	DT
cord-299560-np6nfvf2	45	9	Endoplasmic	Endoplasmic	NNP
cord-299560-np6nfvf2	45	10	reticulum	reticulum	NN
cord-299560-np6nfvf2	45	11	-	-	:
cord-299560-np6nfvf2	45	12	Golgi	Golgi	NNP
cord-299560-np6nfvf2	45	13	intermediate	intermediate	JJ
cord-299560-np6nfvf2	45	14	compartment	compartment	NN
cord-299560-np6nfvf2	45	15	(	(	-LRB-
cord-299560-np6nfvf2	45	16	or	or	CC
cord-299560-np6nfvf2	45	17	ERGIC	ERGIC	NNP
cord-299560-np6nfvf2	45	18	)	)	-RRB-
cord-299560-np6nfvf2	45	19	after	after	IN
cord-299560-np6nfvf2	45	20	infection	infection	NN
cord-299560-np6nfvf2	45	21	.	.	.
cord-299560-np6nfvf2	46	1	Here	here	RB
cord-299560-np6nfvf2	46	2	they	-PRON-	PRP
cord-299560-np6nfvf2	46	3	bud	bud	VBP
cord-299560-np6nfvf2	46	4	within	within	IN
cord-299560-np6nfvf2	46	5	the	the	DT
cord-299560-np6nfvf2	46	6	lumen	lumen	NN
cord-299560-np6nfvf2	46	7	and	and	CC
cord-299560-np6nfvf2	46	8	eventually	eventually	RB
cord-299560-np6nfvf2	46	9	carried	carry	VBN
cord-299560-np6nfvf2	46	10	outside	outside	IN
cord-299560-np6nfvf2	46	11	the	the	DT
cord-299560-np6nfvf2	46	12	cell	cell	NN
cord-299560-np6nfvf2	46	13	through	through	IN
cord-299560-np6nfvf2	46	14	'	'	``
cord-299560-np6nfvf2	46	15	exocytosis	exocytosis	NN
cord-299560-np6nfvf2	46	16	'	'	''
cord-299560-np6nfvf2	46	17	within	within	IN
cord-299560-np6nfvf2	46	18	vesicles	vesicle	NNS
cord-299560-np6nfvf2	46	19	(	(	-LRB-
cord-299560-np6nfvf2	46	20	Gupta	Gupta	NNP
cord-299560-np6nfvf2	46	21	et	et	NNP
cord-299560-np6nfvf2	46	22	al	al	NNP
cord-299560-np6nfvf2	46	23	.	.	NNP
cord-299560-np6nfvf2	46	24	,	,	,
cord-299560-np6nfvf2	46	25	2020	2020	CD
cord-299560-np6nfvf2	46	26	)	)	-RRB-
cord-299560-np6nfvf2	46	27	.	.	.
cord-299560-np6nfvf2	47	1	Replication	replication	NN
cord-299560-np6nfvf2	47	2	of	of	IN
cord-299560-np6nfvf2	47	3	SARS	SARS	NNP
cord-299560-np6nfvf2	47	4	-	-	HYPH
cord-299560-np6nfvf2	47	5	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	47	6	depends	depend	VBZ
cord-299560-np6nfvf2	47	7	on	on	IN
cord-299560-np6nfvf2	47	8	the	the	DT
cord-299560-np6nfvf2	47	9	viral	viral	JJ
cord-299560-np6nfvf2	47	10	RNAdependent	RNAdependent	NNP
cord-299560-np6nfvf2	47	11	RNA	RNA	NNP
cord-299560-np6nfvf2	47	12	polymerase	polymerase	NN
cord-299560-np6nfvf2	47	13	(	(	-LRB-
cord-299560-np6nfvf2	47	14	RdRp	RdRp	NNP
cord-299560-np6nfvf2	47	15	)	)	-RRB-
cord-299560-np6nfvf2	47	16	(	(	-LRB-
cord-299560-np6nfvf2	47	17	Elfiky	Elfiky	NNP
cord-299560-np6nfvf2	47	18	&	&	CC
cord-299560-np6nfvf2	47	19	Azzam	Azzam	NNP
cord-299560-np6nfvf2	47	20	,	,	,
cord-299560-np6nfvf2	47	21	2020	2020	CD
cord-299560-np6nfvf2	47	22	)	)	-RRB-
cord-299560-np6nfvf2	47	23	which	which	WDT
cord-299560-np6nfvf2	47	24	is	be	VBZ
cord-299560-np6nfvf2	47	25	the	the	DT
cord-299560-np6nfvf2	47	26	most	most	RBS
cord-299560-np6nfvf2	47	27	probable	probable	JJ
cord-299560-np6nfvf2	47	28	target	target	NN
cord-299560-np6nfvf2	47	29	of	of	IN
cord-299560-np6nfvf2	47	30	the	the	DT
cord-299560-np6nfvf2	47	31	investigational	investigational	JJ
cord-299560-np6nfvf2	47	32	nucleotide	nucleotide	NN
cord-299560-np6nfvf2	47	33	analogue	analogue	NN
cord-299560-np6nfvf2	47	34	remdesivir	remdesivir	NNP
cord-299560-np6nfvf2	47	35	(	(	-LRB-
cord-299560-np6nfvf2	47	36	RDV	RDV	NNP
cord-299560-np6nfvf2	47	37	)	)	-RRB-
cord-299560-np6nfvf2	47	38	(	(	-LRB-
cord-299560-np6nfvf2	47	39	Agostini	Agostini	NNP
cord-299560-np6nfvf2	47	40	et	et	NNP
cord-299560-np6nfvf2	47	41	al	al	NNP
cord-299560-np6nfvf2	47	42	.	.	.
cord-299560-np6nfvf2	48	1	,	,	,
cord-299560-np6nfvf2	48	2	2018	2018	CD
cord-299560-np6nfvf2	48	3	;	;	:
cord-299560-np6nfvf2	48	4	Jordan	Jordan	NNP
cord-299560-np6nfvf2	48	5	et	et	NNP
cord-299560-np6nfvf2	48	6	al	al	NNP
cord-299560-np6nfvf2	48	7	.	.	NNP
cord-299560-np6nfvf2	48	8	,	,	,
cord-299560-np6nfvf2	48	9	2018	2018	CD
cord-299560-np6nfvf2	48	10	;	;	:
cord-299560-np6nfvf2	48	11	Siegel	Siegel	NNP
cord-299560-np6nfvf2	48	12	et	et	NNP
cord-299560-np6nfvf2	48	13	al	al	NNP
cord-299560-np6nfvf2	48	14	.	.	.
cord-299560-np6nfvf2	49	1	,	,	,
cord-299560-np6nfvf2	49	2	2017	2017	CD
cord-299560-np6nfvf2	49	3	;	;	:
cord-299560-np6nfvf2	49	4	Tchesnokov	Tchesnokov	NNP
cord-299560-np6nfvf2	49	5	et	et	NNP
cord-299560-np6nfvf2	49	6	al	al	NNP
cord-299560-np6nfvf2	49	7	.	.	NNP
cord-299560-np6nfvf2	49	8	,	,	,
cord-299560-np6nfvf2	49	9	2019	2019	CD
cord-299560-np6nfvf2	49	10	)	)	-RRB-
cord-299560-np6nfvf2	49	11	.	.	.
cord-299560-np6nfvf2	50	1	After	after	IN
cord-299560-np6nfvf2	50	2	the	the	DT
cord-299560-np6nfvf2	50	3	outbreak	outbreak	NN
cord-299560-np6nfvf2	50	4	,	,	,
cord-299560-np6nfvf2	50	5	many	many	JJ
cord-299560-np6nfvf2	50	6	kinds	kind	NNS
cord-299560-np6nfvf2	50	7	of	of	IN
cord-299560-np6nfvf2	50	8	medications	medication	NNS
cord-299560-np6nfvf2	50	9	alone	alone	RB
cord-299560-np6nfvf2	50	10	or	or	CC
cord-299560-np6nfvf2	50	11	as	as	IN
cord-299560-np6nfvf2	50	12	adjuvant	adjuvant	JJ
cord-299560-np6nfvf2	50	13	have	have	VBP
cord-299560-np6nfvf2	50	14	been	be	VBN
cord-299560-np6nfvf2	50	15	used	use	VBN
cord-299560-np6nfvf2	50	16	in	in	IN
cord-299560-np6nfvf2	50	17	many	many	JJ
cord-299560-np6nfvf2	50	18	countries	country	NNS
cord-299560-np6nfvf2	50	19	(	(	-LRB-
cord-299560-np6nfvf2	50	20	Islam	Islam	NNP
cord-299560-np6nfvf2	50	21	et	et	NNP
cord-299560-np6nfvf2	50	22	al	al	NNP
cord-299560-np6nfvf2	50	23	.	.	NNP
cord-299560-np6nfvf2	50	24	,	,	,
cord-299560-np6nfvf2	50	25	2020	2020	CD
cord-299560-np6nfvf2	50	26	)	)	-RRB-
cord-299560-np6nfvf2	50	27	.	.	.
cord-299560-np6nfvf2	51	1	The	the	DT
cord-299560-np6nfvf2	51	2	usage	usage	NN
cord-299560-np6nfvf2	51	3	of	of	IN
cord-299560-np6nfvf2	51	4	already	already	RB
cord-299560-np6nfvf2	51	5	known	know	VBN
cord-299560-np6nfvf2	51	6	viral	viral	JJ
cord-299560-np6nfvf2	51	7	treatments	treatment	NNS
cord-299560-np6nfvf2	51	8	have	have	VBP
cord-299560-np6nfvf2	51	9	many	many	JJ
cord-299560-np6nfvf2	51	10	advantages	advantage	NNS
cord-299560-np6nfvf2	51	11	as	as	IN
cord-299560-np6nfvf2	51	12	the	the	DT
cord-299560-np6nfvf2	51	13	pharmacodynamics	pharmacodynamic	NNS
cord-299560-np6nfvf2	51	14	,	,	,
cord-299560-np6nfvf2	51	15	pharmacokinetics	pharmacokinetic	NNS
cord-299560-np6nfvf2	51	16	,	,	,
cord-299560-np6nfvf2	51	17	and	and	CC
cord-299560-np6nfvf2	51	18	safety	safety	NN
cord-299560-np6nfvf2	51	19	profiles	profile	NNS
cord-299560-np6nfvf2	51	20	of	of	IN
cord-299560-np6nfvf2	51	21	these	these	DT
cord-299560-np6nfvf2	51	22	medications	medication	NNS
cord-299560-np6nfvf2	51	23	have	have	VBP
cord-299560-np6nfvf2	51	24	already	already	RB
cord-299560-np6nfvf2	51	25	been	be	VBN
cord-299560-np6nfvf2	51	26	recognized	recognize	VBN
cord-299560-np6nfvf2	51	27	(	(	-LRB-
cord-299560-np6nfvf2	51	28	Das	Das	NNP
cord-299560-np6nfvf2	51	29	et	et	FW
cord-299560-np6nfvf2	51	30	al	al	NNP
cord-299560-np6nfvf2	51	31	.	.	NNP
cord-299560-np6nfvf2	51	32	,	,	,
cord-299560-np6nfvf2	51	33	2020	2020	CD
cord-299560-np6nfvf2	51	34	)	)	-RRB-
cord-299560-np6nfvf2	51	35	.	.	.
cord-299560-np6nfvf2	52	1	Certain	certain	JJ
cord-299560-np6nfvf2	52	2	drugs	drug	NNS
cord-299560-np6nfvf2	52	3	have	have	VBP
cord-299560-np6nfvf2	52	4	several	several	JJ
cord-299560-np6nfvf2	52	5	protein	protein	NN
cord-299560-np6nfvf2	52	6	targets	target	NNS
cord-299560-np6nfvf2	52	7	and	and	CC
cord-299560-np6nfvf2	52	8	many	many	JJ
cord-299560-np6nfvf2	52	9	illnesses	illness	NNS
cord-299560-np6nfvf2	52	10	share	share	VBP
cord-299560-np6nfvf2	52	11	overlapping	overlap	VBG
cord-299560-np6nfvf2	52	12	molecular	molecular	JJ
cord-299560-np6nfvf2	52	13	paths	path	NNS
cord-299560-np6nfvf2	52	14	.	.	.
cord-299560-np6nfvf2	53	1	In	in	IN
cord-299560-np6nfvf2	53	2	such	such	JJ
cord-299560-np6nfvf2	53	3	cases	case	NNS
cord-299560-np6nfvf2	53	4	,	,	,
cord-299560-np6nfvf2	53	5	reusing	reuse	VBG
cord-299560-np6nfvf2	53	6	drugs	drug	NNS
cord-299560-np6nfvf2	53	7	for	for	IN
cord-299560-np6nfvf2	53	8	more	more	JJR
cord-299560-np6nfvf2	53	9	than	than	IN
cord-299560-np6nfvf2	53	10	one	one	CD
cord-299560-np6nfvf2	53	11	objective	objective	NN
cord-299560-np6nfvf2	53	12	and	and	CC
cord-299560-np6nfvf2	53	13	finding	find	VBG
cord-299560-np6nfvf2	53	14	their	-PRON-	PRP$
cord-299560-np6nfvf2	53	15	novice	novice	NN
cord-299560-np6nfvf2	53	16	uses	use	NNS
cord-299560-np6nfvf2	53	17	can	can	MD
cord-299560-np6nfvf2	53	18	considerably	considerably	RB
cord-299560-np6nfvf2	53	19	decrease	decrease	VB
cord-299560-np6nfvf2	53	20	the	the	DT
cord-299560-np6nfvf2	53	21	time	time	NN
cord-299560-np6nfvf2	53	22	in	in	IN
cord-299560-np6nfvf2	53	23	finding	find	VBG
cord-299560-np6nfvf2	53	24	new	new	JJ
cord-299560-np6nfvf2	53	25	cures	cure	NNS
cord-299560-np6nfvf2	53	26	for	for	IN
cord-299560-np6nfvf2	53	27	unforeseen	unforeseen	JJ
cord-299560-np6nfvf2	53	28	diseases	disease	NNS
cord-299560-np6nfvf2	53	29	(	(	-LRB-
cord-299560-np6nfvf2	53	30	Muralidharan	Muralidharan	NNP
cord-299560-np6nfvf2	53	31	et	et	NNP
cord-299560-np6nfvf2	53	32	al	al	NNP
cord-299560-np6nfvf2	53	33	.	.	NNP
cord-299560-np6nfvf2	53	34	,	,	,
cord-299560-np6nfvf2	53	35	2020	2020	CD
cord-299560-np6nfvf2	53	36	)	)	-RRB-
cord-299560-np6nfvf2	53	37	.	.	.
cord-299560-np6nfvf2	54	1	RDV	RDV	NNP
cord-299560-np6nfvf2	54	2	exhibits	exhibit	VBZ
cord-299560-np6nfvf2	54	3	broad	broad	JJ
cord-299560-np6nfvf2	54	4	-	-	HYPH
cord-299560-np6nfvf2	54	5	spectrum	spectrum	NN
cord-299560-np6nfvf2	54	6	antiviral	antiviral	JJ
cord-299560-np6nfvf2	54	7	activity	activity	NN
cord-299560-np6nfvf2	54	8	against	against	IN
cord-299560-np6nfvf2	54	9	RNA	RNA	NNP
cord-299560-np6nfvf2	54	10	viruses	virus	NNS
cord-299560-np6nfvf2	54	11	,	,	,
cord-299560-np6nfvf2	54	12	and	and	CC
cord-299560-np6nfvf2	54	13	former	former	JJ
cord-299560-np6nfvf2	54	14	studies	study	NNS
cord-299560-np6nfvf2	54	15	with	with	IN
cord-299560-np6nfvf2	54	16	RdRps	RdRps	NNP
cord-299560-np6nfvf2	54	17	from	from	IN
cord-299560-np6nfvf2	54	18	Ebola	Ebola	NNP
cord-299560-np6nfvf2	54	19	virus	virus	NN
cord-299560-np6nfvf2	54	20	(	(	-LRB-
cord-299560-np6nfvf2	54	21	EBOV	EBOV	NNP
cord-299560-np6nfvf2	54	22	)	)	-RRB-
cord-299560-np6nfvf2	54	23	and	and	CC
cord-299560-np6nfvf2	55	1	Middle	Middle	NNP
cord-299560-np6nfvf2	55	2	East	East	NNP
cord-299560-np6nfvf2	55	3	respiratory	respiratory	JJ
cord-299560-np6nfvf2	55	4	syndrome	syndrome	NN
cord-299560-np6nfvf2	55	5	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	55	6	(	(	-LRB-
cord-299560-np6nfvf2	55	7	MERS	MERS	NNP
cord-299560-np6nfvf2	55	8	-	-	HYPH
cord-299560-np6nfvf2	55	9	CoV	CoV	NNP
cord-299560-np6nfvf2	55	10	)	)	-RRB-
cord-299560-np6nfvf2	55	11	have	have	VBP
cord-299560-np6nfvf2	55	12	shown	show	VBN
cord-299560-np6nfvf2	55	13	that	that	IN
cord-299560-np6nfvf2	55	14	delayed	delay	VBN
cord-299560-np6nfvf2	55	15	chain	chain	NN
cord-299560-np6nfvf2	55	16	-	-	HYPH
cord-299560-np6nfvf2	55	17	termination	termination	NN
cord-299560-np6nfvf2	55	18	is	be	VBZ
cord-299560-np6nfvf2	55	19	RDV	RDV	NNP
cord-299560-np6nfvf2	55	20	's	's	POS
cord-299560-np6nfvf2	55	21	conceivable	conceivable	JJ
cord-299560-np6nfvf2	55	22	mechanism	mechanism	NN
cord-299560-np6nfvf2	55	23	of	of	IN
cord-299560-np6nfvf2	55	24	action	action	NN
cord-299560-np6nfvf2	55	25	(	(	-LRB-
cord-299560-np6nfvf2	55	26	Figure	figure	NN
cord-299560-np6nfvf2	55	27	2	2	CD
cord-299560-np6nfvf2	55	28	)	)	-RRB-
cord-299560-np6nfvf2	55	29	(	(	-LRB-
cord-299560-np6nfvf2	55	30	Agostini	Agostini	NNP
cord-299560-np6nfvf2	55	31	et	et	NNP
cord-299560-np6nfvf2	55	32	al	al	NNP
cord-299560-np6nfvf2	55	33	.	.	.
cord-299560-np6nfvf2	56	1	,	,	,
cord-299560-np6nfvf2	56	2	2018	2018	CD
cord-299560-np6nfvf2	56	3	;	;	:
cord-299560-np6nfvf2	56	4	Jordan	Jordan	NNP
cord-299560-np6nfvf2	56	5	et	et	NNP
cord-299560-np6nfvf2	56	6	al	al	NNP
cord-299560-np6nfvf2	56	7	.	.	NNP
cord-299560-np6nfvf2	56	8	,	,	,
cord-299560-np6nfvf2	56	9	2018	2018	CD
cord-299560-np6nfvf2	56	10	;	;	:
cord-299560-np6nfvf2	56	11	Siegel	Siegel	NNP
cord-299560-np6nfvf2	56	12	et	et	NNP
cord-299560-np6nfvf2	56	13	al	al	NNP
cord-299560-np6nfvf2	56	14	.	.	.
cord-299560-np6nfvf2	57	1	,	,	,
cord-299560-np6nfvf2	57	2	2017	2017	CD
cord-299560-np6nfvf2	57	3	;	;	:
cord-299560-np6nfvf2	57	4	Tchesnokov	Tchesnokov	NNP
cord-299560-np6nfvf2	57	5	et	et	NNP
cord-299560-np6nfvf2	57	6	al	al	NNP
cord-299560-np6nfvf2	57	7	.	.	NNP
cord-299560-np6nfvf2	57	8	,	,	,
cord-299560-np6nfvf2	57	9	2019	2019	CD
cord-299560-np6nfvf2	57	10	)	)	-RRB-
cord-299560-np6nfvf2	57	11	.	.	.
cord-299560-np6nfvf2	58	1	Recently	recently	RB
cord-299560-np6nfvf2	58	2	,	,	,
cord-299560-np6nfvf2	58	3	Gordon	Gordon	NNP
cord-299560-np6nfvf2	58	4	,	,	,
cord-299560-np6nfvf2	58	5	Tchesnokov	Tchesnokov	NNP
cord-299560-np6nfvf2	58	6	,	,	,
cord-299560-np6nfvf2	58	7	Woolner	Woolner	NNP
cord-299560-np6nfvf2	58	8	,	,	,
cord-299560-np6nfvf2	58	9	et	et	NNP
cord-299560-np6nfvf2	58	10	al	al	NNP
cord-299560-np6nfvf2	58	11	.	.	.
cord-299560-np6nfvf2	59	1	(	(	-LRB-
cord-299560-np6nfvf2	59	2	2020	2020	CD
cord-299560-np6nfvf2	59	3	)	)	-RRB-
cord-299560-np6nfvf2	59	4	proved	prove	VBD
cord-299560-np6nfvf2	59	5	that	that	IN
cord-299560-np6nfvf2	59	6	RdRp	RdRp	NNP
cord-299560-np6nfvf2	59	7	effectively	effectively	RB
cord-299560-np6nfvf2	59	8	incorporates	incorporate	VBZ
cord-299560-np6nfvf2	59	9	the	the	DT
cord-299560-np6nfvf2	59	10	active	active	JJ
cord-299560-np6nfvf2	59	11	triphosphate	triphosphate	NN
cord-299560-np6nfvf2	59	12	form	form	NN
cord-299560-np6nfvf2	59	13	of	of	IN
cord-299560-np6nfvf2	59	14	RDV	RDV	NNP
cord-299560-np6nfvf2	59	15	(	(	-LRB-
cord-299560-np6nfvf2	59	16	RDV	RDV	NNP
cord-299560-np6nfvf2	59	17	-	-	HYPH
cord-299560-np6nfvf2	59	18	TP	TP	NNP
cord-299560-np6nfvf2	59	19	)	)	-RRB-
cord-299560-np6nfvf2	59	20	into	into	IN
cord-299560-np6nfvf2	59	21	RNA	RNA	NNP
cord-299560-np6nfvf2	59	22	,	,	,
cord-299560-np6nfvf2	59	23	causing	cause	VBG
cord-299560-np6nfvf2	59	24	termination	termination	NN
cord-299560-np6nfvf2	59	25	of	of	IN
cord-299560-np6nfvf2	59	26	RNA	RNA	NNP
cord-299560-np6nfvf2	59	27	synthesis	synthesis	NN
cord-299560-np6nfvf2	59	28	.	.	.
cord-299560-np6nfvf2	60	1	The	the	DT
cord-299560-np6nfvf2	60	2	investigators	investigator	NNS
cord-299560-np6nfvf2	60	3	obtained	obtain	VBD
cord-299560-np6nfvf2	60	4	almost	almost	RB
cord-299560-np6nfvf2	60	5	identical	identical	JJ
cord-299560-np6nfvf2	60	6	results	result	NNS
cord-299560-np6nfvf2	60	7	with	with	IN
cord-299560-np6nfvf2	60	8	SARS	SARS	NNP
cord-299560-np6nfvf2	60	9	-	-	HYPH
cord-299560-np6nfvf2	60	10	CoV	CoV	NNP
cord-299560-np6nfvf2	60	11	,	,	,
cord-299560-np6nfvf2	60	12	MERS	MERS	NNP
cord-299560-np6nfvf2	60	13	-	-	HYPH
cord-299560-np6nfvf2	60	14	CoV	CoV	NNP
cord-299560-np6nfvf2	60	15	,	,	,
cord-299560-np6nfvf2	60	16	and	and	CC
cord-299560-np6nfvf2	60	17	SARS	SARS	NNP
cord-299560-np6nfvf2	60	18	-	-	HYPH
cord-299560-np6nfvf2	60	19	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	60	20	RdRps	RdRps	NNP
cord-299560-np6nfvf2	60	21	and	and	CC
cord-299560-np6nfvf2	60	22	concluded	conclude	VBD
cord-299560-np6nfvf2	60	23	that	that	IN
cord-299560-np6nfvf2	60	24	the	the	DT
cord-299560-np6nfvf2	60	25	distinguished	distinguished	JJ
cord-299560-np6nfvf2	60	26	property	property	NN
cord-299560-np6nfvf2	60	27	of	of	IN
cord-299560-np6nfvf2	60	28	RDV	RDV	NNP
cord-299560-np6nfvf2	60	29	-	-	HYPH
cord-299560-np6nfvf2	60	30	TP	TP	NNP
cord-299560-np6nfvf2	60	31	is	be	VBZ
cord-299560-np6nfvf2	60	32	its	-PRON-	PRP$
cord-299560-np6nfvf2	60	33	high	high	JJ
cord-299560-np6nfvf2	60	34	discernment	discernment	NN
cord-299560-np6nfvf2	60	35	over	over	IN
cord-299560-np6nfvf2	60	36	incorporation	incorporation	NN
cord-299560-np6nfvf2	60	37	of	of	IN
cord-299560-np6nfvf2	60	38	its	-PRON-	PRP$
cord-299560-np6nfvf2	60	39	natural	natural	JJ
cord-299560-np6nfvf2	60	40	nucleotide	nucleotide	JJ
cord-299560-np6nfvf2	60	41	counterpart	counterpart	NN
cord-299560-np6nfvf2	60	42	ATP	ATP	NNP
cord-299560-np6nfvf2	60	43	.	.	.
cord-299560-np6nfvf2	61	1	RDV	RDV	NNP
cord-299560-np6nfvf2	61	2	,	,	,
cord-299560-np6nfvf2	61	3	formerly	formerly	RB
cord-299560-np6nfvf2	61	4	known	know	VBN
cord-299560-np6nfvf2	61	5	as	as	IN
cord-299560-np6nfvf2	61	6	GS-5734	GS-5734	NNS
cord-299560-np6nfvf2	61	7	,	,	,
cord-299560-np6nfvf2	61	8	is	be	VBZ
cord-299560-np6nfvf2	61	9	a	a	DT
cord-299560-np6nfvf2	61	10	monophosphoramidate	monophosphoramidate	JJ
cord-299560-np6nfvf2	61	11	prodrug	prodrug	NN
cord-299560-np6nfvf2	61	12	of	of	IN
cord-299560-np6nfvf2	61	13	an	an	DT
cord-299560-np6nfvf2	61	14	adenosine	adenosine	NN
cord-299560-np6nfvf2	61	15	analog	analog	NN
cord-299560-np6nfvf2	61	16	that	that	WDT
cord-299560-np6nfvf2	61	17	was	be	VBD
cord-299560-np6nfvf2	61	18	developed	develop	VBN
cord-299560-np6nfvf2	61	19	in	in	IN
cord-299560-np6nfvf2	61	20	response	response	NN
cord-299560-np6nfvf2	61	21	to	to	IN
cord-299560-np6nfvf2	61	22	the	the	DT
cord-299560-np6nfvf2	61	23	Ebola	Ebola	NNP
cord-299560-np6nfvf2	61	24	outbreak	outbreak	NN
cord-299560-np6nfvf2	61	25	in	in	IN
cord-299560-np6nfvf2	61	26	West	West	NNP
cord-299560-np6nfvf2	61	27	Africa	Africa	NNP
cord-299560-np6nfvf2	61	28	from	from	IN
cord-299560-np6nfvf2	61	29	2014	2014	CD
cord-299560-np6nfvf2	61	30	.	.	.
cord-299560-np6nfvf2	62	1	RDV	RDV	NNP
cord-299560-np6nfvf2	62	2	binds	bind	VBZ
cord-299560-np6nfvf2	62	3	to	to	IN
cord-299560-np6nfvf2	62	4	RdRp	RdRp	NNP
cord-299560-np6nfvf2	62	5	and	and	CC
cord-299560-np6nfvf2	62	6	acts	act	VBZ
cord-299560-np6nfvf2	62	7	as	as	IN
cord-299560-np6nfvf2	62	8	RNA	RNA	NNP
cord-299560-np6nfvf2	62	9	chain	chain	NN
cord-299560-np6nfvf2	62	10	terminator	terminator	NN
cord-299560-np6nfvf2	62	11	.	.	.
cord-299560-np6nfvf2	63	1	It	-PRON-	PRP
cord-299560-np6nfvf2	63	2	exhibits	exhibit	VBZ
cord-299560-np6nfvf2	63	3	effective	effective	JJ
cord-299560-np6nfvf2	63	4	in	in	IN
cord-299560-np6nfvf2	63	5	vitro	vitro	FW
cord-299560-np6nfvf2	63	6	activity	activity	NN
cord-299560-np6nfvf2	63	7	against	against	IN
cord-299560-np6nfvf2	63	8	SARS	SARS	NNP
cord-299560-np6nfvf2	63	9	-	-	HYPH
cord-299560-np6nfvf2	63	10	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	63	11	with	with	IN
cord-299560-np6nfvf2	63	12	an	an	DT
cord-299560-np6nfvf2	63	13	EC	EC	NNP
cord-299560-np6nfvf2	63	14	50	50	CD
cord-299560-np6nfvf2	63	15	at	at	IN
cord-299560-np6nfvf2	63	16	48	48	CD
cord-299560-np6nfvf2	63	17	h	h	NN
cord-299560-np6nfvf2	63	18	of	of	IN
cord-299560-np6nfvf2	63	19	0.77	0.77	CD
cord-299560-np6nfvf2	63	20	mM	mm	CD
cord-299560-np6nfvf2	63	21	in	in	IN
cord-299560-np6nfvf2	63	22	Vero	Vero	NNP
cord-299560-np6nfvf2	63	23	E6	E6	NNP
cord-299560-np6nfvf2	63	24	cells	cell	NNS
cord-299560-np6nfvf2	63	25	.	.	.
cord-299560-np6nfvf2	64	1	Comparable	comparable	JJ
cord-299560-np6nfvf2	64	2	activity	activity	NN
cord-299560-np6nfvf2	64	3	has	have	VBZ
cord-299560-np6nfvf2	64	4	been	be	VBN
cord-299560-np6nfvf2	64	5	shown	show	VBN
cord-299560-np6nfvf2	64	6	against	against	IN
cord-299560-np6nfvf2	64	7	other	other	JJ
cord-299560-np6nfvf2	64	8	zoonotic	zoonotic	JJ
cord-299560-np6nfvf2	64	9	coronaviruses	coronaviruse	NNS
cord-299560-np6nfvf2	64	10	with	with	IN
cord-299560-np6nfvf2	64	11	EC	EC	NNP
cord-299560-np6nfvf2	64	12	50	50	CD
cord-299560-np6nfvf2	64	13	values	value	NNS
cord-299560-np6nfvf2	64	14	of	of	IN
cord-299560-np6nfvf2	64	15	0.07	0.07	CD
cord-299560-np6nfvf2	64	16	mM	mm	CD
cord-299560-np6nfvf2	64	17	demonstrated	demonstrate	VBD
cord-299560-np6nfvf2	64	18	for	for	IN
cord-299560-np6nfvf2	64	19	both	both	DT
cord-299560-np6nfvf2	64	20	SARS	SARS	NNP
cord-299560-np6nfvf2	64	21	-	-	HYPH
cord-299560-np6nfvf2	64	22	CoV-1	CoV-1	NNP
cord-299560-np6nfvf2	64	23	and	and	CC
cord-299560-np6nfvf2	64	24	MERS	MERS	NNP
cord-299560-np6nfvf2	64	25	-	-	HYPH
cord-299560-np6nfvf2	64	26	CoV	cov	NN
cord-299560-np6nfvf2	64	27	Sheahan	Sheahan	NNP
cord-299560-np6nfvf2	64	28	et	et	NNP
cord-299560-np6nfvf2	64	29	al	al	NNP
cord-299560-np6nfvf2	64	30	.	.	.
cord-299560-np6nfvf2	65	1	,	,	,
cord-299560-np6nfvf2	65	2	2017	2017	CD
cord-299560-np6nfvf2	66	1	Sheahan	Sheahan	NNP
cord-299560-np6nfvf2	66	2	et	et	NNP
cord-299560-np6nfvf2	66	3	al	al	NNP
cord-299560-np6nfvf2	66	4	.	.	.
cord-299560-np6nfvf2	67	1	,	,	,
cord-299560-np6nfvf2	67	2	,	,	,
cord-299560-np6nfvf2	67	3	2020	2020	CD
cord-299560-np6nfvf2	68	1	Wang	Wang	NNP
cord-299560-np6nfvf2	68	2	et	et	NNP
cord-299560-np6nfvf2	68	3	al	al	NNP
cord-299560-np6nfvf2	68	4	.	.	NNP
cord-299560-np6nfvf2	68	5	,	,	,
cord-299560-np6nfvf2	68	6	2020	2020	CD
cord-299560-np6nfvf2	68	7	)	)	-RRB-
cord-299560-np6nfvf2	68	8	.	.	.
cord-299560-np6nfvf2	69	1	RDV	RDV	NNP
cord-299560-np6nfvf2	69	2	is	be	VBZ
cord-299560-np6nfvf2	69	3	very	very	RB
cord-299560-np6nfvf2	69	4	discerning	discerning	JJ
cord-299560-np6nfvf2	69	5	for	for	IN
cord-299560-np6nfvf2	69	6	viral	viral	JJ
cord-299560-np6nfvf2	69	7	polymerases	polymerase	NNS
cord-299560-np6nfvf2	69	8	,	,	,
cord-299560-np6nfvf2	69	9	hence	hence	RB
cord-299560-np6nfvf2	69	10	a	a	DT
cord-299560-np6nfvf2	69	11	low	low	JJ
cord-299560-np6nfvf2	69	12	propensity	propensity	NN
cord-299560-np6nfvf2	69	13	to	to	TO
cord-299560-np6nfvf2	69	14	cause	cause	VB
cord-299560-np6nfvf2	69	15	human	human	JJ
cord-299560-np6nfvf2	69	16	toxicity	toxicity	NN
cord-299560-np6nfvf2	69	17	.	.	.
cord-299560-np6nfvf2	70	1	In	in	IN
cord-299560-np6nfvf2	70	2	addition	addition	NN
cord-299560-np6nfvf2	70	3	,	,	,
cord-299560-np6nfvf2	70	4	it	-PRON-	PRP
cord-299560-np6nfvf2	70	5	has	have	VBZ
cord-299560-np6nfvf2	70	6	shown	show	VBN
cord-299560-np6nfvf2	70	7	to	to	TO
cord-299560-np6nfvf2	70	8	have	have	VB
cord-299560-np6nfvf2	70	9	a	a	DT
cord-299560-np6nfvf2	70	10	wide	wide	JJ
cord-299560-np6nfvf2	70	11	therapeutic	therapeutic	JJ
cord-299560-np6nfvf2	70	12	index	index	NN
cord-299560-np6nfvf2	70	13	in	in	IN
cord-299560-np6nfvf2	70	14	a	a	DT
cord-299560-np6nfvf2	70	15	human	human	JJ
cord-299560-np6nfvf2	70	16	airway	airway	NN
cord-299560-np6nfvf2	70	17	epithelial	epithelial	JJ
cord-299560-np6nfvf2	70	18	cell	cell	NN
cord-299560-np6nfvf2	70	19	model	model	NN
cord-299560-np6nfvf2	71	1	(	(	-LRB-
cord-299560-np6nfvf2	71	2	Sheahan	Sheahan	NNP
cord-299560-np6nfvf2	71	3	et	et	NNP
cord-299560-np6nfvf2	71	4	al	al	NNP
cord-299560-np6nfvf2	71	5	.	.	NNP
cord-299560-np6nfvf2	71	6	,	,	,
cord-299560-np6nfvf2	71	7	2020	2020	CD
cord-299560-np6nfvf2	71	8	)	)	-RRB-
cord-299560-np6nfvf2	71	9	.	.	.
cord-299560-np6nfvf2	72	1	The	the	DT
cord-299560-np6nfvf2	72	2	drug	drug	NN
cord-299560-np6nfvf2	72	3	also	also	RB
cord-299560-np6nfvf2	72	4	exhibits	exhibit	VBZ
cord-299560-np6nfvf2	72	5	a	a	DT
cord-299560-np6nfvf2	72	6	high	high	JJ
cord-299560-np6nfvf2	72	7	genetic	genetic	JJ
cord-299560-np6nfvf2	72	8	hurdle	hurdle	NN
cord-299560-np6nfvf2	72	9	to	to	IN
cord-299560-np6nfvf2	72	10	resistance	resistance	NN
cord-299560-np6nfvf2	72	11	in	in	IN
cord-299560-np6nfvf2	72	12	coronaviruses	coronaviruse	NNS
cord-299560-np6nfvf2	72	13	and	and	CC
cord-299560-np6nfvf2	72	14	has	have	VBZ
cord-299560-np6nfvf2	72	15	an	an	DT
cord-299560-np6nfvf2	72	16	extended	extend	VBN
cord-299560-np6nfvf2	72	17	intracellular	intracellular	JJ
cord-299560-np6nfvf2	72	18	half	half	JJ
cord-299560-np6nfvf2	72	19	-	-	HYPH
cord-299560-np6nfvf2	72	20	life	life	NN
cord-299560-np6nfvf2	72	21	that	that	WDT
cord-299560-np6nfvf2	72	22	permits	permit	VBZ
cord-299560-np6nfvf2	72	23	for	for	IN
cord-299560-np6nfvf2	72	24	once	once	RB
cord-299560-np6nfvf2	72	25	-	-	HYPH
cord-299560-np6nfvf2	72	26	daily	daily	NN
cord-299560-np6nfvf2	72	27	dosing	dosing	NN
cord-299560-np6nfvf2	72	28	(	(	-LRB-
cord-299560-np6nfvf2	72	29	Agostini	Agostini	NNP
cord-299560-np6nfvf2	72	30	et	et	NNP
cord-299560-np6nfvf2	72	31	al	al	NNP
cord-299560-np6nfvf2	72	32	.	.	NNP
cord-299560-np6nfvf2	72	33	,	,	,
cord-299560-np6nfvf2	72	34	2018	2018	CD
cord-299560-np6nfvf2	72	35	;	;	:
cord-299560-np6nfvf2	72	36	Sheahan	Sheahan	NNP
cord-299560-np6nfvf2	72	37	et	et	NNP
cord-299560-np6nfvf2	72	38	al	al	NNP
cord-299560-np6nfvf2	72	39	.	.	NNP
cord-299560-np6nfvf2	72	40	,	,	,
cord-299560-np6nfvf2	72	41	2020	2020	CD
cord-299560-np6nfvf2	72	42	)	)	-RRB-
cord-299560-np6nfvf2	72	43	.	.	.
cord-299560-np6nfvf2	73	1	The	the	DT
cord-299560-np6nfvf2	73	2	safety	safety	NN
cord-299560-np6nfvf2	73	3	and	and	CC
cord-299560-np6nfvf2	73	4	pharmacokinetics	pharmacokinetic	NNS
cord-299560-np6nfvf2	73	5	of	of	IN
cord-299560-np6nfvf2	73	6	RDV	RDV	NNP
cord-299560-np6nfvf2	73	7	were	be	VBD
cord-299560-np6nfvf2	73	8	assessed	assess	VBN
cord-299560-np6nfvf2	73	9	in	in	IN
cord-299560-np6nfvf2	73	10	single	single	JJ
cord-299560-np6nfvf2	73	11	-	-	HYPH
cord-299560-np6nfvf2	73	12	and	and	CC
cord-299560-np6nfvf2	73	13	multiple	multiple	JJ
cord-299560-np6nfvf2	73	14	-	-	HYPH
cord-299560-np6nfvf2	73	15	dose	dose	NN
cord-299560-np6nfvf2	73	16	phase	phase	NN
cord-299560-np6nfvf2	73	17	Intravenous	intravenous	JJ
cord-299560-np6nfvf2	73	18	infusions	infusion	NNS
cord-299560-np6nfvf2	73	19	between	between	IN
cord-299560-np6nfvf2	73	20	3	3	CD
cord-299560-np6nfvf2	73	21	mg	mg	NN
cord-299560-np6nfvf2	73	22	and	and	CC
cord-299560-np6nfvf2	73	23	225	225	CD
cord-299560-np6nfvf2	73	24	mg	mg	NNS
cord-299560-np6nfvf2	73	25	and	and	CC
cord-299560-np6nfvf2	73	26	were	be	VBD
cord-299560-np6nfvf2	73	27	well	well	RB
cord-299560-np6nfvf2	73	28	-	-	HYPH
cord-299560-np6nfvf2	73	29	tolerated	tolerate	VBN
cord-299560-np6nfvf2	73	30	without	without	IN
cord-299560-np6nfvf2	73	31	any	any	DT
cord-299560-np6nfvf2	73	32	evidence	evidence	NN
cord-299560-np6nfvf2	73	33	of	of	IN
cord-299560-np6nfvf2	73	34	kidney	kidney	NN
cord-299560-np6nfvf2	73	35	or	or	CC
cord-299560-np6nfvf2	73	36	liver	liver	NN
cord-299560-np6nfvf2	73	37	toxicity	toxicity	NN
cord-299560-np6nfvf2	73	38	.	.	.
cord-299560-np6nfvf2	74	1	RDV	RDV	NNP
cord-299560-np6nfvf2	74	2	showed	show	VBD
cord-299560-np6nfvf2	74	3	linear	linear	JJ
cord-299560-np6nfvf2	74	4	pharmacokinetics	pharmacokinetic	NNS
cord-299560-np6nfvf2	74	5	within	within	IN
cord-299560-np6nfvf2	74	6	this	this	DT
cord-299560-np6nfvf2	74	7	dose	dose	JJ
cord-299560-np6nfvf2	74	8	range	range	NN
cord-299560-np6nfvf2	74	9	and	and	CC
cord-299560-np6nfvf2	74	10	an	an	DT
cord-299560-np6nfvf2	74	11	intracellular	intracellular	JJ
cord-299560-np6nfvf2	74	12	half	half	JJ
cord-299560-np6nfvf2	74	13	-	-	HYPH
cord-299560-np6nfvf2	74	14	life	life	NN
cord-299560-np6nfvf2	74	15	of	of	IN
cord-299560-np6nfvf2	74	16	more	more	JJR
cord-299560-np6nfvf2	74	17	than	than	IN
cord-299560-np6nfvf2	74	18	35	35	CD
cord-299560-np6nfvf2	74	19	h.	h.	NN
cord-299560-np6nfvf2	74	20	Ensuing	ensue	VBG
cord-299560-np6nfvf2	74	21	multiple	multiple	JJ
cord-299560-np6nfvf2	74	22	-	-	HYPH
cord-299560-np6nfvf2	74	23	dose	dose	NN
cord-299560-np6nfvf2	74	24	infusions	infusion	NNS
cord-299560-np6nfvf2	74	25	,	,	,
cord-299560-np6nfvf2	74	26	reversible	reversible	JJ
cord-299560-np6nfvf2	74	27	aspartate	aspartate	NN
cord-299560-np6nfvf2	74	28	aminotransferase	aminotransferase	NN
cord-299560-np6nfvf2	74	29	and	and	CC
cord-299560-np6nfvf2	74	30	alanine	alanine	NN
cord-299560-np6nfvf2	74	31	transaminase	transaminase	FW
cord-299560-np6nfvf2	74	32	elevations	elevation	NNS
cord-299560-np6nfvf2	74	33	ensued	ensue	VBD
cord-299560-np6nfvf2	74	34	(	(	-LRB-
cord-299560-np6nfvf2	74	35	WHO	who	WP
cord-299560-np6nfvf2	74	36	,	,	,
cord-299560-np6nfvf2	74	37	2020b	2020b	CD
cord-299560-np6nfvf2	74	38	)	)	-RRB-
cord-299560-np6nfvf2	74	39	.	.	.
cord-299560-np6nfvf2	75	1	The	the	DT
cord-299560-np6nfvf2	75	2	dose	dose	NN
cord-299560-np6nfvf2	75	3	under	under	IN
cord-299560-np6nfvf2	75	4	investigation	investigation	NN
cord-299560-np6nfvf2	75	5	for	for	IN
cord-299560-np6nfvf2	75	6	treatment	treatment	NN
cord-299560-np6nfvf2	75	7	of	of	IN
cord-299560-np6nfvf2	75	8	COVID-19	COVID-19	NNP
cord-299560-np6nfvf2	75	9	is	be	VBZ
cord-299560-np6nfvf2	75	10	200	200	CD
cord-299560-np6nfvf2	75	11	mg	mg	NN
cord-299560-np6nfvf2	75	12	intravenously	intravenously	RB
cord-299560-np6nfvf2	75	13	(	(	-LRB-
cord-299560-np6nfvf2	75	14	IV	IV	NNP
cord-299560-np6nfvf2	75	15	)	)	-RRB-
cord-299560-np6nfvf2	75	16	on	on	IN
cord-299560-np6nfvf2	75	17	day	day	NN
cord-299560-np6nfvf2	75	18	1	1	CD
cord-299560-np6nfvf2	75	19	followed	follow	VBD
cord-299560-np6nfvf2	75	20	by	by	IN
cord-299560-np6nfvf2	75	21	100	100	CD
cord-299560-np6nfvf2	75	22	mg	mg	NNP
cord-299560-np6nfvf2	75	23	IV	IV	NNP
cord-299560-np6nfvf2	75	24	daily	daily	RB
cord-299560-np6nfvf2	75	25	for	for	IN
cord-299560-np6nfvf2	75	26	up	up	IN
cord-299560-np6nfvf2	75	27	to	to	TO
cord-299560-np6nfvf2	75	28	10	10	CD
cord-299560-np6nfvf2	75	29	days	day	NNS
cord-299560-np6nfvf2	75	30	,	,	,
cord-299560-np6nfvf2	75	31	infused	infuse	VBN
cord-299560-np6nfvf2	75	32	over	over	IN
cord-299560-np6nfvf2	75	33	30	30	CD
cord-299560-np6nfvf2	75	34	-	-	SYM
cord-299560-np6nfvf2	75	35	60	60	CD
cord-299560-np6nfvf2	75	36	min	min	NN
cord-299560-np6nfvf2	75	37	.	.	.
cord-299560-np6nfvf2	76	1	The	the	DT
cord-299560-np6nfvf2	76	2	initial	initial	JJ
cord-299560-np6nfvf2	76	3	clinical	clinical	JJ
cord-299560-np6nfvf2	76	4	use	use	NN
cord-299560-np6nfvf2	76	5	of	of	IN
cord-299560-np6nfvf2	76	6	RDV	RDV	NNP
cord-299560-np6nfvf2	76	7	was	be	VBD
cord-299560-np6nfvf2	76	8	conducted	conduct	VBN
cord-299560-np6nfvf2	76	9	by	by	IN
cord-299560-np6nfvf2	76	10	Jacob	Jacob	NNP
cord-299560-np6nfvf2	76	11	et	et	NNP
cord-299560-np6nfvf2	76	12	al	al	NNP
cord-299560-np6nfvf2	76	13	in	in	IN
cord-299560-np6nfvf2	76	14	2016	2016	CD
cord-299560-np6nfvf2	76	15	to	to	TO
cord-299560-np6nfvf2	76	16	treat	treat	VB
cord-299560-np6nfvf2	76	17	Ebola	Ebola	NNP
cord-299560-np6nfvf2	76	18	(	(	-LRB-
cord-299560-np6nfvf2	76	19	Jacobs	Jacobs	NNP
cord-299560-np6nfvf2	76	20	et	et	NNP
cord-299560-np6nfvf2	76	21	al	al	NNP
cord-299560-np6nfvf2	76	22	.	.	NNP
cord-299560-np6nfvf2	76	23	,	,	,
cord-299560-np6nfvf2	76	24	2016	2016	CD
cord-299560-np6nfvf2	76	25	)	)	-RRB-
cord-299560-np6nfvf2	76	26	,	,	,
cord-299560-np6nfvf2	76	27	followed	follow	VBN
cord-299560-np6nfvf2	76	28	by	by	IN
cord-299560-np6nfvf2	76	29	case	case	NN
cord-299560-np6nfvf2	76	30	series	series	NN
cord-299560-np6nfvf2	76	31	(	(	-LRB-
cord-299560-np6nfvf2	76	32	Holshue	Holshue	NNP
cord-299560-np6nfvf2	76	33	et	et	NNP
cord-299560-np6nfvf2	76	34	al	al	NNP
cord-299560-np6nfvf2	76	35	.	.	NNP
cord-299560-np6nfvf2	76	36	,	,	,
cord-299560-np6nfvf2	76	37	2020	2020	CD
cord-299560-np6nfvf2	76	38	;	;	:
cord-299560-np6nfvf2	76	39	Kujawski	Kujawski	NNP
cord-299560-np6nfvf2	76	40	et	et	NNP
cord-299560-np6nfvf2	76	41	al	al	NNP
cord-299560-np6nfvf2	76	42	.	.	NNP
cord-299560-np6nfvf2	76	43	,	,	,
cord-299560-np6nfvf2	76	44	2020	2020	CD
cord-299560-np6nfvf2	76	45	)	)	-RRB-
cord-299560-np6nfvf2	76	46	.	.	.
cord-299560-np6nfvf2	76	47	 	 	_SP
cord-299560-np6nfvf2	77	1	As	as	IN
cord-299560-np6nfvf2	77	2	of	of	IN
cord-299560-np6nfvf2	77	3	April	April	NNP
cord-299560-np6nfvf2	77	4	19	19	CD
cord-299560-np6nfvf2	77	5	,	,	,
cord-299560-np6nfvf2	77	6	2020	2020	CD
cord-299560-np6nfvf2	77	7	,	,	,
cord-299560-np6nfvf2	77	8	the	the	DT
cord-299560-np6nfvf2	77	9	following	follow	VBG
cord-299560-np6nfvf2	77	10	studies	study	NNS
cord-299560-np6nfvf2	77	11	are	be	VBP
cord-299560-np6nfvf2	77	12	being	be	VBG
cord-299560-np6nfvf2	77	13	conducted	conduct	VBN
cord-299560-np6nfvf2	77	14	in	in	IN
cord-299560-np6nfvf2	77	15	the	the	DT
cord-299560-np6nfvf2	77	16	United	United	NNP
cord-299560-np6nfvf2	77	17	States	States	NNP
cord-299560-np6nfvf2	77	18	using	use	VBG
cord-299560-np6nfvf2	77	19	RDV	RDV	NNP
cord-299560-np6nfvf2	77	20	to	to	TO
cord-299560-np6nfvf2	77	21	treat	treat	VB
cord-299560-np6nfvf2	77	22	covid-19	covid-19	NNP
cord-299560-np6nfvf2	77	23	(	(	-LRB-
cord-299560-np6nfvf2	77	24	ClinicalTrials.gov	ClinicalTrials.gov	NNP
cord-299560-np6nfvf2	77	25	,	,	,
cord-299560-np6nfvf2	77	26	2020	2020	CD
cord-299560-np6nfvf2	77	27	)	)	-RRB-
cord-299560-np6nfvf2	77	28	:	:	:
cord-299560-np6nfvf2	78	1	NCT04302766	NCT04302766	NNP
cord-299560-np6nfvf2	78	2	,	,	,
cord-299560-np6nfvf2	78	3	NCT04292899	NCT04292899	NNP
cord-299560-np6nfvf2	78	4	,	,	,
cord-299560-np6nfvf2	78	5	NCT04292730	NCT04292730	NNP
cord-299560-np6nfvf2	78	6	,	,	,
cord-299560-np6nfvf2	78	7	NCT04257656	NCT04257656	NNP
cord-299560-np6nfvf2	78	8	,	,	,
cord-299560-np6nfvf2	78	9	NCT04252664	NCT04252664	NNP
cord-299560-np6nfvf2	78	10	,	,	,
cord-299560-np6nfvf2	78	11	NCT04280705	NCT04280705	NNP
cord-299560-np6nfvf2	78	12	.	.	.
cord-299560-np6nfvf2	79	1	In	in	IN
cord-299560-np6nfvf2	79	2	a	a	DT
cord-299560-np6nfvf2	79	3	recent	recent	JJ
cord-299560-np6nfvf2	79	4	study	study	NN
cord-299560-np6nfvf2	79	5	published	publish	VBN
cord-299560-np6nfvf2	79	6	by	by	IN
cord-299560-np6nfvf2	79	7	the	the	DT
cord-299560-np6nfvf2	79	8	New	New	NNP
cord-299560-np6nfvf2	79	9	England	England	NNP
cord-299560-np6nfvf2	79	10	Journal	Journal	NNP
cord-299560-np6nfvf2	79	11	of	of	IN
cord-299560-np6nfvf2	79	12	Medicine	Medicine	NNP
cord-299560-np6nfvf2	79	13	,	,	,
cord-299560-np6nfvf2	79	14	investigators	investigator	NNS
cord-299560-np6nfvf2	79	15	have	have	VBP
cord-299560-np6nfvf2	79	16	used	use	VBN
cord-299560-np6nfvf2	79	17	RDV	RDV	NNP
cord-299560-np6nfvf2	79	18	on	on	IN
cord-299560-np6nfvf2	79	19	a	a	DT
cord-299560-np6nfvf2	79	20	compassionateuse	compassionateuse	NN
cord-299560-np6nfvf2	79	21	basis	basis	NN
cord-299560-np6nfvf2	79	22	to	to	IN
cord-299560-np6nfvf2	79	23	patients	patient	NNS
cord-299560-np6nfvf2	79	24	hospitalized	hospitalize	VBN
cord-299560-np6nfvf2	79	25	with	with	IN
cord-299560-np6nfvf2	79	26	Covid-19	covid-19	NN
cord-299560-np6nfvf2	79	27	.	.	.
cord-299560-np6nfvf2	79	28	Participants	participant	NNS
cord-299560-np6nfvf2	79	29	were	be	VBD
cord-299560-np6nfvf2	79	30	patients	patient	NNS
cord-299560-np6nfvf2	79	31	with	with	IN
cord-299560-np6nfvf2	79	32	confirmed	confirm	VBN
cord-299560-np6nfvf2	79	33	SARS	SARS	NNP
cord-299560-np6nfvf2	79	34	-	-	HYPH
cord-299560-np6nfvf2	79	35	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	79	36	infection	infection	NN
cord-299560-np6nfvf2	79	37	and	and	CC
cord-299560-np6nfvf2	79	38	who	who	WP
cord-299560-np6nfvf2	79	39	had	have	VBD
cord-299560-np6nfvf2	79	40	an	an	DT
cord-299560-np6nfvf2	79	41	oxygen	oxygen	NN
cord-299560-np6nfvf2	79	42	saturation	saturation	NN
cord-299560-np6nfvf2	79	43	of	of	IN
cord-299560-np6nfvf2	79	44	94	94	CD
cord-299560-np6nfvf2	79	45	%	%	NN
cord-299560-np6nfvf2	79	46	or	or	CC
cord-299560-np6nfvf2	79	47	less	less	JJR
cord-299560-np6nfvf2	79	48	in	in	IN
cord-299560-np6nfvf2	79	49	room	room	NN
cord-299560-np6nfvf2	79	50	air	air	NN
cord-299560-np6nfvf2	79	51	or	or	CC
cord-299560-np6nfvf2	79	52	who	who	WP
cord-299560-np6nfvf2	79	53	were	be	VBD
cord-299560-np6nfvf2	79	54	receiving	receive	VBG
cord-299560-np6nfvf2	79	55	oxygen	oxygen	NN
cord-299560-np6nfvf2	79	56	support	support	NN
cord-299560-np6nfvf2	79	57	.	.	.
cord-299560-np6nfvf2	80	1	Patients	patient	NNS
cord-299560-np6nfvf2	80	2	received	receive	VBD
cord-299560-np6nfvf2	80	3	a	a	DT
cord-299560-np6nfvf2	80	4	10-day	10-day	CD
cord-299560-np6nfvf2	80	5	course	course	NN
cord-299560-np6nfvf2	80	6	of	of	IN
cord-299560-np6nfvf2	80	7	RDV	RDV	NNP
cord-299560-np6nfvf2	80	8	,	,	,
cord-299560-np6nfvf2	80	9	comprising	comprise	VBG
cord-299560-np6nfvf2	80	10	of	of	IN
cord-299560-np6nfvf2	80	11	200	200	CD
cord-299560-np6nfvf2	80	12	mg	mg	NNS
cord-299560-np6nfvf2	80	13	administered	administer	VBN
cord-299560-np6nfvf2	80	14	intravenously	intravenously	RB
cord-299560-np6nfvf2	80	15	on	on	IN
cord-299560-np6nfvf2	80	16	day	day	NN
cord-299560-np6nfvf2	80	17	1	1	CD
cord-299560-np6nfvf2	80	18	,	,	,
cord-299560-np6nfvf2	80	19	ensued	ensue	VBD
cord-299560-np6nfvf2	80	20	by	by	IN
cord-299560-np6nfvf2	80	21	100	100	CD
cord-299560-np6nfvf2	80	22	mg	mg	NNP
cord-299560-np6nfvf2	80	23	daily	daily	RB
cord-299560-np6nfvf2	80	24	for	for	IN
cord-299560-np6nfvf2	80	25	the	the	DT
cord-299560-np6nfvf2	80	26	remaining	remain	VBG
cord-299560-np6nfvf2	80	27	9	9	CD
cord-299560-np6nfvf2	80	28	days	day	NNS
cord-299560-np6nfvf2	80	29	of	of	IN
cord-299560-np6nfvf2	80	30	management	management	NN
cord-299560-np6nfvf2	80	31	.	.	.
cord-299560-np6nfvf2	81	1	Overall	overall	RB
cord-299560-np6nfvf2	81	2	,	,	,
cord-299560-np6nfvf2	81	3	61	61	CD
cord-299560-np6nfvf2	81	4	patients	patient	NNS
cord-299560-np6nfvf2	81	5	were	be	VBD
cord-299560-np6nfvf2	81	6	recruited	recruit	VBN
cord-299560-np6nfvf2	81	7	but	but	CC
cord-299560-np6nfvf2	81	8	only	only	JJ
cord-299560-np6nfvf2	81	9	data	datum	NNS
cord-299560-np6nfvf2	81	10	from	from	IN
cord-299560-np6nfvf2	81	11	53	53	CD
cord-299560-np6nfvf2	81	12	patients	patient	NNS
cord-299560-np6nfvf2	81	13	were	be	VBD
cord-299560-np6nfvf2	81	14	analyzed	analyze	VBN
cord-299560-np6nfvf2	81	15	.	.	.
cord-299560-np6nfvf2	82	1	Participants	participant	NNS
cord-299560-np6nfvf2	82	2	were	be	VBD
cord-299560-np6nfvf2	82	3	from	from	IN
cord-299560-np6nfvf2	82	4	the	the	DT
cord-299560-np6nfvf2	82	5	United	United	NNP
cord-299560-np6nfvf2	82	6	States	States	NNP
cord-299560-np6nfvf2	82	7	,	,	,
cord-299560-np6nfvf2	82	8	Europe	Europe	NNP
cord-299560-np6nfvf2	82	9	,	,	,
cord-299560-np6nfvf2	82	10	Canada	Canada	NNP
cord-299560-np6nfvf2	82	11	,	,	,
cord-299560-np6nfvf2	82	12	and	and	CC
cord-299560-np6nfvf2	82	13	Japan	Japan	NNP
cord-299560-np6nfvf2	82	14	.	.	.
cord-299560-np6nfvf2	83	1	More	More	JJR
cord-299560-np6nfvf2	83	2	than	than	IN
cord-299560-np6nfvf2	83	3	50	50	CD
cord-299560-np6nfvf2	83	4	%	%	NN
cord-299560-np6nfvf2	83	5	of	of	IN
cord-299560-np6nfvf2	83	6	patients	patient	NNS
cord-299560-np6nfvf2	83	7	(	(	-LRB-
cord-299560-np6nfvf2	83	8	n	n	CC
cord-299560-np6nfvf2	83	9	¼	¼	NNP
cord-299560-np6nfvf2	83	10	30	30	CD
cord-299560-np6nfvf2	83	11	)	)	-RRB-
cord-299560-np6nfvf2	83	12	were	be	VBD
cord-299560-np6nfvf2	83	13	receiving	receive	VBG
cord-299560-np6nfvf2	83	14	mechanical	mechanical	JJ
cord-299560-np6nfvf2	83	15	ventilation	ventilation	NN
cord-299560-np6nfvf2	83	16	and	and	CC
cord-299560-np6nfvf2	83	17	almost	almost	RB
cord-299560-np6nfvf2	83	18	10	10	CD
cord-299560-np6nfvf2	83	19	%	%	NN
cord-299560-np6nfvf2	83	20	(	(	-LRB-
cord-299560-np6nfvf2	83	21	n	n	NN
cord-299560-np6nfvf2	83	22	¼	¼	NNP
cord-299560-np6nfvf2	83	23	4	4	CD
cord-299560-np6nfvf2	83	24	)	)	-RRB-
cord-299560-np6nfvf2	83	25	were	be	VBD
cord-299560-np6nfvf2	83	26	receiving	receive	VBG
cord-299560-np6nfvf2	83	27	extracorporeal	extracorporeal	JJ
cord-299560-np6nfvf2	83	28	membrane	membrane	NN
cord-299560-np6nfvf2	83	29	oxygenation	oxygenation	NN
cord-299560-np6nfvf2	83	30	.	.	.
cord-299560-np6nfvf2	84	1	On	on	IN
cord-299560-np6nfvf2	84	2	follow	follow	NN
cord-299560-np6nfvf2	84	3	-	-	HYPH
cord-299560-np6nfvf2	84	4	up	up	NN
cord-299560-np6nfvf2	84	5	(	(	-LRB-
cord-299560-np6nfvf2	84	6	median	median	JJ
cord-299560-np6nfvf2	84	7	¼18	¼18	CD
cord-299560-np6nfvf2	84	8	days	day	NNS
cord-299560-np6nfvf2	84	9	)	)	-RRB-
cord-299560-np6nfvf2	84	10	,	,	,
cord-299560-np6nfvf2	84	11	36	36	CD
cord-299560-np6nfvf2	84	12	patients	patient	NNS
cord-299560-np6nfvf2	84	13	(	(	-LRB-
cord-299560-np6nfvf2	84	14	68	68	CD
cord-299560-np6nfvf2	84	15	%	%	NN
cord-299560-np6nfvf2	84	16	)	)	-RRB-
cord-299560-np6nfvf2	84	17	had	have	VBD
cord-299560-np6nfvf2	84	18	an	an	DT
cord-299560-np6nfvf2	84	19	amelioration	amelioration	NN
cord-299560-np6nfvf2	84	20	in	in	IN
cord-299560-np6nfvf2	84	21	oxygen	oxygen	NN
cord-299560-np6nfvf2	84	22	-	-	HYPH
cord-299560-np6nfvf2	84	23	support	support	NN
cord-299560-np6nfvf2	84	24	,	,	,
cord-299560-np6nfvf2	84	25	including	include	VBG
cord-299560-np6nfvf2	84	26	17	17	CD
cord-299560-np6nfvf2	84	27	of	of	IN
cord-299560-np6nfvf2	84	28	30	30	CD
cord-299560-np6nfvf2	84	29	patients	patient	NNS
cord-299560-np6nfvf2	84	30	(	(	-LRB-
cord-299560-np6nfvf2	84	31	57	57	CD
cord-299560-np6nfvf2	84	32	%	%	NN
cord-299560-np6nfvf2	84	33	)	)	-RRB-
cord-299560-np6nfvf2	84	34	getting	get	VBG
cord-299560-np6nfvf2	84	35	mechanical	mechanical	JJ
cord-299560-np6nfvf2	84	36	ventilation	ventilation	NN
cord-299560-np6nfvf2	84	37	who	who	WP
cord-299560-np6nfvf2	84	38	were	be	VBD
cord-299560-np6nfvf2	84	39	extubated	extubate	VBN
cord-299560-np6nfvf2	84	40	.	.	.
cord-299560-np6nfvf2	85	1	Moreover	moreover	RB
cord-299560-np6nfvf2	85	2	,	,	,
cord-299560-np6nfvf2	85	3	25	25	CD
cord-299560-np6nfvf2	85	4	patients	patient	NNS
cord-299560-np6nfvf2	85	5	(	(	-LRB-
cord-299560-np6nfvf2	85	6	47	47	CD
cord-299560-np6nfvf2	85	7	%	%	NN
cord-299560-np6nfvf2	85	8	)	)	-RRB-
cord-299560-np6nfvf2	85	9	were	be	VBD
cord-299560-np6nfvf2	85	10	discharged	discharge	VBN
cord-299560-np6nfvf2	85	11	,	,	,
cord-299560-np6nfvf2	85	12	and	and	CC
cord-299560-np6nfvf2	85	13	7	7	CD
cord-299560-np6nfvf2	85	14	patients	patient	NNS
cord-299560-np6nfvf2	85	15	(	(	-LRB-
cord-299560-np6nfvf2	85	16	13	13	CD
cord-299560-np6nfvf2	85	17	%	%	NN
cord-299560-np6nfvf2	85	18	)	)	-RRB-
cord-299560-np6nfvf2	85	19	expired	expire	VBD
cord-299560-np6nfvf2	85	20	.	.	.
cord-299560-np6nfvf2	86	1	The	the	DT
cord-299560-np6nfvf2	86	2	authors	author	NNS
cord-299560-np6nfvf2	86	3	concluded	conclude	VBD
cord-299560-np6nfvf2	86	4	that	that	IN
cord-299560-np6nfvf2	86	5	use	use	VBP
cord-299560-np6nfvf2	86	6	RDV	RDV	NNP
cord-299560-np6nfvf2	86	7	,	,	,
cord-299560-np6nfvf2	86	8	led	lead	VBN
cord-299560-np6nfvf2	86	9	to	to	IN
cord-299560-np6nfvf2	86	10	clinical	clinical	JJ
cord-299560-np6nfvf2	86	11	improvement	improvement	NN
cord-299560-np6nfvf2	86	12	in	in	IN
cord-299560-np6nfvf2	86	13	36	36	CD
cord-299560-np6nfvf2	86	14	of	of	IN
cord-299560-np6nfvf2	86	15	53	53	CD
cord-299560-np6nfvf2	86	16	patients	patient	NNS
cord-299560-np6nfvf2	86	17	(	(	-LRB-
cord-299560-np6nfvf2	86	18	68	68	CD
cord-299560-np6nfvf2	86	19	%	%	NN
cord-299560-np6nfvf2	86	20	)	)	-RRB-
cord-299560-np6nfvf2	86	21	infected	infect	VBN
cord-299560-np6nfvf2	86	22	with	with	IN
cord-299560-np6nfvf2	86	23	Covid-19	covid-19	NN
cord-299560-np6nfvf2	86	24	.	.	.
cord-299560-np6nfvf2	87	1	In	in	IN
cord-299560-np6nfvf2	87	2	terms	term	NNS
cord-299560-np6nfvf2	87	3	of	of	IN
cord-299560-np6nfvf2	87	4	safety	safety	NN
cord-299560-np6nfvf2	87	5	,	,	,
cord-299560-np6nfvf2	87	6	32	32	CD
cord-299560-np6nfvf2	87	7	patients	patient	NNS
cord-299560-np6nfvf2	87	8	(	(	-LRB-
cord-299560-np6nfvf2	87	9	60	60	CD
cord-299560-np6nfvf2	87	10	%	%	NN
cord-299560-np6nfvf2	87	11	)	)	-RRB-
cord-299560-np6nfvf2	87	12	reported	report	VBD
cord-299560-np6nfvf2	87	13	adverse	adverse	JJ
cord-299560-np6nfvf2	87	14	events	event	NNS
cord-299560-np6nfvf2	87	15	during	during	IN
cord-299560-np6nfvf2	87	16	follow	follow	NN
cord-299560-np6nfvf2	87	17	-	-	HYPH
cord-299560-np6nfvf2	87	18	up	up	NN
cord-299560-np6nfvf2	87	19	.	.	.
cord-299560-np6nfvf2	88	1	The	the	DT
cord-299560-np6nfvf2	88	2	most	most	RBS
cord-299560-np6nfvf2	88	3	common	common	JJ
cord-299560-np6nfvf2	88	4	side	side	NN
cord-299560-np6nfvf2	88	5	events	event	NNS
cord-299560-np6nfvf2	88	6	were	be	VBD
cord-299560-np6nfvf2	88	7	renal	renal	JJ
cord-299560-np6nfvf2	88	8	impairment	impairment	NN
cord-299560-np6nfvf2	88	9	,	,	,
cord-299560-np6nfvf2	88	10	rash	rash	JJ
cord-299560-np6nfvf2	88	11	,	,	,
cord-299560-np6nfvf2	88	12	diarrhea	diarrhea	NN
cord-299560-np6nfvf2	88	13	,	,	,
cord-299560-np6nfvf2	88	14	increased	increase	VBN
cord-299560-np6nfvf2	88	15	hepatic	hepatic	JJ
cord-299560-np6nfvf2	88	16	enzymes	enzyme	NNS
cord-299560-np6nfvf2	88	17	,	,	,
cord-299560-np6nfvf2	88	18	and	and	CC
cord-299560-np6nfvf2	88	19	hypotension	hypotension	NN
cord-299560-np6nfvf2	88	20	.	.	.
cord-299560-np6nfvf2	89	1	Overall	overall	RB
cord-299560-np6nfvf2	89	2	,	,	,
cord-299560-np6nfvf2	89	3	side	side	NN
cord-299560-np6nfvf2	89	4	effects	effect	NNS
cord-299560-np6nfvf2	89	5	were	be	VBD
cord-299560-np6nfvf2	89	6	more	more	RBR
cord-299560-np6nfvf2	89	7	common	common	JJ
cord-299560-np6nfvf2	89	8	in	in	IN
cord-299560-np6nfvf2	89	9	patients	patient	NNS
cord-299560-np6nfvf2	89	10	on	on	IN
cord-299560-np6nfvf2	89	11	invasive	invasive	JJ
cord-299560-np6nfvf2	89	12	ventilation	ventilation	NN
cord-299560-np6nfvf2	89	13	.	.	.
cord-299560-np6nfvf2	90	1	A	a	DT
cord-299560-np6nfvf2	90	2	total	total	NN
cord-299560-np6nfvf2	90	3	of	of	IN
cord-299560-np6nfvf2	90	4	12	12	CD
cord-299560-np6nfvf2	90	5	patients	patient	NNS
cord-299560-np6nfvf2	90	6	(	(	-LRB-
cord-299560-np6nfvf2	90	7	23	23	CD
cord-299560-np6nfvf2	90	8	%	%	NN
cord-299560-np6nfvf2	90	9	)	)	-RRB-
cord-299560-np6nfvf2	90	10	had	have	VBD
cord-299560-np6nfvf2	90	11	grave	grave	JJ
cord-299560-np6nfvf2	90	12	adverse	adverse	JJ
cord-299560-np6nfvf2	90	13	events	event	NNS
cord-299560-np6nfvf2	90	14	,	,	,
cord-299560-np6nfvf2	90	15	most	most	RBS
cord-299560-np6nfvf2	90	16	commonly	commonly	RB
cord-299560-np6nfvf2	90	17	septic	septic	JJ
cord-299560-np6nfvf2	90	18	shock	shock	NN
cord-299560-np6nfvf2	90	19	,	,	,
cord-299560-np6nfvf2	90	20	multiple	multiple	JJ
cord-299560-np6nfvf2	90	21	-	-	HYPH
cord-299560-np6nfvf2	90	22	organ	organ	NN
cord-299560-np6nfvf2	90	23	-	-	HYPH
cord-299560-np6nfvf2	90	24	dysfunction	dysfunction	NN
cord-299560-np6nfvf2	90	25	syndrome	syndrome	NN
cord-299560-np6nfvf2	90	26	,	,	,
cord-299560-np6nfvf2	90	27	hypotension	hypotension	NN
cord-299560-np6nfvf2	90	28	,	,	,
cord-299560-np6nfvf2	90	29	and	and	CC
cord-299560-np6nfvf2	90	30	acute	acute	JJ
cord-299560-np6nfvf2	90	31	kidney	kidney	NN
cord-299560-np6nfvf2	90	32	injury	injury	NN
cord-299560-np6nfvf2	90	33	.	.	.
cord-299560-np6nfvf2	91	1	Four	four	CD
cord-299560-np6nfvf2	91	2	patients	patient	NNS
cord-299560-np6nfvf2	91	3	(	(	-LRB-
cord-299560-np6nfvf2	91	4	8	8	CD
cord-299560-np6nfvf2	91	5	%	%	NN
cord-299560-np6nfvf2	91	6	)	)	-RRB-
cord-299560-np6nfvf2	91	7	terminated	terminate	VBN
cord-299560-np6nfvf2	91	8	RDV	RDV	NNP
cord-299560-np6nfvf2	91	9	treatment	treatment	NN
cord-299560-np6nfvf2	91	10	prematurely	prematurely	RB
cord-299560-np6nfvf2	91	11	:	:	:
cord-299560-np6nfvf2	91	12	one	one	CD
cord-299560-np6nfvf2	91	13	because	because	IN
cord-299560-np6nfvf2	91	14	of	of	IN
cord-299560-np6nfvf2	91	15	deteriorating	deteriorate	VBG
cord-299560-np6nfvf2	91	16	of	of	IN
cord-299560-np6nfvf2	91	17	preexisting	preexisting	JJ
cord-299560-np6nfvf2	91	18	renal	renal	JJ
cord-299560-np6nfvf2	91	19	failure	failure	NN
cord-299560-np6nfvf2	91	20	,	,	,
cord-299560-np6nfvf2	91	21	one	one	CD
cord-299560-np6nfvf2	91	22	because	because	IN
cord-299560-np6nfvf2	91	23	of	of	IN
cord-299560-np6nfvf2	91	24	multiple	multiple	JJ
cord-299560-np6nfvf2	91	25	organ	organ	NN
cord-299560-np6nfvf2	91	26	failure	failure	NN
cord-299560-np6nfvf2	91	27	,	,	,
cord-299560-np6nfvf2	91	28	and	and	CC
cord-299560-np6nfvf2	91	29	two	two	CD
cord-299560-np6nfvf2	91	30	because	because	IN
cord-299560-np6nfvf2	91	31	of	of	IN
cord-299560-np6nfvf2	91	32	transaminitis	transaminitis	NN
cord-299560-np6nfvf2	91	33	,	,	,
cord-299560-np6nfvf2	91	34	including	include	VBG
cord-299560-np6nfvf2	91	35	one	one	CD
cord-299560-np6nfvf2	91	36	patient	patient	NN
cord-299560-np6nfvf2	91	37	with	with	IN
cord-299560-np6nfvf2	91	38	a	a	DT
cord-299560-np6nfvf2	91	39	maculopapular	maculopapular	JJ
cord-299560-np6nfvf2	91	40	rash	rash	JJ
cord-299560-np6nfvf2	92	1	(	(	-LRB-
cord-299560-np6nfvf2	92	2	Grein	Grein	NNP
cord-299560-np6nfvf2	92	3	et	et	NNP
cord-299560-np6nfvf2	92	4	al	al	NNP
cord-299560-np6nfvf2	92	5	.	.	NNP
cord-299560-np6nfvf2	92	6	,	,	,
cord-299560-np6nfvf2	92	7	2020	2020	CD
cord-299560-np6nfvf2	92	8	)	)	-RRB-
cord-299560-np6nfvf2	92	9	.	.	.
cord-299560-np6nfvf2	93	1	On	on	IN
cord-299560-np6nfvf2	93	2	April	April	NNP
cord-299560-np6nfvf2	93	3	29	29	CD
cord-299560-np6nfvf2	93	4	,	,	,
cord-299560-np6nfvf2	93	5	2020	2020	CD
cord-299560-np6nfvf2	93	6	,	,	,
cord-299560-np6nfvf2	93	7	the	the	DT
cord-299560-np6nfvf2	93	8	National	National	NNP
cord-299560-np6nfvf2	93	9	Institute	Institute	NNP
cord-299560-np6nfvf2	93	10	of	of	IN
cord-299560-np6nfvf2	93	11	Allergy	Allergy	NNP
cord-299560-np6nfvf2	93	12	and	and	CC
cord-299560-np6nfvf2	93	13	Infectious	Infectious	NNP
cord-299560-np6nfvf2	93	14	Diseases	Diseases	NNPS
cord-299560-np6nfvf2	93	15	(	(	-LRB-
cord-299560-np6nfvf2	93	16	NIAID	NIAID	NNP
cord-299560-np6nfvf2	93	17	)	)	-RRB-
cord-299560-np6nfvf2	93	18	,	,	,
cord-299560-np6nfvf2	93	19	published	publish	VBD
cord-299560-np6nfvf2	93	20	preliminary	preliminary	JJ
cord-299560-np6nfvf2	93	21	results	result	NNS
cord-299560-np6nfvf2	93	22	on	on	IN
cord-299560-np6nfvf2	93	23	the	the	DT
cord-299560-np6nfvf2	93	24	effect	effect	NN
cord-299560-np6nfvf2	93	25	RVD	RVD	NNP
cord-299560-np6nfvf2	93	26	on	on	IN
cord-299560-np6nfvf2	93	27	covid-19	covid-19	NNP
cord-299560-np6nfvf2	93	28	illness	illness	NN
cord-299560-np6nfvf2	93	29	.	.	.
cord-299560-np6nfvf2	94	1	The	the	DT
cord-299560-np6nfvf2	94	2	randomized	randomized	JJ
cord-299560-np6nfvf2	94	3	,	,	,
cord-299560-np6nfvf2	94	4	controlled	control	VBN
cord-299560-np6nfvf2	94	5	trial	trial	NN
cord-299560-np6nfvf2	94	6	that	that	WDT
cord-299560-np6nfvf2	94	7	was	be	VBD
cord-299560-np6nfvf2	94	8	initiated	initiate	VBN
cord-299560-np6nfvf2	94	9	on	on	IN
cord-299560-np6nfvf2	94	10	February	February	NNP
cord-299560-np6nfvf2	94	11	21	21	CD
cord-299560-np6nfvf2	94	12	,	,	,
cord-299560-np6nfvf2	94	13	2020	2020	CD
cord-299560-np6nfvf2	94	14	involved	involve	VBN
cord-299560-np6nfvf2	94	15	1063	1063	CD
cord-299560-np6nfvf2	94	16	patients	patient	NNS
cord-299560-np6nfvf2	94	17	.	.	.
cord-299560-np6nfvf2	95	1	The	the	DT
cord-299560-np6nfvf2	95	2	mortality	mortality	NN
cord-299560-np6nfvf2	95	3	rate	rate	NN
cord-299560-np6nfvf2	95	4	for	for	IN
cord-299560-np6nfvf2	95	5	the	the	DT
cord-299560-np6nfvf2	95	6	group	group	NN
cord-299560-np6nfvf2	95	7	of	of	IN
cord-299560-np6nfvf2	95	8	individuals	individual	NNS
cord-299560-np6nfvf2	95	9	who	who	WP
cord-299560-np6nfvf2	95	10	received	receive	VBD
cord-299560-np6nfvf2	95	11	RVD	RVD	NNP
cord-299560-np6nfvf2	95	12	was	be	VBD
cord-299560-np6nfvf2	95	13	8	8	CD
cord-299560-np6nfvf2	95	14	%	%	NN
cord-299560-np6nfvf2	95	15	as	as	IN
cord-299560-np6nfvf2	95	16	compared	compare	VBN
cord-299560-np6nfvf2	95	17	to	to	IN
cord-299560-np6nfvf2	95	18	11.6	11.6	CD
cord-299560-np6nfvf2	95	19	%	%	NN
cord-299560-np6nfvf2	95	20	in	in	IN
cord-299560-np6nfvf2	95	21	the	the	DT
cord-299560-np6nfvf2	95	22	placebo	placebo	NN
cord-299560-np6nfvf2	95	23	group	group	NN
cord-299560-np6nfvf2	95	24	(	(	-LRB-
cord-299560-np6nfvf2	95	25	p	p	NN
cord-299560-np6nfvf2	95	26	¼	¼	NNP
cord-299560-np6nfvf2	95	27	0.059	0.059	CD
cord-299560-np6nfvf2	95	28	)	)	-RRB-
cord-299560-np6nfvf2	95	29	.	.	.
cord-299560-np6nfvf2	96	1	For	for	IN
cord-299560-np6nfvf2	96	2	patients	patient	NNS
cord-299560-np6nfvf2	96	3	who	who	WP
cord-299560-np6nfvf2	96	4	survived	survive	VBD
cord-299560-np6nfvf2	96	5	the	the	DT
cord-299560-np6nfvf2	96	6	illness	illness	NN
cord-299560-np6nfvf2	96	7	,	,	,
cord-299560-np6nfvf2	96	8	the	the	DT
cord-299560-np6nfvf2	96	9	median	median	JJ
cord-299560-np6nfvf2	96	10	time	time	NN
cord-299560-np6nfvf2	96	11	to	to	IN
cord-299560-np6nfvf2	96	12	recovery	recovery	NN
cord-299560-np6nfvf2	96	13	was	be	VBD
cord-299560-np6nfvf2	96	14	31	31	CD
cord-299560-np6nfvf2	96	15	%	%	NN
cord-299560-np6nfvf2	96	16	quicker	quick	JJR
cord-299560-np6nfvf2	96	17	for	for	IN
cord-299560-np6nfvf2	96	18	patients	patient	NNS
cord-299560-np6nfvf2	96	19	who	who	WP
cord-299560-np6nfvf2	96	20	received	receive	VBD
cord-299560-np6nfvf2	96	21	RVD	RVD	NNP
cord-299560-np6nfvf2	96	22	compared	compare	VBN
cord-299560-np6nfvf2	96	23	with	with	IN
cord-299560-np6nfvf2	96	24	those	those	DT
cord-299560-np6nfvf2	96	25	who	who	WP
cord-299560-np6nfvf2	96	26	received	receive	VBD
cord-299560-np6nfvf2	96	27	placebo	placebo	NN
cord-299560-np6nfvf2	96	28	(	(	-LRB-
cord-299560-np6nfvf2	96	29	11	11	CD
cord-299560-np6nfvf2	96	30	vs	vs	IN
cord-299560-np6nfvf2	96	31	15	15	CD
cord-299560-np6nfvf2	96	32	days	day	NNS
cord-299560-np6nfvf2	96	33	)	)	-RRB-
cord-299560-np6nfvf2	97	1	(	(	-LRB-
cord-299560-np6nfvf2	97	2	p	p	NN
cord-299560-np6nfvf2	97	3	<	<	XX
cord-299560-np6nfvf2	97	4	0.001	0.001	CD
cord-299560-np6nfvf2	97	5	)	)	-RRB-
cord-299560-np6nfvf2	98	1	(	(	-LRB-
cord-299560-np6nfvf2	98	2	NIH	NIH	NNP
cord-299560-np6nfvf2	98	3	,	,	,
cord-299560-np6nfvf2	98	4	2020	2020	CD
cord-299560-np6nfvf2	98	5	)	)	-RRB-
cord-299560-np6nfvf2	98	6	.	.	.
cord-299560-np6nfvf2	99	1	On	on	IN
cord-299560-np6nfvf2	99	2	April	April	NNP
cord-299560-np6nfvf2	99	3	29	29	CD
cord-299560-np6nfvf2	99	4	,	,	,
cord-299560-np6nfvf2	99	5	2020	2020	CD
cord-299560-np6nfvf2	99	6	,	,	,
cord-299560-np6nfvf2	99	7	Gilead	Gilead	NNP
cord-299560-np6nfvf2	99	8	revealed	reveal	VBD
cord-299560-np6nfvf2	99	9	results	result	NNS
cord-299560-np6nfvf2	99	10	from	from	IN
cord-299560-np6nfvf2	99	11	the	the	DT
cord-299560-np6nfvf2	99	12	openlabel	openlabel	NN
cord-299560-np6nfvf2	99	13	,	,	,
cord-299560-np6nfvf2	99	14	Phase	phase	NN
cord-299560-np6nfvf2	99	15	3	3	CD
cord-299560-np6nfvf2	99	16	SIMPLE	simple	JJ
cord-299560-np6nfvf2	99	17	trial	trial	NN
cord-299560-np6nfvf2	99	18	evaluating	evaluate	VBG
cord-299560-np6nfvf2	99	19	5-day	5-day	JJ
cord-299560-np6nfvf2	99	20	and	and	CC
cord-299560-np6nfvf2	99	21	10-day	10-day	CD
cord-299560-np6nfvf2	99	22	dosing	dosing	NN
cord-299560-np6nfvf2	99	23	durations	duration	NNS
cord-299560-np6nfvf2	99	24	of	of	IN
cord-299560-np6nfvf2	99	25	the	the	DT
cord-299560-np6nfvf2	99	26	investigational	investigational	JJ
cord-299560-np6nfvf2	99	27	antiviral	antiviral	JJ
cord-299560-np6nfvf2	99	28	remdesivir	remdesivir	NNS
cord-299560-np6nfvf2	99	29	in	in	IN
cord-299560-np6nfvf2	99	30	hospitalized	hospitalize	VBN
cord-299560-np6nfvf2	99	31	patients	patient	NNS
cord-299560-np6nfvf2	99	32	with	with	IN
cord-299560-np6nfvf2	99	33	severe	severe	JJ
cord-299560-np6nfvf2	99	34	manifestations	manifestation	NNS
cord-299560-np6nfvf2	99	35	of	of	IN
cord-299560-np6nfvf2	99	36	COVID-19	covid-19	JJ
cord-299560-np6nfvf2	99	37	disease	disease	NN
cord-299560-np6nfvf2	99	38	.	.	.
cord-299560-np6nfvf2	100	1	Inclusion	inclusion	NN
cord-299560-np6nfvf2	100	2	criteria	criterion	NNS
cord-299560-np6nfvf2	100	3	was	be	VBD
cord-299560-np6nfvf2	100	4	pneumonia	pneumonia	NN
cord-299560-np6nfvf2	100	5	and	and	CC
cord-299560-np6nfvf2	100	6	reduced	reduce	VBN
cord-299560-np6nfvf2	100	7	oxygen	oxygen	NN
cord-299560-np6nfvf2	100	8	levels	level	NNS
cord-299560-np6nfvf2	100	9	that	that	WDT
cord-299560-np6nfvf2	100	10	did	do	VBD
cord-299560-np6nfvf2	100	11	not	not	RB
cord-299560-np6nfvf2	100	12	require	require	VB
cord-299560-np6nfvf2	100	13	mechanical	mechanical	JJ
cord-299560-np6nfvf2	100	14	ventilation	ventilation	NN
cord-299560-np6nfvf2	100	15	at	at	IN
cord-299560-np6nfvf2	100	16	the	the	DT
cord-299560-np6nfvf2	100	17	time	time	NN
cord-299560-np6nfvf2	100	18	of	of	IN
cord-299560-np6nfvf2	100	19	study	study	NN
cord-299560-np6nfvf2	100	20	.	.	.
cord-299560-np6nfvf2	101	1	The	the	DT
cord-299560-np6nfvf2	101	2	study	study	NN
cord-299560-np6nfvf2	101	3	showed	show	VBD
cord-299560-np6nfvf2	101	4	that	that	IN
cord-299560-np6nfvf2	101	5	patients	patient	NNS
cord-299560-np6nfvf2	101	6	who	who	WP
cord-299560-np6nfvf2	101	7	received	receive	VBD
cord-299560-np6nfvf2	101	8	a	a	DT
cord-299560-np6nfvf2	101	9	10-day	10-day	CD
cord-299560-np6nfvf2	101	10	treatment	treatment	NN
cord-299560-np6nfvf2	101	11	course	course	NN
cord-299560-np6nfvf2	101	12	of	of	IN
cord-299560-np6nfvf2	101	13	remdesivir	remdesivir	NNP
cord-299560-np6nfvf2	101	14	attained	attain	VBD
cord-299560-np6nfvf2	101	15	comparable	comparable	JJ
cord-299560-np6nfvf2	101	16	improvement	improvement	NN
cord-299560-np6nfvf2	101	17	in	in	IN
cord-299560-np6nfvf2	101	18	clinical	clinical	JJ
cord-299560-np6nfvf2	101	19	status	status	NN
cord-299560-np6nfvf2	101	20	compared	compare	VBN
cord-299560-np6nfvf2	101	21	with	with	IN
cord-299560-np6nfvf2	101	22	those	those	DT
cord-299560-np6nfvf2	101	23	taking	take	VBG
cord-299560-np6nfvf2	101	24	a	a	DT
cord-299560-np6nfvf2	101	25	5-day	5-day	JJ
cord-299560-np6nfvf2	101	26	treatment	treatment	NN
cord-299560-np6nfvf2	101	27	course	course	NN
cord-299560-np6nfvf2	101	28	(	(	-LRB-
cord-299560-np6nfvf2	101	29	Odds	Odds	NNP
cord-299560-np6nfvf2	101	30	Ratio	ratio	NN
cord-299560-np6nfvf2	101	31	:	:	:
cord-299560-np6nfvf2	101	32	0.75	0.75	CD
cord-299560-np6nfvf2	101	33	[	[	-LRB-
cord-299560-np6nfvf2	101	34	95	95	CD
cord-299560-np6nfvf2	101	35	%	%	NN
cord-299560-np6nfvf2	101	36	CI	CI	NNP
cord-299560-np6nfvf2	101	37	0.51	0.51	CD
cord-299560-np6nfvf2	101	38	-1.12	-1.12	CD
cord-299560-np6nfvf2	101	39	]	]	-RRB-
cord-299560-np6nfvf2	101	40	on	on	IN
cord-299560-np6nfvf2	101	41	Day	Day	NNP
cord-299560-np6nfvf2	101	42	14	14	CD
cord-299560-np6nfvf2	101	43	)	)	-RRB-
cord-299560-np6nfvf2	101	44	.	.	.
cord-299560-np6nfvf2	102	1	The	the	DT
cord-299560-np6nfvf2	102	2	time	time	NN
cord-299560-np6nfvf2	102	3	to	to	IN
cord-299560-np6nfvf2	102	4	clinical	clinical	JJ
cord-299560-np6nfvf2	102	5	improvement	improvement	NN
cord-299560-np6nfvf2	102	6	for	for	IN
cord-299560-np6nfvf2	102	7	50	50	CD
cord-299560-np6nfvf2	102	8	percent	percent	NN
cord-299560-np6nfvf2	102	9	of	of	IN
cord-299560-np6nfvf2	102	10	patients	patient	NNS
cord-299560-np6nfvf2	102	11	was	be	VBD
cord-299560-np6nfvf2	102	12	10	10	CD
cord-299560-np6nfvf2	102	13	days	day	NNS
cord-299560-np6nfvf2	102	14	in	in	IN
cord-299560-np6nfvf2	102	15	the	the	DT
cord-299560-np6nfvf2	102	16	5-day	5-day	JJ
cord-299560-np6nfvf2	102	17	treatment	treatment	NN
cord-299560-np6nfvf2	102	18	group	group	NN
cord-299560-np6nfvf2	102	19	and	and	CC
cord-299560-np6nfvf2	102	20	11	11	CD
cord-299560-np6nfvf2	102	21	days	day	NNS
cord-299560-np6nfvf2	102	22	in	in	IN
cord-299560-np6nfvf2	102	23	the	the	DT
cord-299560-np6nfvf2	102	24	10-day	10-day	CD
cord-299560-np6nfvf2	102	25	treatment	treatment	NN
cord-299560-np6nfvf2	102	26	group	group	NN
cord-299560-np6nfvf2	102	27	.	.	.
cord-299560-np6nfvf2	103	1	More	More	JJR
cord-299560-np6nfvf2	103	2	than	than	IN
cord-299560-np6nfvf2	103	3	50	50	CD
cord-299560-np6nfvf2	103	4	%	%	NN
cord-299560-np6nfvf2	103	5	of	of	IN
cord-299560-np6nfvf2	103	6	patients	patient	NNS
cord-299560-np6nfvf2	103	7	in	in	IN
cord-299560-np6nfvf2	103	8	both	both	DT
cord-299560-np6nfvf2	103	9	treatment	treatment	NN
cord-299560-np6nfvf2	103	10	groups	group	NNS
cord-299560-np6nfvf2	103	11	were	be	VBD
cord-299560-np6nfvf2	103	12	discharged	discharge	VBN
cord-299560-np6nfvf2	103	13	from	from	IN
cord-299560-np6nfvf2	103	14	the	the	DT
cord-299560-np6nfvf2	103	15	hospital	hospital	NN
cord-299560-np6nfvf2	103	16	by	by	IN
cord-299560-np6nfvf2	103	17	Day	Day	NNP
cord-299560-np6nfvf2	103	18	14	14	CD
cord-299560-np6nfvf2	103	19	(	(	-LRB-
cord-299560-np6nfvf2	103	20	5-day	5-day	NN
cord-299560-np6nfvf2	103	21	:	:	:
cord-299560-np6nfvf2	103	22	60.0	60.0	CD
cord-299560-np6nfvf2	103	23	%	%	NN
cord-299560-np6nfvf2	103	24	,	,	,
cord-299560-np6nfvf2	103	25	n	n	NNP
cord-299560-np6nfvf2	103	26	¼	¼	NNP
cord-299560-np6nfvf2	103	27	120/200	120/200	NNP
cord-299560-np6nfvf2	104	1	vs.10-day	vs.10-day	NNP
cord-299560-np6nfvf2	104	2	:	:	:
cord-299560-np6nfvf2	104	3	52.3	52.3	CD
cord-299560-np6nfvf2	104	4	%	%	NN
cord-299560-np6nfvf2	104	5	n	n	NN
cord-299560-np6nfvf2	104	6	¼	¼	NNP
cord-299560-np6nfvf2	104	7	103/197	103/197	CD
cord-299560-np6nfvf2	104	8	;	;	:
cord-299560-np6nfvf2	104	9	p	p	NN
cord-299560-np6nfvf2	104	10	¼	¼	CD
cord-299560-np6nfvf2	104	11	0.14	0.14	CD
cord-299560-np6nfvf2	104	12	)	)	-RRB-
cord-299560-np6nfvf2	104	13	.	.	.
cord-299560-np6nfvf2	105	1	At	at	IN
cord-299560-np6nfvf2	105	2	Day	day	NN
cord-299560-np6nfvf2	105	3	14	14	CD
cord-299560-np6nfvf2	105	4	,	,	,
cord-299560-np6nfvf2	105	5	64.5	64.5	CD
cord-299560-np6nfvf2	105	6	percent	percent	NN
cord-299560-np6nfvf2	105	7	(	(	-LRB-
cord-299560-np6nfvf2	105	8	n	n	NNP
cord-299560-np6nfvf2	105	9	¼	¼	NNP
cord-299560-np6nfvf2	105	10	129/200	129/200	NNP
cord-299560-np6nfvf2	105	11	)	)	-RRB-
cord-299560-np6nfvf2	105	12	of	of	IN
cord-299560-np6nfvf2	105	13	patients	patient	NNS
cord-299560-np6nfvf2	105	14	in	in	IN
cord-299560-np6nfvf2	105	15	the	the	DT
cord-299560-np6nfvf2	105	16	5-day	5-day	JJ
cord-299560-np6nfvf2	105	17	treatment	treatment	NN
cord-299560-np6nfvf2	105	18	group	group	NN
cord-299560-np6nfvf2	105	19	and	and	CC
cord-299560-np6nfvf2	105	20	53.8	53.8	CD
cord-299560-np6nfvf2	105	21	percent	percent	NN
cord-299560-np6nfvf2	105	22	(	(	-LRB-
cord-299560-np6nfvf2	105	23	n	n	CC
cord-299560-np6nfvf2	105	24	¼	¼	NNP
cord-299560-np6nfvf2	105	25	106/197	106/197	NNP
cord-299560-np6nfvf2	105	26	)	)	-RRB-
cord-299560-np6nfvf2	105	27	of	of	IN
cord-299560-np6nfvf2	105	28	patients	patient	NNS
cord-299560-np6nfvf2	105	29	in	in	IN
cord-299560-np6nfvf2	105	30	the	the	DT
cord-299560-np6nfvf2	105	31	10-day	10-day	CD
cord-299560-np6nfvf2	105	32	treatment	treatment	NN
cord-299560-np6nfvf2	105	33	group	group	NN
cord-299560-np6nfvf2	105	34	achieved	achieve	VBD
cord-299560-np6nfvf2	105	35	clinical	clinical	JJ
cord-299560-np6nfvf2	105	36	recovery	recovery	NN
cord-299560-np6nfvf2	105	37	.	.	.
cord-299560-np6nfvf2	106	1	The	the	DT
cord-299560-np6nfvf2	106	2	overall	overall	JJ
cord-299560-np6nfvf2	106	3	mortality	mortality	NN
cord-299560-np6nfvf2	106	4	rate	rate	NN
cord-299560-np6nfvf2	106	5	at	at	IN
cord-299560-np6nfvf2	106	6	Day	day	NN
cord-299560-np6nfvf2	106	7	14	14	CD
cord-299560-np6nfvf2	106	8	was	be	VBD
cord-299560-np6nfvf2	106	9	7	7	CD
cord-299560-np6nfvf2	106	10	percent	percent	NN
cord-299560-np6nfvf2	106	11	(	(	-LRB-
cord-299560-np6nfvf2	106	12	n	n	NN
cord-299560-np6nfvf2	106	13	¼	¼	NNP
cord-299560-np6nfvf2	106	14	23/320	23/320	CD
cord-299560-np6nfvf2	106	15	)	)	-RRB-
cord-299560-np6nfvf2	106	16	across	across	IN
cord-299560-np6nfvf2	106	17	both	both	DT
cord-299560-np6nfvf2	106	18	treatment	treatment	NN
cord-299560-np6nfvf2	106	19	groups	group	NNS
cord-299560-np6nfvf2	106	20	,	,	,
cord-299560-np6nfvf2	106	21	with	with	IN
cord-299560-np6nfvf2	106	22	64	64	CD
cord-299560-np6nfvf2	106	23	percent	percent	NN
cord-299560-np6nfvf2	106	24	(	(	-LRB-
cord-299560-np6nfvf2	106	25	n	n	NN
cord-299560-np6nfvf2	106	26	¼	¼	NNP
cord-299560-np6nfvf2	106	27	205/320	205/320	NNP
cord-299560-np6nfvf2	106	28	)	)	-RRB-
cord-299560-np6nfvf2	106	29	of	of	IN
cord-299560-np6nfvf2	106	30	patients	patient	NNS
cord-299560-np6nfvf2	106	31	showing	show	VBG
cord-299560-np6nfvf2	106	32	clinical	clinical	JJ
cord-299560-np6nfvf2	106	33	improvement	improvement	NN
cord-299560-np6nfvf2	106	34	at	at	IN
cord-299560-np6nfvf2	106	35	Day	day	NN
cord-299560-np6nfvf2	106	36	14	14	CD
cord-299560-np6nfvf2	106	37	and	and	CC
cord-299560-np6nfvf2	106	38	61	61	CD
cord-299560-np6nfvf2	106	39	percent	percent	NN
cord-299560-np6nfvf2	106	40	(	(	-LRB-
cord-299560-np6nfvf2	106	41	n	n	CC
cord-299560-np6nfvf2	106	42	¼	¼	NNP
cord-299560-np6nfvf2	106	43	196/320	196/320	CD
cord-299560-np6nfvf2	106	44	)	)	-RRB-
cord-299560-np6nfvf2	106	45	of	of	IN
cord-299560-np6nfvf2	106	46	patients	patient	NNS
cord-299560-np6nfvf2	106	47	discharged	discharge	VBN
cord-299560-np6nfvf2	106	48	from	from	IN
cord-299560-np6nfvf2	106	49	the	the	DT
cord-299560-np6nfvf2	106	50	hospital	hospital	NN
cord-299560-np6nfvf2	106	51	.	.	.
cord-299560-np6nfvf2	107	1	No	no	DT
cord-299560-np6nfvf2	107	2	unforeseen	unforeseen	JJ
cord-299560-np6nfvf2	107	3	side	side	NN
cord-299560-np6nfvf2	107	4	effects	effect	NNS
cord-299560-np6nfvf2	107	5	were	be	VBD
cord-299560-np6nfvf2	107	6	detected	detect	VBN
cord-299560-np6nfvf2	107	7	with	with	IN
cord-299560-np6nfvf2	107	8	the	the	DT
cord-299560-np6nfvf2	107	9	use	use	NN
cord-299560-np6nfvf2	107	10	of	of	IN
cord-299560-np6nfvf2	107	11	RDV	RDV	NNP
cord-299560-np6nfvf2	107	12	across	across	IN
cord-299560-np6nfvf2	107	13	either	either	DT
cord-299560-np6nfvf2	107	14	treatment	treatment	NN
cord-299560-np6nfvf2	107	15	group	group	NN
cord-299560-np6nfvf2	107	16	(	(	-LRB-
cord-299560-np6nfvf2	107	17	Gilead	Gilead	NNP
cord-299560-np6nfvf2	107	18	,	,	,
cord-299560-np6nfvf2	107	19	2020	2020	CD
cord-299560-np6nfvf2	107	20	)	)	-RRB-
cord-299560-np6nfvf2	107	21	.	.	.
cord-299560-np6nfvf2	108	1	On	on	IN
cord-299560-np6nfvf2	108	2	May	May	NNP
cord-299560-np6nfvf2	108	3	1	1	CD
cord-299560-np6nfvf2	108	4	,	,	,
cord-299560-np6nfvf2	108	5	2020	2020	CD
cord-299560-np6nfvf2	108	6	,	,	,
cord-299560-np6nfvf2	108	7	the	the	DT
cord-299560-np6nfvf2	108	8	Food	Food	NNP
cord-299560-np6nfvf2	108	9	and	and	CC
cord-299560-np6nfvf2	108	10	Drug	Drug	NNP
cord-299560-np6nfvf2	108	11	Administration	Administration	NNP
cord-299560-np6nfvf2	108	12	(	(	-LRB-
cord-299560-np6nfvf2	108	13	FDA	FDA	NNP
cord-299560-np6nfvf2	108	14	)	)	-RRB-
cord-299560-np6nfvf2	108	15	issued	issue	VBD
cord-299560-np6nfvf2	108	16	an	an	DT
cord-299560-np6nfvf2	108	17	Emergency	Emergency	NNP
cord-299560-np6nfvf2	108	18	Use	Use	NNP
cord-299560-np6nfvf2	108	19	Authorization	Authorization	NNP
cord-299560-np6nfvf2	108	20	(	(	-LRB-
cord-299560-np6nfvf2	108	21	EUA	EUA	NNP
cord-299560-np6nfvf2	108	22	)	)	-RRB-
cord-299560-np6nfvf2	108	23	for	for	IN
cord-299560-np6nfvf2	108	24	emergency	emergency	NN
cord-299560-np6nfvf2	108	25	use	use	NN
cord-299560-np6nfvf2	108	26	of	of	IN
cord-299560-np6nfvf2	108	27	RDV	RDV	NNP
cord-299560-np6nfvf2	108	28	for	for	IN
cord-299560-np6nfvf2	108	29	the	the	DT
cord-299560-np6nfvf2	108	30	treatment	treatment	NN
cord-299560-np6nfvf2	108	31	of	of	IN
cord-299560-np6nfvf2	108	32	hospitalized	hospitalize	VBN
cord-299560-np6nfvf2	108	33	2019	2019	CD
cord-299560-np6nfvf2	108	34	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	108	35	disease	disease	NN
cord-299560-np6nfvf2	108	36	(	(	-LRB-
cord-299560-np6nfvf2	108	37	COVID-19	COVID-19	NNP
cord-299560-np6nfvf2	108	38	)	)	-RRB-
cord-299560-np6nfvf2	108	39	patients	patient	NNS
cord-299560-np6nfvf2	108	40	based	base	VBN
cord-299560-np6nfvf2	108	41	on	on	IN
cord-299560-np6nfvf2	108	42	review	review	NN
cord-299560-np6nfvf2	108	43	of	of	IN
cord-299560-np6nfvf2	108	44	the	the	DT
cord-299560-np6nfvf2	108	45	topline	topline	JJ
cord-299560-np6nfvf2	108	46	data	datum	NNS
cord-299560-np6nfvf2	108	47	from	from	IN
cord-299560-np6nfvf2	108	48	the	the	DT
cord-299560-np6nfvf2	108	49	Gilead	Gilead	NNP
cord-299560-np6nfvf2	108	50	-	-	HYPH
cord-299560-np6nfvf2	108	51	sponsored	sponsor	VBN
cord-299560-np6nfvf2	108	52	open	open	JJ
cord-299560-np6nfvf2	108	53	-	-	HYPH
cord-299560-np6nfvf2	108	54	label	label	NN
cord-299560-np6nfvf2	108	55	trial	trial	NN
cord-299560-np6nfvf2	108	56	that	that	WDT
cord-299560-np6nfvf2	108	57	evaluated	evaluate	VBD
cord-299560-np6nfvf2	108	58	different	different	JJ
cord-299560-np6nfvf2	108	59	durations	duration	NNS
cord-299560-np6nfvf2	108	60	of	of	IN
cord-299560-np6nfvf2	108	61	RDV	RDV	NNP
cord-299560-np6nfvf2	108	62	(	(	-LRB-
cord-299560-np6nfvf2	108	63	NCT04292899	NCT04292899	NNP
cord-299560-np6nfvf2	108	64	)	)	-RRB-
cord-299560-np6nfvf2	108	65	,	,	,
cord-299560-np6nfvf2	108	66	and	and	CC
cord-299560-np6nfvf2	108	67	from	from	IN
cord-299560-np6nfvf2	108	68	the	the	DT
cord-299560-np6nfvf2	108	69	randomized	randomized	JJ
cord-299560-np6nfvf2	108	70	,	,	,
cord-299560-np6nfvf2	108	71	double	double	JJ
cord-299560-np6nfvf2	108	72	-	-	HYPH
cord-299560-np6nfvf2	108	73	blinded	blinded	JJ
cord-299560-np6nfvf2	108	74	,	,	,
cord-299560-np6nfvf2	108	75	placebo	placebo	NN
cord-299560-np6nfvf2	108	76	-	-	HYPH
cord-299560-np6nfvf2	108	77	controlled	control	VBN
cord-299560-np6nfvf2	108	78	trial	trial	NN
cord-299560-np6nfvf2	108	79	conducted	conduct	VBN
cord-299560-np6nfvf2	108	80	by	by	IN
cord-299560-np6nfvf2	108	81	NIAID	NIAID	NNP
cord-299560-np6nfvf2	108	82	(	(	-LRB-
cord-299560-np6nfvf2	108	83	NCT04280705	NCT04280705	NNP
cord-299560-np6nfvf2	108	84	)	)	-RRB-
cord-299560-np6nfvf2	108	85	(	(	-LRB-
cord-299560-np6nfvf2	108	86	FDA	FDA	NNP
cord-299560-np6nfvf2	108	87	,	,	,
cord-299560-np6nfvf2	108	88	2020	2020	CD
cord-299560-np6nfvf2	108	89	)	)	-RRB-
cord-299560-np6nfvf2	108	90	.	.	.
cord-299560-np6nfvf2	109	1	Remdesivir	Remdesivir	NNP
cord-299560-np6nfvf2	109	2	might	may	MD
cord-299560-np6nfvf2	109	3	be	be	VB
cord-299560-np6nfvf2	109	4	crucial	crucial	JJ
cord-299560-np6nfvf2	109	5	for	for	IN
cord-299560-np6nfvf2	109	6	ensuring	ensure	VBG
cord-299560-np6nfvf2	109	7	an	an	DT
cord-299560-np6nfvf2	109	8	efficient	efficient	JJ
cord-299560-np6nfvf2	109	9	treatment	treatment	NN
cord-299560-np6nfvf2	109	10	,	,	,
cord-299560-np6nfvf2	109	11	decrease	decrease	VB
cord-299560-np6nfvf2	109	12	mortality	mortality	NN
cord-299560-np6nfvf2	109	13	and	and	CC
cord-299560-np6nfvf2	109	14	allow	allow	VB
cord-299560-np6nfvf2	109	15	early	early	JJ
cord-299560-np6nfvf2	109	16	discharge	discharge	NN
cord-299560-np6nfvf2	109	17	in	in	IN
cord-299560-np6nfvf2	109	18	relation	relation	NN
cord-299560-np6nfvf2	109	19	to	to	TO
cord-299560-np6nfvf2	109	20	Covid-19	covid-19	VB
cord-299560-np6nfvf2	109	21	.	.	.
cord-299560-np6nfvf2	110	1	Ongoing	ongoing	JJ
cord-299560-np6nfvf2	110	2	randomized	randomized	JJ
cord-299560-np6nfvf2	110	3	,	,	,
cord-299560-np6nfvf2	110	4	placebo	placebo	NN
cord-299560-np6nfvf2	110	5	-	-	HYPH
cord-299560-np6nfvf2	110	6	controlled	control	VBN
cord-299560-np6nfvf2	110	7	trials	trial	NNS
cord-299560-np6nfvf2	110	8	are	be	VBP
cord-299560-np6nfvf2	110	9	critical	critical	JJ
cord-299560-np6nfvf2	110	10	in	in	IN
cord-299560-np6nfvf2	110	11	delineating	delineate	VBG
cord-299560-np6nfvf2	110	12	its	-PRON-	PRP$
cord-299560-np6nfvf2	110	13	efficacy	efficacy	NN
cord-299560-np6nfvf2	110	14	.	.	.
cord-299560-np6nfvf2	111	1	In	in	IN
cord-299560-np6nfvf2	111	2	silico	silico	NN
cord-299560-np6nfvf2	111	3	study	study	VBP
cord-299560-np6nfvf2	111	4	the	the	DT
cord-299560-np6nfvf2	111	5	inhibition	inhibition	NN
cord-299560-np6nfvf2	111	6	of	of	IN
cord-299560-np6nfvf2	111	7	Angiotensin	Angiotensin	NNP
cord-299560-np6nfvf2	111	8	converting	convert	VBG
cord-299560-np6nfvf2	111	9	enzyme	enzyme	NN
cord-299560-np6nfvf2	111	10	2	2	CD
cord-299560-np6nfvf2	111	11	receptor	receptor	NN
cord-299560-np6nfvf2	111	12	of	of	IN
cord-299560-np6nfvf2	111	13	COVID-19	COVID-19	NNP
cord-299560-np6nfvf2	111	14	by	by	IN
cord-299560-np6nfvf2	111	15	Ammoides	Ammoides	NNP
cord-299560-np6nfvf2	111	16	verticillata	verticillata	VBZ
cord-299560-np6nfvf2	111	17	components	component	NNS
cord-299560-np6nfvf2	111	18	harvested	harvest	VBN
cord-299560-np6nfvf2	111	19	from	from	IN
cord-299560-np6nfvf2	111	20	western	western	JJ
cord-299560-np6nfvf2	111	21	Algeria	Algeria	NNP
cord-299560-np6nfvf2	111	22	Coronavirus	Coronavirus	NNP
cord-299560-np6nfvf2	111	23	susceptibility	susceptibility	NN
cord-299560-np6nfvf2	111	24	to	to	IN
cord-299560-np6nfvf2	111	25	the	the	DT
cord-299560-np6nfvf2	111	26	antiviral	antiviral	JJ
cord-299560-np6nfvf2	111	27	remdesivir	remdesivir	NNS
cord-299560-np6nfvf2	111	28	(	(	-LRB-
cord-299560-np6nfvf2	111	29	GS-5734	GS-5734	NNP
cord-299560-np6nfvf2	111	30	)	)	-RRB-
cord-299560-np6nfvf2	111	31	is	be	VBZ
cord-299560-np6nfvf2	111	32	mediated	mediate	VBN
cord-299560-np6nfvf2	111	33	by	by	IN
cord-299560-np6nfvf2	111	34	the	the	DT
cord-299560-np6nfvf2	111	35	viral	viral	JJ
cord-299560-np6nfvf2	111	36	polymerase	polymerase	NN
cord-299560-np6nfvf2	111	37	and	and	CC
cord-299560-np6nfvf2	111	38	the	the	DT
cord-299560-np6nfvf2	111	39	proofreading	proofreading	NN
cord-299560-np6nfvf2	111	40	exoribonuclease	exoribonuclease	NN
cord-299560-np6nfvf2	111	41	Activation	Activation	NNP
cord-299560-np6nfvf2	111	42	of	of	IN
cord-299560-np6nfvf2	111	43	the	the	DT
cord-299560-np6nfvf2	111	44	SARS	SARS	NNP
cord-299560-np6nfvf2	111	45	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	111	46	spike	spike	NN
cord-299560-np6nfvf2	111	47	protein	protein	NN
cord-299560-np6nfvf2	111	48	via	via	IN
cord-299560-np6nfvf2	111	49	sequential	sequential	JJ
cord-299560-np6nfvf2	111	50	proteolytic	proteolytic	JJ
cord-299560-np6nfvf2	111	51	cleavage	cleavage	NN
cord-299560-np6nfvf2	111	52	at	at	IN
cord-299560-np6nfvf2	111	53	two	two	CD
cord-299560-np6nfvf2	111	54	distinct	distinct	JJ
cord-299560-np6nfvf2	111	55	sites	site	NNS
cord-299560-np6nfvf2	111	56	Novel	Novel	NNP
cord-299560-np6nfvf2	111	57	2019	2019	CD
cord-299560-np6nfvf2	111	58	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	111	59	structure	structure	NN
cord-299560-np6nfvf2	111	60	,	,	,
cord-299560-np6nfvf2	111	61	mechanism	mechanism	NN
cord-299560-np6nfvf2	111	62	of	of	IN
cord-299560-np6nfvf2	111	63	action	action	NN
cord-299560-np6nfvf2	111	64	,	,	,
cord-299560-np6nfvf2	111	65	antiviral	antiviral	JJ
cord-299560-np6nfvf2	111	66	drug	drug	NN
cord-299560-np6nfvf2	111	67	promises	promise	NNS
cord-299560-np6nfvf2	111	68	and	and	CC
cord-299560-np6nfvf2	111	69	rule	rule	VB
cord-299560-np6nfvf2	111	70	out	out	RP
cord-299560-np6nfvf2	111	71	against	against	IN
cord-299560-np6nfvf2	111	72	its	-PRON-	PRP$
cord-299560-np6nfvf2	111	73	treatment	treatment	NN
cord-299560-np6nfvf2	111	74	An	an	DT
cord-299560-np6nfvf2	111	75	investigation	investigation	NN
cord-299560-np6nfvf2	111	76	into	into	IN
cord-299560-np6nfvf2	111	77	the	the	DT
cord-299560-np6nfvf2	111	78	identification	identification	NN
cord-299560-np6nfvf2	111	79	of	of	IN
cord-299560-np6nfvf2	111	80	potential	potential	JJ
cord-299560-np6nfvf2	111	81	inhibitors	inhibitor	NNS
cord-299560-np6nfvf2	111	82	of	of	IN
cord-299560-np6nfvf2	111	83	SARS	SARS	NNP
cord-299560-np6nfvf2	111	84	-	-	HYPH
cord-299560-np6nfvf2	111	85	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	111	86	main	main	JJ
cord-299560-np6nfvf2	111	87	protease	protease	NN
cord-299560-np6nfvf2	111	88	using	use	VBG
cord-299560-np6nfvf2	111	89	molecular	molecular	JJ
cord-299560-np6nfvf2	111	90	docking	docking	NN
cord-299560-np6nfvf2	111	91	study	study	NN
cord-299560-np6nfvf2	111	92	Natural	natural	JJ
cord-299560-np6nfvf2	111	93	products	product	NNS
cord-299560-np6nfvf2	111	94	may	may	MD
cord-299560-np6nfvf2	111	95	interfere	interfere	VB
cord-299560-np6nfvf2	111	96	with	with	IN
cord-299560-np6nfvf2	111	97	SARS	SARS	NNP
cord-299560-np6nfvf2	111	98	-	-	HYPH
cord-299560-np6nfvf2	111	99	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	111	100	attachment	attachment	NN
cord-299560-np6nfvf2	111	101	to	to	IN
cord-299560-np6nfvf2	111	102	the	the	DT
cord-299560-np6nfvf2	111	103	host	host	NN
cord-299560-np6nfvf2	111	104	cell	cell	NN
cord-299560-np6nfvf2	111	105	SARS	SARS	NNP
cord-299560-np6nfvf2	111	106	-	-	HYPH
cord-299560-np6nfvf2	111	107	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	112	1	RNA	RNA	NNP
cord-299560-np6nfvf2	112	2	dependent	dependent	JJ
cord-299560-np6nfvf2	112	3	RNA	RNA	NNP
cord-299560-np6nfvf2	112	4	polymerase	polymerase	NN
cord-299560-np6nfvf2	112	5	(	(	-LRB-
cord-299560-np6nfvf2	112	6	RdRp	RdRp	NNP
cord-299560-np6nfvf2	112	7	)	)	-RRB-
cord-299560-np6nfvf2	112	8	targeting	target	VBG
cord-299560-np6nfvf2	112	9	:	:	:
cord-299560-np6nfvf2	113	1	An	an	DT
cord-299560-np6nfvf2	113	2	in	in	IN
cord-299560-np6nfvf2	113	3	silico	silico	NN
cord-299560-np6nfvf2	113	4	perspective	perspective	NN
cord-299560-np6nfvf2	113	5	Novel	Novel	NNP
cord-299560-np6nfvf2	113	6	guanosine	guanosine	NN
cord-299560-np6nfvf2	113	7	derivatives	derivative	NNS
cord-299560-np6nfvf2	113	8	against	against	IN
cord-299560-np6nfvf2	113	9	MERS	MERS	NNP
cord-299560-np6nfvf2	113	10	CoV	CoV	NNP
cord-299560-np6nfvf2	113	11	polymerase	polymerase	NNP
cord-299560-np6nfvf2	113	12	:	:	:
cord-299560-np6nfvf2	114	1	An	an	DT
cord-299560-np6nfvf2	114	2	in	in	IN
cord-299560-np6nfvf2	114	3	silico	silico	NN
cord-299560-np6nfvf2	114	4	perspective	perspective	NN
cord-299560-np6nfvf2	114	5	Drug	drug	NN
cord-299560-np6nfvf2	114	6	repurposing	repurpose	VBG
cord-299560-np6nfvf2	114	7	for	for	IN
cord-299560-np6nfvf2	114	8	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	114	9	(	(	-LRB-
cord-299560-np6nfvf2	114	10	COVID-19	COVID-19	NNP
cord-299560-np6nfvf2	114	11	)	)	-RRB-
cord-299560-np6nfvf2	114	12	:	:	:
cord-299560-np6nfvf2	115	1	in	in	IN
cord-299560-np6nfvf2	115	2	silico	silico	NN
cord-299560-np6nfvf2	115	3	screening	screening	NN
cord-299560-np6nfvf2	115	4	of	of	IN
cord-299560-np6nfvf2	115	5	known	know	VBN
cord-299560-np6nfvf2	115	6	drugs	drug	NNS
cord-299560-np6nfvf2	115	7	against	against	IN
cord-299560-np6nfvf2	115	8	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	115	9	3CL	3cl	CD
cord-299560-np6nfvf2	115	10	hydrolase	hydrolase	NN
cord-299560-np6nfvf2	115	11	and	and	CC
cord-299560-np6nfvf2	115	12	protease	protease	NN
cord-299560-np6nfvf2	115	13	enzymes	enzyme	NNS
cord-299560-np6nfvf2	115	14	Reverse	reverse	VBP
cord-299560-np6nfvf2	115	15	vaccinology	vaccinology	NN
cord-299560-np6nfvf2	115	16	approach	approach	NN
cord-299560-np6nfvf2	115	17	to	to	TO
cord-299560-np6nfvf2	115	18	design	design	VB
cord-299560-np6nfvf2	115	19	a	a	DT
cord-299560-np6nfvf2	115	20	novel	novel	JJ
cord-299560-np6nfvf2	115	21	multi	multi	JJ
cord-299560-np6nfvf2	115	22	-	-	JJ
cord-299560-np6nfvf2	115	23	epitope	epitope	JJ
cord-299560-np6nfvf2	115	24	vaccine	vaccine	NN
cord-299560-np6nfvf2	115	25	candidate	candidate	NN
cord-299560-np6nfvf2	115	26	against	against	IN
cord-299560-np6nfvf2	115	27	COVID-19	COVID-19	NNP
cord-299560-np6nfvf2	115	28	:	:	:
cord-299560-np6nfvf2	115	29	An	an	DT
cord-299560-np6nfvf2	115	30	in	in	IN
cord-299560-np6nfvf2	115	31	silico	silico	NN
cord-299560-np6nfvf2	115	32	study	study	NN
cord-299560-np6nfvf2	115	33	Andrographolide	Andrographolide	NNP
cord-299560-np6nfvf2	115	34	as	as	IN
cord-299560-np6nfvf2	115	35	a	a	DT
cord-299560-np6nfvf2	115	36	potential	potential	JJ
cord-299560-np6nfvf2	115	37	inhibitor	inhibitor	NN
cord-299560-np6nfvf2	115	38	of	of	IN
cord-299560-np6nfvf2	115	39	SARS	SARS	NNP
cord-299560-np6nfvf2	115	40	-	-	HYPH
cord-299560-np6nfvf2	115	41	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	115	42	main	main	JJ
cord-299560-np6nfvf2	115	43	protease	protease	NN
cord-299560-np6nfvf2	115	44	:	:	:
cord-299560-np6nfvf2	116	1	An	an	DT
cord-299560-np6nfvf2	116	2	in	in	IN
cord-299560-np6nfvf2	116	3	silico	silico	NN
cord-299560-np6nfvf2	116	4	approach	approach	NN
cord-299560-np6nfvf2	117	1	Food	Food	NNP
cord-299560-np6nfvf2	117	2	and	and	CC
cord-299560-np6nfvf2	117	3	Drug	Drug	NNP
cord-299560-np6nfvf2	117	4	Administration	Administration	NNP
cord-299560-np6nfvf2	117	5	(	(	-LRB-
cord-299560-np6nfvf2	117	6	FDA	FDA	NNP
cord-299560-np6nfvf2	117	7	)	)	-RRB-
cord-299560-np6nfvf2	117	8	Gilead	Gilead	NNP
cord-299560-np6nfvf2	117	9	announces	announce	VBZ
cord-299560-np6nfvf2	117	10	results	result	NNS
cord-299560-np6nfvf2	117	11	from	from	IN
cord-299560-np6nfvf2	117	12	phase	phase	NN
cord-299560-np6nfvf2	117	13	3	3	CD
cord-299560-np6nfvf2	117	14	trial	trial	NN
cord-299560-np6nfvf2	117	15	of	of	IN
cord-299560-np6nfvf2	117	16	investigational	investigational	JJ
cord-299560-np6nfvf2	117	17	antiviral	antiviral	JJ
cord-299560-np6nfvf2	117	18	remdesivir	remdesivir	NNS
cord-299560-np6nfvf2	117	19	in	in	IN
cord-299560-np6nfvf2	117	20	patients	patient	NNS
cord-299560-np6nfvf2	117	21	with	with	IN
cord-299560-np6nfvf2	117	22	severe	severe	JJ
cord-299560-np6nfvf2	117	23	COVID-19	covid-19	NN
cord-299560-np6nfvf2	117	24	.	.	.
cord-299560-np6nfvf2	118	1	Gilead	Gilead	NNP
cord-299560-np6nfvf2	118	2	Sciences	Sciences	NNPS
cord-299560-np6nfvf2	118	3	Remdesivir	Remdesivir	NNP
cord-299560-np6nfvf2	118	4	is	be	VBZ
cord-299560-np6nfvf2	118	5	a	a	DT
cord-299560-np6nfvf2	118	6	direct	direct	JJ
cord-299560-np6nfvf2	118	7	-	-	HYPH
cord-299560-np6nfvf2	118	8	acting	act	VBG
cord-299560-np6nfvf2	118	9	antiviral	antiviral	JJ
cord-299560-np6nfvf2	118	10	that	that	WDT
cord-299560-np6nfvf2	118	11	inhibits	inhibit	VBZ
cord-299560-np6nfvf2	118	12	RNA	rna	NN
cord-299560-np6nfvf2	118	13	-	-	HYPH
cord-299560-np6nfvf2	118	14	dependent	dependent	JJ
cord-299560-np6nfvf2	118	15	RNA	RNA	NNP
cord-299560-np6nfvf2	118	16	polymerase	polymerase	NN
cord-299560-np6nfvf2	118	17	from	from	IN
cord-299560-np6nfvf2	118	18	severe	severe	JJ
cord-299560-np6nfvf2	118	19	acute	acute	JJ
cord-299560-np6nfvf2	118	20	respiratory	respiratory	JJ
cord-299560-np6nfvf2	118	21	syndrome	syndrome	NN
cord-299560-np6nfvf2	118	22	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	118	23	2	2	CD
cord-299560-np6nfvf2	118	24	with	with	IN
cord-299560-np6nfvf2	118	25	high	high	JJ
cord-299560-np6nfvf2	118	26	potency	potency	NN
cord-299560-np6nfvf2	119	1	The	the	DT
cord-299560-np6nfvf2	119	2	antiviral	antiviral	JJ
cord-299560-np6nfvf2	119	3	compound	compound	NN
cord-299560-np6nfvf2	119	4	remdesivir	remdesivir	NNS
cord-299560-np6nfvf2	119	5	potently	potently	RB
cord-299560-np6nfvf2	119	6	inhibits	inhibit	VBZ
cord-299560-np6nfvf2	119	7	RNAdependent	RNAdependent	NNP
cord-299560-np6nfvf2	119	8	RNA	RNA	NNP
cord-299560-np6nfvf2	119	9	polymerase	polymerase	NN
cord-299560-np6nfvf2	119	10	from	from	IN
cord-299560-np6nfvf2	119	11	Middle	Middle	NNP
cord-299560-np6nfvf2	119	12	East	East	NNP
cord-299560-np6nfvf2	119	13	respiratory	respiratory	JJ
cord-299560-np6nfvf2	119	14	syndrome	syndrome	NN
cord-299560-np6nfvf2	119	15	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	119	16	Compassionate	compassionate	JJ
cord-299560-np6nfvf2	119	17	use	use	NN
cord-299560-np6nfvf2	119	18	of	of	IN
cord-299560-np6nfvf2	119	19	remdesivir	remdesivir	NNS
cord-299560-np6nfvf2	119	20	for	for	IN
cord-299560-np6nfvf2	119	21	patients	patient	NNS
cord-299560-np6nfvf2	119	22	with	with	IN
cord-299560-np6nfvf2	119	23	severe	severe	JJ
cord-299560-np6nfvf2	119	24	Covid-19	covid-19	NN
cord-299560-np6nfvf2	119	25	In	in	IN
cord-299560-np6nfvf2	119	26	-	-	HYPH
cord-299560-np6nfvf2	119	27	silico	silico	NN
cord-299560-np6nfvf2	119	28	approaches	approach	NNS
cord-299560-np6nfvf2	119	29	to	to	TO
cord-299560-np6nfvf2	119	30	detect	detect	VB
cord-299560-np6nfvf2	119	31	inhibitors	inhibitor	NNS
cord-299560-np6nfvf2	119	32	of	of	IN
cord-299560-np6nfvf2	119	33	the	the	DT
cord-299560-np6nfvf2	119	34	human	human	JJ
cord-299560-np6nfvf2	119	35	severe	severe	JJ
cord-299560-np6nfvf2	119	36	acute	acute	JJ
cord-299560-np6nfvf2	119	37	respiratory	respiratory	JJ
cord-299560-np6nfvf2	119	38	syndrome	syndrome	NN
cord-299560-np6nfvf2	119	39	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	119	40	envelope	envelope	NN
cord-299560-np6nfvf2	119	41	protein	protein	NN
cord-299560-np6nfvf2	119	42	ion	ion	NN
cord-299560-np6nfvf2	119	43	channel	channel	NN
cord-299560-np6nfvf2	120	1	A	a	DT
cord-299560-np6nfvf2	120	2	review	review	NN
cord-299560-np6nfvf2	120	3	on	on	IN
cord-299560-np6nfvf2	120	4	the	the	DT
cord-299560-np6nfvf2	120	5	cleavage	cleavage	NN
cord-299560-np6nfvf2	120	6	priming	priming	NN
cord-299560-np6nfvf2	120	7	of	of	IN
cord-299560-np6nfvf2	120	8	the	the	DT
cord-299560-np6nfvf2	120	9	spike	spike	NN
cord-299560-np6nfvf2	120	10	protein	protein	NN
cord-299560-np6nfvf2	120	11	on	on	IN
cord-299560-np6nfvf2	120	12	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	120	13	by	by	IN
cord-299560-np6nfvf2	120	14	angiotensin	angiotensin	NN
cord-299560-np6nfvf2	120	15	-	-	HYPH
cord-299560-np6nfvf2	120	16	converting	convert	VBG
cord-299560-np6nfvf2	120	17	enzyme-2	enzyme-2	NNP
cord-299560-np6nfvf2	120	18	and	and	CC
cord-299560-np6nfvf2	120	19	furin	furin	NN
cord-299560-np6nfvf2	121	1	The	the	DT
cord-299560-np6nfvf2	121	2	novel	novel	JJ
cord-299560-np6nfvf2	121	3	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	121	4	2019	2019	CD
cord-299560-np6nfvf2	121	5	(	(	-LRB-
cord-299560-np6nfvf2	121	6	2019-nCoV	2019-ncov	CD
cord-299560-np6nfvf2	121	7	)	)	-RRB-
cord-299560-np6nfvf2	121	8	uses	use	VBZ
cord-299560-np6nfvf2	121	9	the	the	DT
cord-299560-np6nfvf2	121	10	SARS	SARS	NNP
cord-299560-np6nfvf2	121	11	-	-	HYPH
cord-299560-np6nfvf2	121	12	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	121	13	receptor	receptor	NN
cord-299560-np6nfvf2	121	14	ACE2	ACE2	NNP
cord-299560-np6nfvf2	121	15	and	and	CC
cord-299560-np6nfvf2	121	16	the	the	DT
cord-299560-np6nfvf2	121	17	cellular	cellular	JJ
cord-299560-np6nfvf2	121	18	protease	protease	NN
cord-299560-np6nfvf2	121	19	TMPRSS2	TMPRSS2	NNP
cord-299560-np6nfvf2	121	20	for	for	IN
cord-299560-np6nfvf2	121	21	entry	entry	NN
cord-299560-np6nfvf2	121	22	into	into	IN
cord-299560-np6nfvf2	121	23	target	target	NN
cord-299560-np6nfvf2	121	24	cells	cell	NNS
cord-299560-np6nfvf2	122	1	First	first	JJ
cord-299560-np6nfvf2	122	2	case	case	NN
cord-299560-np6nfvf2	122	3	of	of	IN
cord-299560-np6nfvf2	122	4	2019	2019	CD
cord-299560-np6nfvf2	122	5	novel	novel	JJ
cord-299560-np6nfvf2	122	6	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	122	7	in	in	IN
cord-299560-np6nfvf2	122	8	the	the	DT
cord-299560-np6nfvf2	122	9	United	United	NNP
cord-299560-np6nfvf2	122	10	States	States	NNP
cord-299560-np6nfvf2	122	11	A	a	DT
cord-299560-np6nfvf2	122	12	molecular	molecular	JJ
cord-299560-np6nfvf2	122	13	modeling	modeling	NN
cord-299560-np6nfvf2	122	14	approach	approach	NN
cord-299560-np6nfvf2	122	15	to	to	TO
cord-299560-np6nfvf2	122	16	identify	identify	VB
cord-299560-np6nfvf2	122	17	effective	effective	JJ
cord-299560-np6nfvf2	122	18	antiviral	antiviral	JJ
cord-299560-np6nfvf2	122	19	phytochemicals	phytochemical	NNS
cord-299560-np6nfvf2	122	20	against	against	IN
cord-299560-np6nfvf2	122	21	the	the	DT
cord-299560-np6nfvf2	122	22	main	main	JJ
cord-299560-np6nfvf2	122	23	protease	protease	NN
cord-299560-np6nfvf2	122	24	of	of	IN
cord-299560-np6nfvf2	122	25	SARS	SARS	NNP
cord-299560-np6nfvf2	122	26	-	-	HYPH
cord-299560-np6nfvf2	122	27	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	123	1	Late	late	JJ
cord-299560-np6nfvf2	123	2	Ebola	Ebola	NNP
cord-299560-np6nfvf2	123	3	virus	virus	NN
cord-299560-np6nfvf2	123	4	relapse	relapse	NN
cord-299560-np6nfvf2	123	5	causing	cause	VBG
cord-299560-np6nfvf2	123	6	meningoencephalitis	meningoencephalitis	NNP
cord-299560-np6nfvf2	123	7	:	:	:
cord-299560-np6nfvf2	123	8	A	a	DT
cord-299560-np6nfvf2	123	9	case	case	NN
cord-299560-np6nfvf2	123	10	report	report	NN
cord-299560-np6nfvf2	123	11	Initiation	Initiation	NNP
cord-299560-np6nfvf2	123	12	,	,	,
cord-299560-np6nfvf2	123	13	extension	extension	NN
cord-299560-np6nfvf2	123	14	,	,	,
cord-299560-np6nfvf2	123	15	and	and	CC
cord-299560-np6nfvf2	123	16	termination	termination	NN
cord-299560-np6nfvf2	123	17	of	of	IN
cord-299560-np6nfvf2	123	18	RNA	RNA	NNP
cord-299560-np6nfvf2	123	19	synthesis	synthesis	NN
cord-299560-np6nfvf2	123	20	by	by	IN
cord-299560-np6nfvf2	123	21	a	a	DT
cord-299560-np6nfvf2	123	22	paramyxovirus	paramyxovirus	JJ
cord-299560-np6nfvf2	123	23	polymerase	polymerase	NN
cord-299560-np6nfvf2	123	24	Discovery	Discovery	NNP
cord-299560-np6nfvf2	123	25	of	of	IN
cord-299560-np6nfvf2	123	26	potential	potential	JJ
cord-299560-np6nfvf2	123	27	multi	multi	JJ
cord-299560-np6nfvf2	123	28	-	-	JJ
cord-299560-np6nfvf2	123	29	target	target	NN
cord-299560-np6nfvf2	123	30	-	-	HYPH
cord-299560-np6nfvf2	123	31	directed	direct	VBN
cord-299560-np6nfvf2	123	32	ligands	ligand	NNS
cord-299560-np6nfvf2	123	33	by	by	IN
cord-299560-np6nfvf2	123	34	targeting	target	VBG
cord-299560-np6nfvf2	123	35	host	host	NN
cord-299560-np6nfvf2	123	36	-	-	HYPH
cord-299560-np6nfvf2	123	37	specific	specific	JJ
cord-299560-np6nfvf2	123	38	SARS	SARS	NNP
cord-299560-np6nfvf2	123	39	-	-	:
cord-299560-np6nfvf2	123	40	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	123	41	structurally	structurally	RB
cord-299560-np6nfvf2	123	42	conserved	conserve	VBN
cord-299560-np6nfvf2	123	43	main	main	JJ
cord-299560-np6nfvf2	123	44	protease$	protease$	NN
cord-299560-np6nfvf2	123	45	Identification	identification	NN
cord-299560-np6nfvf2	123	46	of	of	IN
cord-299560-np6nfvf2	123	47	chymotrypsin	chymotrypsin	JJ
cord-299560-np6nfvf2	123	48	-	-	HYPH
cord-299560-np6nfvf2	123	49	like	like	JJ
cord-299560-np6nfvf2	123	50	protease	protease	NN
cord-299560-np6nfvf2	123	51	inhibitors	inhibitor	NNS
cord-299560-np6nfvf2	123	52	of	of	IN
cord-299560-np6nfvf2	123	53	SARS	SARS	NNP
cord-299560-np6nfvf2	123	54	-	-	HYPH
cord-299560-np6nfvf2	123	55	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	123	56	via	via	IN
cord-299560-np6nfvf2	123	57	integrated	integrate	VBN
cord-299560-np6nfvf2	123	58	computational	computational	JJ
cord-299560-np6nfvf2	123	59	approach	approach	NN
cord-299560-np6nfvf2	124	1	Targeting	target	VBG
cord-299560-np6nfvf2	124	2	SARS	SARS	NNP
cord-299560-np6nfvf2	124	3	-	-	HYPH
cord-299560-np6nfvf2	124	4	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	124	5	:	:	:
cord-299560-np6nfvf2	125	1	A	a	DT
cord-299560-np6nfvf2	125	2	systematic	systematic	JJ
cord-299560-np6nfvf2	125	3	drug	drug	NN
cord-299560-np6nfvf2	125	4	repurposing	repurposing	NN
cord-299560-np6nfvf2	125	5	approach	approach	NN
cord-299560-np6nfvf2	125	6	to	to	TO
cord-299560-np6nfvf2	125	7	identify	identify	VB
cord-299560-np6nfvf2	125	8	promising	promising	JJ
cord-299560-np6nfvf2	125	9	inhibitors	inhibitor	NNS
cord-299560-np6nfvf2	125	10	against	against	IN
cord-299560-np6nfvf2	125	11	3C	3c	NN
cord-299560-np6nfvf2	125	12	-	-	HYPH
cord-299560-np6nfvf2	125	13	like	like	JJ
cord-299560-np6nfvf2	125	14	proteinase	proteinase	NN
cord-299560-np6nfvf2	125	15	and	and	CC
cord-299560-np6nfvf2	125	16	2'-O	2'-o	CD
cord-299560-np6nfvf2	125	17	-	-	HYPH
cord-299560-np6nfvf2	125	18	ribose	ribose	NN
cord-299560-np6nfvf2	126	1	methyltransferase	methyltransferase	NNP
cord-299560-np6nfvf2	126	2	First	first	RB
cord-299560-np6nfvf2	126	3	12	12	CD
cord-299560-np6nfvf2	126	4	patients	patient	NNS
cord-299560-np6nfvf2	126	5	with	with	IN
cord-299560-np6nfvf2	126	6	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	126	7	disease	disease	NN
cord-299560-np6nfvf2	126	8	2019	2019	CD
cord-299560-np6nfvf2	126	9	(	(	-LRB-
cord-299560-np6nfvf2	126	10	COVID-19	COVID-19	NNP
cord-299560-np6nfvf2	126	11	)	)	-RRB-
cord-299560-np6nfvf2	126	12	in	in	IN
cord-299560-np6nfvf2	126	13	the	the	DT
cord-299560-np6nfvf2	126	14	United	United	NNP
cord-299560-np6nfvf2	126	15	States	States	NNP
cord-299560-np6nfvf2	126	16	.	.	.
cord-299560-np6nfvf2	127	1	medRxiv	medRxiv	NNP
cord-299560-np6nfvf2	127	2	Computational	computational	JJ
cord-299560-np6nfvf2	127	3	studies	study	NNS
cord-299560-np6nfvf2	127	4	of	of	IN
cord-299560-np6nfvf2	127	5	drug	drug	NN
cord-299560-np6nfvf2	127	6	repurposing	repurposing	NN
cord-299560-np6nfvf2	127	7	and	and	CC
cord-299560-np6nfvf2	127	8	synergism	synergism	NN
cord-299560-np6nfvf2	127	9	of	of	IN
cord-299560-np6nfvf2	127	10	lopinavir	lopinavir	NNS
cord-299560-np6nfvf2	127	11	,	,	,
cord-299560-np6nfvf2	127	12	oseltamivir	oseltamivir	FW
cord-299560-np6nfvf2	127	13	and	and	CC
cord-299560-np6nfvf2	127	14	ritonavir	ritonavir	NNP
cord-299560-np6nfvf2	127	15	binding	bind	VBG
cord-299560-np6nfvf2	127	16	with	with	IN
cord-299560-np6nfvf2	127	17	SARS	SARS	NNP
cord-299560-np6nfvf2	127	18	-	-	HYPH
cord-299560-np6nfvf2	127	19	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	127	20	protease	protease	NN
cord-299560-np6nfvf2	127	21	against	against	IN
cord-299560-np6nfvf2	127	22	COVID-19	COVID-19	NNP
cord-299560-np6nfvf2	127	23	Clinical	clinical	JJ
cord-299560-np6nfvf2	127	24	trial	trial	NN
cord-299560-np6nfvf2	127	25	shows	show	VBZ
cord-299560-np6nfvf2	127	26	remdesivir	remdesivir	NNP
cord-299560-np6nfvf2	127	27	accelerates	accelerate	VBZ
cord-299560-np6nfvf2	127	28	recovery	recovery	NN
cord-299560-np6nfvf2	127	29	from	from	IN
cord-299560-np6nfvf2	127	30	advanced	advanced	JJ
cord-299560-np6nfvf2	127	31	COVID-19	COVID-19	NNP
cord-299560-np6nfvf2	127	32	Peptide	Peptide	NNP
cord-299560-np6nfvf2	127	33	-	-	HYPH
cord-299560-np6nfvf2	127	34	like	like	JJ
cord-299560-np6nfvf2	127	35	and	and	CC
cord-299560-np6nfvf2	127	36	small	small	JJ
cord-299560-np6nfvf2	127	37	-	-	HYPH
cord-299560-np6nfvf2	127	38	molecule	molecule	NN
cord-299560-np6nfvf2	127	39	inhibitors	inhibitor	NNS
cord-299560-np6nfvf2	127	40	against	against	IN
cord-299560-np6nfvf2	127	41	Covid-19	Covid-19	NNP
cord-299560-np6nfvf2	127	42	COVID-2019	COVID-2019	NNP
cord-299560-np6nfvf2	128	1	:	:	:
cord-299560-np6nfvf2	128	2	Update	update	VB
cord-299560-np6nfvf2	128	3	on	on	IN
cord-299560-np6nfvf2	128	4	epidemiology	epidemiology	NN
cord-299560-np6nfvf2	128	5	,	,	,
cord-299560-np6nfvf2	128	6	disease	disease	NN
cord-299560-np6nfvf2	128	7	spread	spread	NN
cord-299560-np6nfvf2	128	8	and	and	CC
cord-299560-np6nfvf2	128	9	management	management	NN
cord-299560-np6nfvf2	129	1	In	in	IN
cord-299560-np6nfvf2	129	2	-	-	HYPH
cord-299560-np6nfvf2	129	3	silico	silico	NN
cord-299560-np6nfvf2	129	4	homology	homology	NN
cord-299560-np6nfvf2	129	5	assisted	assist	VBN
cord-299560-np6nfvf2	129	6	identification	identification	NN
cord-299560-np6nfvf2	129	7	of	of	IN
cord-299560-np6nfvf2	129	8	inhibitor	inhibitor	NN
cord-299560-np6nfvf2	129	9	of	of	IN
cord-299560-np6nfvf2	129	10	RNA	RNA	NNP
cord-299560-np6nfvf2	129	11	binding	bind	VBG
cord-299560-np6nfvf2	129	12	against	against	IN
cord-299560-np6nfvf2	129	13	2019-nCoV	2019-ncov	CD
cord-299560-np6nfvf2	129	14	N	n	CD
cord-299560-np6nfvf2	129	15	-	-	HYPH
cord-299560-np6nfvf2	129	16	protein	protein	NN
cord-299560-np6nfvf2	129	17	(	(	-LRB-
cord-299560-np6nfvf2	129	18	N	n	CD
cord-299560-np6nfvf2	129	19	terminal	terminal	NN
cord-299560-np6nfvf2	129	20	domain	domain	NN
cord-299560-np6nfvf2	129	21	)	)	-RRB-
cord-299560-np6nfvf2	130	1	Coronavirus	Coronavirus	NNP
cord-299560-np6nfvf2	130	2	envelope	envelope	NN
cord-299560-np6nfvf2	130	3	protein	protein	NN
cord-299560-np6nfvf2	130	4	:	:	:
cord-299560-np6nfvf2	130	5	Current	current	JJ
cord-299560-np6nfvf2	130	6	knowledge	knowledge	NN
cord-299560-np6nfvf2	130	7	Comparative	comparative	JJ
cord-299560-np6nfvf2	130	8	therapeutic	therapeutic	JJ
cord-299560-np6nfvf2	130	9	efficacy	efficacy	NN
cord-299560-np6nfvf2	130	10	of	of	IN
cord-299560-np6nfvf2	130	11	remdesivir	remdesivir	NNP
cord-299560-np6nfvf2	130	12	and	and	CC
cord-299560-np6nfvf2	130	13	combination	combination	NN
cord-299560-np6nfvf2	130	14	lopinavir	lopinavir	NNS
cord-299560-np6nfvf2	130	15	,	,	,
cord-299560-np6nfvf2	130	16	ritonavir	ritonavir	NNP
cord-299560-np6nfvf2	130	17	,	,	,
cord-299560-np6nfvf2	130	18	and	and	CC
cord-299560-np6nfvf2	130	19	interferon	interferon	NN
cord-299560-np6nfvf2	130	20	beta	beta	NN
cord-299560-np6nfvf2	130	21	against	against	IN
cord-299560-np6nfvf2	130	22	MERS	MERS	NNP
cord-299560-np6nfvf2	130	23	-	-	HYPH
cord-299560-np6nfvf2	130	24	CoV	CoV	NNP
cord-299560-np6nfvf2	130	25	Broad	Broad	NNP
cord-299560-np6nfvf2	130	26	-	-	HYPH
cord-299560-np6nfvf2	130	27	spectrum	spectrum	NN
cord-299560-np6nfvf2	130	28	antiviral	antiviral	JJ
cord-299560-np6nfvf2	130	29	GS-5734	GS-5734	NNS
cord-299560-np6nfvf2	131	1	inhibits	inhibit	NNS
cord-299560-np6nfvf2	131	2	both	both	DT
cord-299560-np6nfvf2	131	3	epidemic	epidemic	NN
cord-299560-np6nfvf2	131	4	and	and	CC
cord-299560-np6nfvf2	131	5	zoonotic	zoonotic	JJ
cord-299560-np6nfvf2	131	6	coronaviruses	coronaviruses	NNPS
cord-299560-np6nfvf2	131	7	Discovery	Discovery	NNP
cord-299560-np6nfvf2	131	8	and	and	CC
cord-299560-np6nfvf2	131	9	synthesis	synthesis	NN
cord-299560-np6nfvf2	131	10	of	of	IN
cord-299560-np6nfvf2	131	11	a	a	DT
cord-299560-np6nfvf2	131	12	phosphoramidate	phosphoramidate	JJ
cord-299560-np6nfvf2	131	13	prodrug	prodrug	NN
cord-299560-np6nfvf2	131	14	of	of	IN
cord-299560-np6nfvf2	131	15	a	a	DT
cord-299560-np6nfvf2	131	16	pyrrolo[2,1-f][triazin-4-amino	pyrrolo[2,1-f][triazin-4-amino	JJ
cord-299560-np6nfvf2	131	17	]	]	-RRB-
cord-299560-np6nfvf2	131	18	adenine	adenine	NN
cord-299560-np6nfvf2	131	19	C	c	NN
cord-299560-np6nfvf2	131	20	-	-	HYPH
cord-299560-np6nfvf2	131	21	nucleoside	nucleoside	NN
cord-299560-np6nfvf2	131	22	(	(	-LRB-
cord-299560-np6nfvf2	131	23	GS-5734	GS-5734	NNS
cord-299560-np6nfvf2	131	24	)	)	-RRB-
cord-299560-np6nfvf2	131	25	for	for	IN
cord-299560-np6nfvf2	131	26	the	the	DT
cord-299560-np6nfvf2	131	27	treatment	treatment	NN
cord-299560-np6nfvf2	131	28	of	of	IN
cord-299560-np6nfvf2	131	29	Ebola	Ebola	NNP
cord-299560-np6nfvf2	131	30	and	and	CC
cord-299560-np6nfvf2	131	31	emerging	emerge	VBG
cord-299560-np6nfvf2	131	32	viruses	virus	NNS
cord-299560-np6nfvf2	132	1	An	an	DT
cord-299560-np6nfvf2	132	2	in	in	IN
cord-299560-np6nfvf2	132	3	-	-	HYPH
cord-299560-np6nfvf2	132	4	silico	silico	NN
cord-299560-np6nfvf2	132	5	evaluation	evaluation	NN
cord-299560-np6nfvf2	132	6	of	of	IN
cord-299560-np6nfvf2	132	7	different	different	JJ
cord-299560-np6nfvf2	132	8	Saikosaponins	saikosaponin	NNS
cord-299560-np6nfvf2	132	9	for	for	IN
cord-299560-np6nfvf2	132	10	their	-PRON-	PRP$
cord-299560-np6nfvf2	132	11	potency	potency	NN
cord-299560-np6nfvf2	132	12	against	against	IN
cord-299560-np6nfvf2	132	13	SARS	SARS	NNP
cord-299560-np6nfvf2	132	14	-	-	HYPH
cord-299560-np6nfvf2	132	15	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	132	16	using	use	VBG
cord-299560-np6nfvf2	132	17	NSP15	nsp15	NN
cord-299560-np6nfvf2	132	18	and	and	CC
cord-299560-np6nfvf2	132	19	fusion	fusion	NN
cord-299560-np6nfvf2	132	20	spike	spike	NN
cord-299560-np6nfvf2	132	21	glycoprotein	glycoprotein	NN
cord-299560-np6nfvf2	132	22	as	as	IN
cord-299560-np6nfvf2	132	23	targets	target	NNS
cord-299560-np6nfvf2	132	24	Mechanism	Mechanism	NNP
cord-299560-np6nfvf2	132	25	of	of	IN
cord-299560-np6nfvf2	132	26	inhibition	inhibition	NN
cord-299560-np6nfvf2	132	27	of	of	IN
cord-299560-np6nfvf2	132	28	Ebola	Ebola	NNP
cord-299560-np6nfvf2	132	29	virus	virus	NN
cord-299560-np6nfvf2	132	30	RNA	rna	NN
cord-299560-np6nfvf2	132	31	-	-	HYPH
cord-299560-np6nfvf2	132	32	dependent	dependent	JJ
cord-299560-np6nfvf2	132	33	RNA	RNA	NNP
cord-299560-np6nfvf2	132	34	polymerase	polymerase	NN
cord-299560-np6nfvf2	132	35	by	by	IN
cord-299560-np6nfvf2	132	36	remdesivir	remdesivir	NNP
cord-299560-np6nfvf2	132	37	Identification	Identification	NNP
cord-299560-np6nfvf2	132	38	of	of	IN
cord-299560-np6nfvf2	132	39	new	new	JJ
cord-299560-np6nfvf2	132	40	anti	anti	JJ
cord-299560-np6nfvf2	132	41	-	-	JJ
cord-299560-np6nfvf2	132	42	nCoV	ncov	JJ
cord-299560-np6nfvf2	132	43	drug	drug	NN
cord-299560-np6nfvf2	132	44	chemical	chemical	NN
cord-299560-np6nfvf2	132	45	compounds	compound	NNS
cord-299560-np6nfvf2	132	46	from	from	IN
cord-299560-np6nfvf2	132	47	Indian	indian	JJ
cord-299560-np6nfvf2	132	48	spices	spice	NNS
cord-299560-np6nfvf2	132	49	exploiting	exploit	VBG
cord-299560-np6nfvf2	132	50	SARS	SARS	NNP
cord-299560-np6nfvf2	132	51	-	-	HYPH
cord-299560-np6nfvf2	132	52	CoV-2	CoV-2	NNP
cord-299560-np6nfvf2	132	53	main	main	JJ
cord-299560-np6nfvf2	132	54	protease	protease	NN
cord-299560-np6nfvf2	132	55	as	as	IN
cord-299560-np6nfvf2	132	56	target	target	NN
cord-299560-np6nfvf2	132	57	Stilbene	Stilbene	NNP
cord-299560-np6nfvf2	132	58	-	-	HYPH
cord-299560-np6nfvf2	132	59	based	base	VBN
cord-299560-np6nfvf2	132	60	natural	natural	JJ
cord-299560-np6nfvf2	132	61	compounds	compound	NNS
cord-299560-np6nfvf2	132	62	as	as	IN
cord-299560-np6nfvf2	132	63	promising	promising	JJ
cord-299560-np6nfvf2	132	64	drug	drug	NN
cord-299560-np6nfvf2	132	65	candidates	candidate	NNS
cord-299560-np6nfvf2	132	66	against	against	IN
cord-299560-np6nfvf2	132	67	COVID-19	COVID-19	NNP
cord-299560-np6nfvf2	132	68	Remdesivir	Remdesivir	NNP
cord-299560-np6nfvf2	132	69	and	and	CC
cord-299560-np6nfvf2	132	70	chloroquine	chloroquine	NN
cord-299560-np6nfvf2	132	71	effectively	effectively	RB
cord-299560-np6nfvf2	132	72	inhibit	inhibit	VBP
cord-299560-np6nfvf2	132	73	the	the	DT
cord-299560-np6nfvf2	132	74	recently	recently	RB
cord-299560-np6nfvf2	132	75	emerged	emerge	VBN
cord-299560-np6nfvf2	132	76	novel	novel	JJ
cord-299560-np6nfvf2	132	77	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	132	78	(	(	-LRB-
cord-299560-np6nfvf2	132	79	2019-nCoV	2019-ncov	CD
cord-299560-np6nfvf2	132	80	)	)	-RRB-
cord-299560-np6nfvf2	132	81	in	in	IN
cord-299560-np6nfvf2	132	82	vitro	vitro	FW
cord-299560-np6nfvf2	132	83	Coronavirus	Coronavirus	NNP
cord-299560-np6nfvf2	132	84	disease	disease	NN
cord-299560-np6nfvf2	132	85	2019	2019	CD
cord-299560-np6nfvf2	133	1	(	(	-LRB-
cord-299560-np6nfvf2	133	2	COVID-19	COVID-19	NNP
cord-299560-np6nfvf2	133	3	)	)	-RRB-
cord-299560-np6nfvf2	133	4	Situation	Situation	NNP
cord-299560-np6nfvf2	133	5	Report	Report	NNP
cord-299560-np6nfvf2	133	6	-89	-89	NNP
cord-299560-np6nfvf2	133	7	WHO	who	WP
cord-299560-np6nfvf2	133	8	R&D	r&d	NN
cord-299560-np6nfvf2	133	9	blueprint	blueprint	NN
cord-299560-np6nfvf2	133	10	:	:	:
cord-299560-np6nfvf2	134	1	Ad	ad	NN
cord-299560-np6nfvf2	134	2	-	-	HYPH
cord-299560-np6nfvf2	134	3	hoc	hoc	FW
cord-299560-np6nfvf2	134	4	expert	expert	NN
cord-299560-np6nfvf2	134	5	consultation	consultation	NN
cord-299560-np6nfvf2	134	6	on	on	IN
cord-299560-np6nfvf2	134	7	clinical	clinical	JJ
cord-299560-np6nfvf2	134	8	trials	trial	NNS
cord-299560-np6nfvf2	134	9	for	for	IN
cord-299560-np6nfvf2	134	10	Ebola	Ebola	NNP
cord-299560-np6nfvf2	134	11	therapeutics	therapeutic	NNS
cord-299560-np6nfvf2	134	12	Cryo	Cryo	NNP
cord-299560-np6nfvf2	134	13	-	-	HYPH
cord-299560-np6nfvf2	134	14	EM	EM	NNP
cord-299560-np6nfvf2	134	15	structure	structure	NN
cord-299560-np6nfvf2	134	16	of	of	IN
cord-299560-np6nfvf2	134	17	the	the	DT
cord-299560-np6nfvf2	134	18	2019-nCoV	2019-ncov	CD
cord-299560-np6nfvf2	134	19	spike	spike	NN
cord-299560-np6nfvf2	134	20	in	in	IN
cord-299560-np6nfvf2	134	21	the	the	DT
cord-299560-np6nfvf2	134	22	prefusion	prefusion	NN
cord-299560-np6nfvf2	134	23	conformation	conformation	NNP
cord-299560-np6nfvf2	134	24	Fusion	Fusion	NNP
cord-299560-np6nfvf2	134	25	mechanism	mechanism	NN
cord-299560-np6nfvf2	134	26	of	of	IN
cord-299560-np6nfvf2	134	27	2019-nCoV	2019-ncov	CD
cord-299560-np6nfvf2	134	28	and	and	CC
cord-299560-np6nfvf2	134	29	fusion	fusion	NN
cord-299560-np6nfvf2	134	30	inhibitors	inhibitor	NNS
cord-299560-np6nfvf2	134	31	targeting	target	VBG
cord-299560-np6nfvf2	134	32	HR1	HR1	NNP
cord-299560-np6nfvf2	134	33	domain	domain	NN
cord-299560-np6nfvf2	134	34	in	in	IN
cord-299560-np6nfvf2	134	35	spike	spike	NN
cord-299560-np6nfvf2	134	36	protein	protein	NN
cord-299560-np6nfvf2	135	1	A	a	DT
cord-299560-np6nfvf2	135	2	novel	novel	JJ
cord-299560-np6nfvf2	135	3	coronavirus	coronavirus	NN
cord-299560-np6nfvf2	135	4	from	from	IN
cord-299560-np6nfvf2	135	5	patients	patient	NNS
cord-299560-np6nfvf2	135	6	with	with	IN
cord-299560-np6nfvf2	135	7	pneumonia	pneumonia	NN
cord-299560-np6nfvf2	135	8	in	in	IN
cord-299560-np6nfvf2	135	9	China	China	NNP
cord-299560-np6nfvf2	135	10	Special	special	JJ
cord-299560-np6nfvf2	135	11	appreciation	appreciation	NN
cord-299560-np6nfvf2	135	12	for	for	IN
cord-299560-np6nfvf2	135	13	architect	architect	NN
cord-299560-np6nfvf2	135	14	Riad	Riad	NNP
cord-299560-np6nfvf2	135	15	Younes	Younes	NNP
cord-299560-np6nfvf2	135	16	for	for	IN
cord-299560-np6nfvf2	135	17	developing	develop	VBG
cord-299560-np6nfvf2	135	18	the	the	DT
cord-299560-np6nfvf2	135	19	figures	figure	NNS
cord-299560-np6nfvf2	135	20	.	.	.
cord-299560-np6nfvf2	136	1	The	the	DT
cord-299560-np6nfvf2	136	2	authors	author	NNS
cord-299560-np6nfvf2	136	3	have	have	VBP
cord-299560-np6nfvf2	136	4	no	no	DT
cord-299560-np6nfvf2	136	5	potential	potential	JJ
cord-299560-np6nfvf2	136	6	conflicts	conflict	NNS
cord-299560-np6nfvf2	136	7	of	of	IN
cord-299560-np6nfvf2	136	8	interest	interest	NN
cord-299560-np6nfvf2	136	9	relevant	relevant	JJ
cord-299560-np6nfvf2	136	10	to	to	IN
cord-299560-np6nfvf2	136	11	this	this	DT
cord-299560-np6nfvf2	136	12	article	article	NN
cord-299560-np6nfvf2	136	13	to	to	TO
cord-299560-np6nfvf2	136	14	disclose	disclose	VB
cord-299560-np6nfvf2	136	15	.	.	.
cord-299560-np6nfvf2	137	1	The	the	DT
cord-299560-np6nfvf2	137	2	authors	author	NNS
cord-299560-np6nfvf2	137	3	have	have	VBP
cord-299560-np6nfvf2	137	4	no	no	DT
cord-299560-np6nfvf2	137	5	financial	financial	JJ
cord-299560-np6nfvf2	137	6	relationships	relationship	NNS
cord-299560-np6nfvf2	137	7	relevant	relevant	JJ
cord-299560-np6nfvf2	137	8	to	to	IN
cord-299560-np6nfvf2	137	9	this	this	DT
cord-299560-np6nfvf2	137	10	article	article	NN
cord-299560-np6nfvf2	137	11	to	to	TO
cord-299560-np6nfvf2	137	12	disclose	disclose	VB
cord-299560-np6nfvf2	137	13	.	.	.